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Abstract 
Chromosome segregation is a complex, but subsequently error- prone process, 
who’s accuracy is essential to prevent uneven DNA distribution between mother 
and daughter cells. Such unequal chromosome segregation can often result in 
aneuploidy, which is a prevalent phenotype of cancer cells, and so surveillance 
mechanisms must exist within the cell cycle to detect and correct the cause of 
such chromosome division errors, before allowing the cell to divide. 
The Spindle Assembly Checkpoint (SAC) has evolved to monitor the interaction 
between microtubules, and the point at which they attach sister chromosomes, 
the kinetochore. By detecting attachment and resulting tension abnormalities, 
the SAC halts the metaphase to anaphase transition if chromosomes are not 
aligned correctly at the metaphase plate. By disallowing cell division to occur in 
the absence of proper chromosome alignment, the SAC minimises the 
frequency of uneven DNA distribution and the consequent problems this can 
incur. Silencing of the SAC, and normal cell progression is not promoted until 
correction mechanisms have achieved proper bioriented chromosome 
attachments.    
The target of the SAC is widely accepted to be Cell Division Cycle 20 (Cdc20), 
which is the activator of the Anaphase Promoting Complex or Cyclosome 
(APC/C), the E3 ubiquitin ligase that drives cells into anaphase. By inhibiting 
Cdc20, the activity of the APC/C is halted, and cells are arrested at metaphase. 
A number of key proteins are believed to be involved in the sequestration of 
Cdc20, by incorporating it into an inhibitory Mitotic Checkpoint Complex (MCC). 
This MCC complex is believed to comprise of Cdc20, BubR1, Bub1 and Mad2, 
although there is speculation as to whether Mad2 is part of the complex, or 
merely promotes its formation.  
The proteins involved in the MCC all localise to kinetochores with activation of 
the SAC, although it remains unclear as to whether the MCC forms at the 
kinetochore upon localisation of the various components, or can form in part or 
as a whole, moving to kinetochores upon SAC activation. Sub-complexes of the 
MCC have been detected outside of mitosis, which provide evidence in favour 
of a kinetochore-independent MCC formation. However, if this were the case, it 
could be assumed that modification (such as phosphorylation) to either MCC 
components or the APC/C itself would need to occur in mitosis or with SAC 
activation, allowing for APC/C inhibition only with SAC activation, and to prevent 
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non-specific inhibition of APC/C by the MCC elsewhere in the cell cycle. These 
issues still remain unclear.   
In order to investigate further, the requirement of direct kinetochore localisation 
of MCC components in the formation of the complex, this thesis aims to provide 
evidence of the effect of disrupting such kinetochore localisation upon 
checkpoint function, as well as the impact of removal of Cdc20 modifications on 
MCC formation. In addition to this, the protein-protein interaction domains 
between Cdc20 and BubR1, proven essential for SAC function, are investigated 
within Drosophila melanogaster. 
Collectively, the data in this thesis provides an insight into the regulation of SAC 
in Drosophila. The Cdk1/Cyclin B phosphorylation of Fizzy (the Drosophila 
homologue of Cdc20) is confirmed to have an effect on MCC formation, and can 
be mapped to three specific sites on the N-terminal of Fizzy, which are 
conserved across various species. In addition to the effect of Cdk1/Cyclin B 
phosphorylation on the interaction between Fizzy and other SAC proteins, the 
importance of the BubR1 KEN box motif on the Fizzy-BubR1-Mad2 interaction 
is confirmed, implicating another essential domain for MCC formation in 
Drosophila. With regard to kinetochore localisation of SAC components, a 
model is achieved in which a dramatic reduction of Mps1, previously shown to 
disturb kinetochore localisation of Mad1, Mad2 and BubR1 in Xenopus, 
confirms a role for Mad2 kinetochore localisation in SAC activation, even though 
Fizzy localisation is unperturbed. Overall, these findings may provide a useful 
insight into the complex relationships, kinetochore localisation requirements and 
inter-protein dependencies within the regulation of MCC formation and SAC 
signalling in Drosophila melanogaster.   
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Chapter 1.  Introduction 
1.1. Normal Cell Cycle Progression 
The primary function of the cell cycle is to accurately duplicate chromosomal 
DNA and segregate the copied DNA into two genetically identical daughter 
cells. These two processes define the major phases of the mammalian cell 
cycle; S phase (or synthesis phase), and M phase (Mitosis). Mitosis itself 
consists of nuclear division (true mitosis) brought about by the complex 
machinery of the mitotic spindle, and cytoplasmic division (cytokinesis). Within 
the cell cycle, two major checkpoints exist, to prevent cell progression in the 
presence of DNA damage and to prevent the onset of anaphase in the 
presence of misaligned chromosomes.  
1.1.1.  M Phase 
M phase is comprised of 5 principle stages (Alberts et al., 2002) beginning with 
Prophase. Here, the replicated chromosomes condense and the mitotic spindle 
assembles outside of the nucleus, between the two centrosomes. 
Prometaphase then begins with nuclear envelope breakdown, allowing 
chromosomes to attach spindle microtubules via kinetochores. The 
chromosomes are then aligned at the spindle equator, between the spindle 
poles and sister chromatids and are attached to opposite poles of the spindle 
via kinetochore microtubules. This phase is referred to as metaphase. During 
the fourth phase of mitosis, anaphase, the sister chromatids are separated into 
the two sister chromatids, kinetochore microtubules shorten and spindle poles 
move apart to bring about chromosome segregation. The cell then moves into 
telophase, where the two sets of daughter chromosomes reach opposite poles 
of the cell and once there, condense. At this stage a new nuclear envelope 
forms around each set of segregated chromosomes, completing the formation 
of two daughter nuclei containing a diploid complement of chromosomes 
identical to that of the parent cell, marking the completion of mitosis. Following 
mitosis, the final stage of cell division is cytokinesis, or division of the 
cytoplasm, which "pinches" the cell into two independent cells each with their 
own identical nuclei. This series of events must always proceed in the stated 
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order, and mechanisms exist to ensure that the cell cycle cannot continue to the 
next stage without successful completion of the previous stage (figure 1.1). 
 
 
 
Figure 1.1. An overview of M phase and cytokinesis. 
 
During early mitosis, the pairs of sister chromatids are attached to the mitotic 
spindle by microtubules. By mid-mitosis or metaphase, each of the pair of sister 
chromatids are attached to separate microtubules, originating from opposite 
poles of the spindle, with sister chromatid cohesion destroyed during anaphase, 
whereby microtubules pull the separated chromosomes to opposite ends of the 
cell. The two sets of chromosomes are packaged into two daughter nuclei, with 
constriction of the cytoplasm and deposition of a new membrane during 
cytokinesis marking the end of the cell cycle. Image taken from: 
http://www.le.ac.uk/ge/genie/vgec/he/cellcycle.html.  
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1.2.     Introduction to the Mitotic Spindle Assembly Checkpoint 
Referred to as the "guardian of the genome" (Iwanaga and Jeang, 2002) the 
spindle assembly checkpoint (SAC) ensures that all chromosomes are properly 
aligned at the metaphase plate before the cell cycle is allowed to progress to 
anaphase. This ensures that premature sister chromatid separation is avoided, 
and so daughter cells receive an equal and identical chromosome compliment. 
So why is this checkpoint so important? Chromosome instability and aneuploidy 
(abnormal chromosome number) has profound effects (Hassold and Hunt, 
2001) and is linked to various cancers (Yuen et al., 2005). The SAC is critical in 
the preservation of euploidy (normal chromosome number), loss of which is a 
common characteristic of cancer cells, contributing to their malignant 
progression (Weaver and Cleveland, 2006; Weaver et al., 2006). Loss or 
downregulation of SAC components have been reported in a number of cancer 
cell lines. An example of such a component is the SAC protein Mad2. Mutation 
of SAC component Mad2 has been linked to diseases including gastric cancer 
(Kim et al., 2005) and has been found to be downregulated in cancer cell lines. 
With links between kinetochore dysfunction and cancer (Li and Benezra, 1996), 
the importance of the SAC in human disease is becoming ever more apparent.  
SAC components are commonly being researched as potential gene therapy 
targets where downregulated in cancer cell lines (Morozov et al., 2007) , as well 
as targets for anti-tumour therapies due to the lethality of cells with complete 
loss of checkpoint function (Kops et al., 2005).  
1.2.1. Initial implications into the existence of a mitotic spindle assembly 
checkpoint by the identification of Mads and Bubs. 
In 1991, two groups (lead by Andrew Murray and Andrew Hoyt) set out to 
isolate mutations in budding yeast, defective on any feedback mechanism 
preventing cells leaving mitosis until an intact spindle is present. The data they 
published identified two key groups of mutations, mad and bub, and resulted in 
the first implication of a mitotic checkpoint related to the dependency of 
microtubule function in mitotic exit.  
(Li and Murray, 1991) isolated five mutants in Saccharomyces cerevisiae, 
mapped to three loci, named Mitotic Arrest Deficiency (mad) to reflect the 
progression of the mutants through mitosis whether or not a spindle is present 
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(and therefore, in the presence of unattached kinetochores). The mad mutants 
were shown to die at the end of nuclear division, presumably whilst attempting 
to segregate their chromosomes in the absence of a functional spindle. The 
technique they employed, utilised their understanding that a protein kinase, 
called Maturation Promoting Factor (MPF), regulates mitotic entry and induces 
mitotic spindle assembly. Benomyl (which inhibits microtubule polymerisation) 
was used to slow down microtubule assembly in mad mutants, allowing them 
more time to assemble their spindle. By observing activated MPF in mad cells 
as they progress through the cell cycle under this treatment, they showed that 
MPF levels in these mutants failed to stabilise. The consequence of this was 
decreased MPF levels pushing mad cells towards mitotic exit, regardless of 
their non-functional mitotic spindle. Premature mitotic exit in the presence of 
Benomyl resulted in cell death. The properties of these mad mutants, including 
the requirement of cells to pass through mitosis to be killed by Benomyl and the 
ability to override Benomyl-induced death using independent methods to delay 
mitotic exit, implicates that mad mutants are defective in a feedback control 
mechanism, now understood to be the SAC.  
In addition to the work carried out by Li and Murray (1991), (Hoyt et al., 1991) 
used a similar approach (also in yeast), screening with Benzymidazole (a 
Benomyl-related compound) to isolate three mutants in which budding was 
uninhibited. The Budding Uninhibited by Benzymidazole mutants, named bub, 
proceeded to the next cell cycle stage to replicate their DNA and duplicate their 
spindle, despite unsuccessful completion of mitosis.  By crossing bub mutants 
into an α-tubulin mutant, in order to replace chemical microtubule disruption with 
genetic disruption, they confirmed that the phenotype displayed by these 
mutants was microtubule-specific. They also demonstrated that this microtubule 
disruption alone was not sufficient to cause cell death. As with the mad mutants, 
cells were also required to progress through the cell cycle in order for lethality to 
incur. Also in accordance with results observed in mad mutants, the regulation 
of MPF activity was also affected in bub strains.  
The identification of mad and bub mutants was the first time that the existence 
of a mitotic spindle assembly checkpoint, linked to MPF activity, was implied. At 
this time, many key SAC proteins had yet to be discovered, and so the 
understanding into the mechanisms by which Mad and Bub proteins may 
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regulate MPF was unclear. Subsequent studies into these proteins has lead to 
our current understanding of SAC components including Mad1, Mad2, Bub1, 
Bub3 and Bub-Related kinase 1 (BubR1), and provided a platform for the 
development of current models of spindle assembly checkpoint regulation of the 
metaphase to anaphase transition in mitosis.  
 
Drosophila H . sapiens X . leavis S. cerevisiae S. pombe 
Fizzy Cdc20 Cdc20 Cdc20 Cdc20 
BubR1 BubR1 BubR1 Mad3 Mad3 
Mad2 Mad2 Mad2 Mad2 Mad2 
Ald Mps1 Mps1 Mps1 Mps1 
 
Table 1.1. Key spindle checkpoint homologues.  
 
Table showing the key Drosophila checkpoint protein names and their 
homologues in humans, Xenopus, and yeast. 
 
1.3. The DNA Damage Checkpoint: A Brief Overview 
The DNA damage response, or DNA damage checkpoint, acts at G1/S as well 
as within S-phase and G2/M (but not in mitosis) to block the cell cycle in the 
presence of any potentially lethal genetic errors which may result from 
chromosomal DNA damage. A highly conserved surveillance mechanism 
triggers a cascade of events which coordinate the repair of the detected lesion 
with cell cycle arrest. The checkpoint is only satisfied once the offending lesion 
has been successfully removed and repaired. Failure of the cell to detect DNA 
damage can have catastrophic effects, and has been linked to increased cancer 
susceptibility. 
DNA damage can present itself in various forms. The nucleotides of DNA are 
continuously subject to modification by hydrolysis and oxidation reactions, these 
can lead to the introduction of genetic error of a number of types. External 
environmental factors can also contribute to genetic modification, such as 
exposure to ultraviolet (UV) radiation (Sancar and Reardon, 2004). 
Alterations in DNA structure most commonly affect one DNA strand at a given 
site, resulting in a single strand break (ssb), however, it is possible for both 
strands of the DNA to be disrupted, resulting in a double strand break (dsb). 
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Because breaks in DNA are capable of fragmenting chromosomes and can 
often lead to chromosomal rearrangements if the DNA repair machinery 
accidently fuses broken DNA ends from different chromosomes, they are 
potentially very harmful and so must be repaired. 
The DNA damage checkpoint does not respond to all genetic errors within 
chromosomal DNA, it only becomes active when the normal routes of DNA 
repair are unable rectify the problem, or the damage has caused replication 
forks to stall and produce abnormal DNA structures. In eukaryotes the DNA 
damage response is under the control of two members of the phosphoinositide 
three-kinase-related kinase family (PIKK) (Zhang et al., 2006), ATM and ATR 
(Lovejoy and Cortez, 2009; Cimprich and Cortez, 2008; Barr et al., 2003). 
ATM is specialised to the repair of double-strand breaks (dsb), and its activation 
is required for checkpoint activation in response to these breaks (Pereg et al., 
2006; Shiloh, 2003). ATR is also required for checkpoint activation in response 
to dsbs, but is also responsible for a number of other responses, such as those 
to nucleotide damage (ssbs) and stalled replication forks (Zhang et al., 2006). 
The specific recruitment of either ATM or ATR to sites of DNA damage is 
believed to be due to their localisation requiring different proteins or complexes. 
In the case of ATR, recruitment is believed to be via a protein named RPA, 
whereas ATM recruitment to dsbs is believed to be in response to its activation 
by binding of the MRN complex (Jazayeri et al., 2006) Once recruited, the ATM 
and ATR can initiate the DNA damage response, halting the cell cycle and 
initiating the relevant repair mechanisms. 
Simple nucleotide alterations (single strand breaks) can be repaired by two 
systems; the first is base excision repair (BER) the second system is nucleotide 
excision repair. Double stranded breaks can be repaired by two mechanisms, 
non-homologous end joining (NHEJ) and homologous recombination. If repair 
mechanisms are unable to rectify DNA damage, the block on cell cycle 
progression may never be lifted, or more commonly, the cell will be subject to 
death by apoptosis.   
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1.4. The Eukaryotic cell cycle is highly ordered and tightly regulated 
The cell cycle consists of a highly ordered sequence of biochemical events, 
triggered in a specific order and at specific time points. This control system is 
tightly regulated by a number of key components, mainly the cyclin-dependent 
kinases (Cdks). These biochemical switches control the transitions of the cell 
cycle through three main phases; cell cycle start, defining entry into the cycle at 
late G1 phase, and the two cell cycle checkpoints; the G2/M checkpoint 
(controlling entry into mitosis), and the spindle assembly checkpoint (SAC) 
which controls the metaphase to anaphase transition.  
1.4.1.   An Introduction to Cyclin-Dependent kinases  
Cdks are small serine/threonine heterodimeric protein kinases that require 
association with a cyclin subunit for their activation. The kinase is inactive when 
it is not bound to its cyclin subunit, with the kinase activation site actively 
blocked in the absence of cyclin (De Bondt et al., 1993). Once bound, cyclin-
Cdk must also undergo phosphorylation of a particular threonine residue of the 
kinase subunit activation loop (specific to each individual kinase) which is also 
required for its full activation (Zhang et al., 1998). Cyclin-Cdk dimers are 
relatively stable, with dissociation of those tested displaying half-lives of up to a 
number of h (Kobayashi et al., 1994). Each cyclin-Cdk complex promotes the 
activation of the next in sequence, maintaining the highly ordered fashion of the 
cycle. In most cases the concentration of kinase subunit is relatively constant 
throughout the cell cycle, whereas the concentration of the cyclin subunit 
oscillates, with this changing concentration of cyclins during the cell cycle 
believed to be one factor which leads to the specific timing of Cdk activation.  
Members of the Cdk and cyclin families have binding surfaces which are largely 
interchangeable, thus allowing many different cyclin-Cdk combinations to form 
in cells. These contribute to a number of cellular processes, but with regard to 
those cyclins involved in regulation of the cell cycle, the classic model organises 
them according to which of the three main phases (G1, G2/M or Metaphase 
/anaphase) they control. In this model, cyclin E – Cdk2 activation is required to 
initiate S phase, cyclin A – Cdk1 is then responsible for its continuation, with B-
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type cyclins and Cdk1 or Cdk2 responsible for initial entry into mitosis 
(Yamaguchi et al., 2000).  
Active Cdks can also be switched off in a number of ways, examples of which 
include the degradation of the cyclin subunit by ubiquitin-mediated proteolysis 
(Jarviluoma et al., 2006), or being subject to association with inhibitor proteins 
or modification caused by inhibitory phosphorylations (Harvey and Kellogg, 
2003). 
1.4.2. Cell cycle regulators and their destruction by ubiquitin-dependent 
proteolysis 
Ubiquitin dependent proteolysis of cell cycle regulators, such as cyclins, is one 
means by which the unidirectional nature of cell cycle transitions are achieved. 
The activation of Cdks, as well as proteolytic destruction of cell cycle regulators, 
is an irreversible mechanism which facilitates the highly ordered nature of cell 
cycle events (Tyers and Jorgensen, 2000).  
Cyclins, Cdk inhibitors, as well as other regulatory proteins, are targeted for 
degradation by a process known as ubiquitination, whereby multiple copies of 
the 76-amino acid polypeptide ubiquitin are conjugated to proteins via 
isopeptide linkage. Ubiquitination is carried out in multiple steps; ubiquitin 
activation, conjugation, and protein ligation by a set of enzymes known as E1, 
E2 and E3 ubiquitin ligases (Pickart, 2001). Ubiquitinated proteins are then 
recognised and destroyed by a large ~2.5MDa multisbunit complex called the 
proteosome. 
Ubiquitin ligases are categorised into four major classes, based on their 
structural motif; HECT-type, U-box-type, PHD-finger type and ring-finger-type 
(Ingham et al., 2004; Fang et al., 2003; Joazeiro and Weissman, 2000; Kamura 
et al., 1999; Ohta et al., 1999). Ring-finger ubiquitin ligases are further 
categorised into subfamilies, the largest of which is the cullin-based E3’s, which 
contain a distinct globular C-terminal domain (or cullin homology domain) as 
well as a series of N-terminal five-helix-bundle repeats (cullin repeats). Two 
major classes of cullin-based ring-finger E3 ubiquitin ligases, the SKP1-CUL1-
F-box-protein (SCF) complex, and the anaphase-promoting complex, or 
cyclosome (APC/C), have a central role in cell cycle transitions, regulating the 
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G1-S transition and the metaphase to anaphase transition respectively. As part 
of the same category of E3 ubiquitin ligases, the APC/C and SCF complex are 
therefore structurally similar to one another, yet their cellular functions are 
distinct, with APC/C active between anaphase to the end of G1, and SCF active 
from G1 to early M phase but is mainly functional at G1-S phase (Nakayama 
and Nakayama, 2006).  
1.4.2.1.  The SCF complex 
The SCF is comprised of three core subunits, the RING protein Rbx1, the cullin 
Cul1, and Skp1. The SCF complex interacts with a number of interchangeable 
F-box bridging proteins via Skp1, which contain at least one F-box domain to 
mediate protein-protein interactions. This domain regulates the binding 
specificity of the SCF (Bai et al., 1996), allowing specific recruitment of target 
proteins to the SCF for ubiquitination, based upon the identity of the associated 
F-box protein (Feldman, 1997; Skowyra et al., 1997). The rate of substrate 
ubiquitination is also controlled by the changing affinity of the substrate to its 
corresponding F-box, rather than core enzyme activity, which remains largely 
unchanged throughout the cell cycle. 
The recognition of target substrates by F-box proteins is usually dependent on 
modification, commonly in the form of substrate phosphorylation (von der Lehr 
et al., 2003; Yoshida et al., 2002; Nash et al., 2001; Feldman, 1997). The ability 
of the SCF to recognise phosphorylated residues on the substrate called 
phosphodegrons, allows substrate discrimination. A phosphodegron is one or a 
series of phosphorylated residues that directly interact with protein-protein 
interaction domain motifs (such as an F-box motif) in an E3 ubiquitin ligase, to 
link the substrate to the conjugation machinery (Winston et al., 1999). This 
means that until a specific cluster of residues within the target substrate are 
phosphorylated, they will not be recognised by their corresponding F-box, and 
cannot be targeted for degradation by the SCF. As these phosphorylations are 
often carried out by Cdks, this ubiquitin-mediated proteolysis can be linked to 
specific times in the cell cycle, based on levels of Cdk activity.   
In yeast, the cell cycle can be divided into high and low Cdk activity states, with 
low activity lasting from telophase until late G1, and high activity from G1/S to 
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anaphase.  The oscillating levels of high and low Cdk activity allow a distinct 
pattern of DNA replication and chromosome segregation (as low Cdk activity is 
required for the formation of prereplicatory complexes and high Cdk activity is 
required for initiation of DNA replication and subsequent drive into mitosis). 
During stages of low activity, SCF proteolysis is largely prevented, with 
ubiquitination by the APC/C possible, whereas SCF-dependent degradation is 
stimulated and APC/C activity inhibited in cell cycle stages where Cdk activity is 
high, allowing specific activation of SCF at G1/S and APC/C at mitosis (Nash et 
al., 2001).   
1.4. The anaphase promoting complex / cyclosome (APC/C) 
The ability of cells to regulate the metaphase-anaphase transition in the 
presence of misaligned chromosomes or unattached kinetochores is crucial in 
maintaining genome stability. The SAC prevents anaphase onset by targeting 
the activation of the anaphase-promoting complex or cyclosome (APC/C). The 
APC/C is a 1.5MDa E3 ubiquitin ligase complex, comprised of at least 12 
subunits, which during normal mitosis, triggers the transition from metaphase to 
anaphase (reviewed in Morgan, 2007). The APC/C performs its function by 
assembling polyubiquitin chains on substrate proteins, which then targets these 
substrates for destruction by the 26S proteosome (a multi-subunit proteosome 
which targets multi-ubiquitinated proteins for degradation) in order to inactivate 
proteins who’s action is no longer required (Thornton and Toczyski, 2006). The 
various targets of the APC/C contain amino acid sequence motifs which are 
believed to be required for their recognition and subsequent ubiquitination, the 
most frequently observed being destruction boxes (D-boxes) and KEN boxes 
(Peters, 2006). 
The APC/C was Initially implicated in the destruction of mitotic cyclins during 
metaphase, (Clute and Pines, 1999; Irniger et al., 1995; King et al., 1995; 
Sudakin et al., 1995) in a normal cell cycle, the APC/C is found in the 
interphase nucleus, spreading throughout the cytoplasm to associate with the 
spindle apparatus during mitosis. The activity of APC/C depends upon two 
cofactors, cell division cycle 20 (Cdc20) and Cdh1, which interact transiently 
with APC/C to activate it during early mitosis, and from late mitosis to the G1-S 
transition, respectively (Peters, 2006).  
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With important roles in cyclin proteolysis (Tang et al., 2001b; Irniger et al., 1995; 
King et al., 1995) APC/C ubiquitin ligase (E3) activity is required for cell 
proliferation in all eukaryotes, although the most well known function of the 
APC/C is its role in sister chromatid separation (Kudo et al., 2006). In order for 
chromosome segregation to occur, the cohesion between sister chromatids 
must be removed. This is initiated at metaphase by active APC/CCdc20-mediated 
ubiquitination of securin, a protein which functions as a co-chaperone and 
inhibitor of the protein separase. Once activated, separase cleaves a subunit of 
cohesin, the Scc1 complex, who’s function is to hold sister chromatids together. 
This results in their separation and the subsequent onset of anaphase (Kudo et 
al., 2006). In the absence of APC/C, cells are unable to separate sister 
chromatids and progress through mitosis (Au et al., 2002; Peters, 2002).   
During mitosis, phosphorylation of Cdh1 by CDK’s  (Zachariae et al., 1998), as 
well as binding of nucleoporins to Cdh1 (Jeganathan et al., 2006), prevents 
APC/C-Cdh1 binding. This ensures that APC/CCdc20 is the major form of APC/C 
present. At the metaphase-to-anaphase transition, APC/CCdc20 also initiates 
degradation of cyclin B, lowering Cdk1 activity. The previously described 
separase (free of securin due to APC/C degradation) is also capable of direct 
binding with cyclin B and inhibiting Cdk1 (Gorr et al., 2005). Inhibition of Cdk1 
reduces the level of CDK activity rendering it insufficient to prevent Cdh1 from 
binding APC/C. Active APC/CCdh1 also degrades Cdc20, leading to a complex 
switching mechanism from APC/CCdc20 to APC/CCdh1 as the cell undergoes 
mitotic exit (Peters, 2006).  
1.4.1.  The specific nature of APC/C activity 
The action of APC/C requires one of two WD40 proteins as activators, Cdh1, or 
in the case of its mitotic role, Cdc20 (Burton and Solomon, 2001; Visintin et al., 
1997). Although the precise function of these WD40 activators remains 
speculative, it has been suggested that they may interact dynamically with the 
APC/C to recruit substrates by their WD40 domains, or to enhance the specific 
activity of the APC/C (Yu, 2007; Peters, 2006). The substrate specificity of 
APC/C is critical, as its role in mitotic progression requires the ability to select 
different substrates for destruction at specific times. Understanding of how this 
specificity is achieved remains poor, but WD40 activator proteins Cdc20 and 
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Cdh1 appear to be key (Visintin et al., 1997). One model predicts that WD40 
activator proteins act as substrate-recognition motifs  to  bind  and  “usher” 
substrates to the APC/C due to their ability to bind both substrate and the 
APC/C itself (Yamano et al., 2004), although, prior to this, a destruction box (D-
box) motif was discovered on the N-terminus of cyclin B1 which was required 
for its ubiquitination by APC/C (Sancar et al., 2004).This is believed to be the 
most common motif recognised by the APC/C, which includes some version of 
the sequence RXXLXXXXXN, where R is arginine, X is any amino acid, L is 
leucine and N is asparagine. Loosely conserved D-boxes have been found to 
mediate the destruction of many APC/C substrates, functioning as recognition 
sequences for both APC/CCdc20 and APC/CCdh1. Four different models have 
been proposed to explain the contribution of Cdc20 to D-box-dependent 
substrate recognition by APC/C (Yu, 2007).  
The sequential model proposes that the D-box first binds to Cdc20, then to 
APC/C. In the composite binding pocket model, the D-box binding site is formed 
at the Cdc20-APC/C interface. In the multivalency model, both Cdc20 and 
APC/C contain binding sites for the D-box and other APC/C substrates. The 
final model, the allostery model, predicts a conformational change on APC/C 
triggered by Cdc20 binding which reveals a D-box binding pocket.  Alternative 
destruction motifs also exist such as the KEN-Box motif found on Cdc20 
(Pfleger and Kirschner, 2000). The KEN box motif includes versions of the 
amino acid sequence KENXXXN, where K is lysine and E is glutamate. It is 
understood that the KEN box is required for ubiquitination of substrates after 
anaphase and in G1 where only APC/CCdh1 is active (Bashir and Pagano, 2004; 
Pfleger and Kirschner, 2000; Visintin et al., 1997).  Although Cdc20 may be 
capable of direct binding with D-box motifs due to its WD40 domain (Kraft et al., 
2005), it has been shown that the receptor for the D-box of Cyclin B is the 
protein-protein interaction domain or TPR domain of the  APC3/Cdc27 subunit, 
not Cdc20 (Vodermaier, 2004; Vodermaier and Peters, 2004; Yamano et al., 
2004). In addition, TPR-domain containing APC/C subunits may also interact 
with substrates independently of WD40 activators (Steen et al., 2008; Yamano 
et al., 2004). As well as the presence of a WD40 activator protein, the APC/C 
can only ubiquitinate substrates with the help of a further two co-factors, an 
ubiquitin-activating (E1) enzyme, and an ubiquitin-conjugating (E2) enzyme. E1 
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functions to create a thioester bond between its active-site cysteine and the C-
terminal glycine residue of ubiquitin, resulting in ubiquitin activation (Hershko et 
al., 1981). Ubiquitin is then transferred to the active-site of the E2 molecule 
(Hershko et al., 1983), which with the joint activity of E3, transfers ubiquitin to 
the targeted substrate (Hershko and Ciechanover, 1998).   
It is therefore believed that all APC/C interactions require ternary complex 
formation (between APC/C, the substrate, and one WD40 activator protein) in 
the presence of E1 and E2 for the ubiquitination reaction to occur (Passmore et 
al., 2005). One hypothesis (Baker et al., 2007) predicts that APC/C is loaded 
with the target substrate before the transfer of ubiquitin takes place through the 
association of an E2 enzyme. This model is described with regard to current 
understanding of the SAC and mitotic checkpoint complex (MCC), whereby the 
complex associates with APC/C to inhibit ligase activity until the SAC is 
satisfied. Once satisfied, and all chromosomes are properly aligned, the rapid 
destruction of cyclin B occurs. In prometaphase, cyclin B already associates 
with APC/C, yet it is not destroyed until the metaphase-anaphase transition 
(Jeganathan et al., 2006), in the presence of the WD40 activator Cdc20.  
Closely related to the importance of the ability of the APC/C to target specific 
substrates is the mechanism by which it can ignore substrates until specific 
points in the cell cycle. The activity of APC/C oscillates throughout the cell 
cycle, with lower activity in S and G2 phase, and high during mitosis and G1. If 
the APC/C is active throughout, how does it select when to target a specific 
substrate and when to ignore it? One model proposes an explanation for SAC-
independent destruction of APC/C substrates in that early mitotic APC/C 
substrates are very efficiently targeted to any residual checkpoint-independent 
APC/CCdc20 (van Leuken et al., 2008). It also considers the possibility that 
APC/CCdc20 may become increasingly active with its progressive 
phosphorylation immediately after nuclear envelope breakdown (NEB) 
(Lindqvist et al., 2007), whilst the checkpoint specifically prevents the ability of 
APC/C to recognise securin or cyclin B.  At present it remains unclear as to 
whether specific features of APC/C substrates determine the timing of their 
destruction. Alternatively, since it has been observed that phosphorylated 
APC/C and Cdc20 are enriched at kinetochores (Lindqvist et al., 2007; 
Acquaviva et al., 2004), where cyclin B1 degradation is initiated upon 
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checkpoint release, it is proposed that different pools of APC/C, with regard to 
their intracellular localisation, may hold the answer (van Leuken et al., 2008).  
1.5. The Kinetochore 
Kinetochores themselves are large protein assemblies built upon the end or 
middle of centromeres. Their primary function is to create load-bearing 
attachments between chromosomes and microtubules in the dividing cell, upon 
which proper partitioning of sister chromatids to the daughter cell depends 
(Walczak and Heald, 2008; Wittmann et al., 2001).  
Microtubule-kinetochore attachment itself is subject to various models. Initially a 
"search and capture" model was proposed, whereby microtubule dynamic 
instability was suggested to be a feature allowing them to explore space, 
selectively stabilising once they hit their targets (Waters et al., 1996). During 
mitosis, the target of these dynamic microtubules is the kinetochore, for which a 
crucial function is the stabilisation of kinetochore-bound microtubules (Shaw et 
al., 1998; Waters et al., 1996; Zhai et al., 1996). Evidence also exists that 
kinetochores can promote the growth of small microtubule stubs generated in 
their vicinity (Tulu et al., 2006; Telzer et al., 1975), as well as being capable of 
maintaining attachment to growing or disassembling microtubules (Shaw et al., 
1998).   
1.5.1.  Kinetochore Feedback Mechanisms 
Two proposed, and related, feedback mechanisms exist in which the 
kinetochore is fundamental, the first being the SAC. Here, cell cycle progression 
is synchronised with microtubule attachment, whereby sister chromatid 
cohesion and mitotic exit through degradation of Cyclin B is regulated by 
kinetochore-microtubule attachment or tension. The second feedback 
mechanism involves recognition of correct and incorrect kinetochore-
microtubule attachments (Kelly and Funabiki, 2009; Pinsky and Biggins, 2005). 
Correct attachments, whereby sister kinetochores are attached to opposite 
spindle poles (bi-orientation or amphitelic attachment), are stabilised. This 
allows equal distribution of sister chromatids to daughter cells at anaphase (Li 
and Nicklas, 1995; Nicklas and Koch, 1969). Incorrect attachments such as 
merotelic (in which a sister is connected to both spindle poles) and syntelic 
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attachment (in which both sisters in a pair connect to the same spindle pole) fail 
to stabilise, allowing their subsequent correction (Lampson et al., 2004; Cimini 
et al., 2003; Nicklas and Koch, 1969). 
The potential link between these two mechanisms lies with Aurora B 
(Santaguida and Musacchio, 2009). Aurora B has been proposed to be 
indirectly involved in the SAC, by destabilising incorrect or tension-less 
kinetochore-microtubule attachments. For this reason it has been suggested 
that Aurora B is required to activate the SAC in response to decreased tension, 
implicating its involvement in tension sensing across the centromere (Stern and 
Murray, 2001). A proposed mechanism for the action of Aurora B in 
destabilising incorrect attachment relates to its phosphorylation of members of 
the kinesin-13 family, which catalyse depolymerisation at the ends of 
microtubules (Moores et al., 2006) and contribute to correction of chromosome 
attachment errors (Kline-Smith and Walczak, 2004). The most well 
characterised member of this family is mitotic centromere associated kinases 
(MCAK). Aurora B phosphorylates multiple sites on MCAK to regulate its 
localisation to the inner centromere or kinetochore (Buster et al., 2007; Andrews 
et al., 2004). The destabilisation of tension-less kinetochore-microtubule 
attachments by Aurora B in turn leads to the recruitment of SAC proteins such 
as Mad2, BubR1 and Bub3 to the kinetochore to activate the checkpoint and 
arrest cell cycle progression (Pinsky et al., 2006; Pinsky and Biggins, 2005). 
Unattached kinetochores also fall into the category of tension-less. With 
nocodazole treatment (and resulting lack of attachment) Aurora B is active at 
kinetochores (Liu and Lampson, 2009; Liu et al., 2009), raising questions as to 
the direct implications of Aurora B activity in SAC control. However, the 
requirement of Aurora B for recruitment of SAC proteins to the kinetochore 
(which is a requirement of the SAC) in the presence of microtubule 
depolymerising drugs (Ditchfield et al., 2003; Hauf, 2003) strengthens the case 
for a direct involvement of Aurora B in SAC control and reinforces the link 
between kinetochore-microtubule attachment, error correction, and the SAC 
(Santaguida and Musacchio, 2009). 
It is clear that the kinetochore is key in the SAC response, but what is the actual 
trigger that causes SAC to become active and prevent the metaphase to 
anaphase transition?  
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1.6.2.  Kinetochore Stretch 
SAC monitoring of kinetochore attachment as a crucial mechanism to ensure 
accurate chromosome segregation and genomic stability, is a widely accepted 
concept (Yuen et al., 2005). However, the less understood role of tension in 
SAC release remains the topic of much debate. Chromosome biorientation 
stretches chromatin between microtubules and attached kinetochores, and the 
potential affect of stretch within the kinetochore itself is often overlooked. In 
recent months, a new aspect of tension with relation to SAC has been brought 
to our attention. Two separate groups have focussed on the importance of 
tension in SAC release by attempting to distinguish between interkinetochore 
stretch (the stretch between sister kinetochores) produced by kinetochore-
microtubule attachment, and intrakinetochore stretch (stretch within 
kinetochores).  
1.6.2.1. Interkinetochore versus intrakinetochore stretch 
The first (Uchida et al., 2009) used a HeLa cell line that stably expresses two 
components of the kinetochore, GFP- Centromere Protein A (CENP-A) to mark 
the inner kinetochore and mCherry-Mis12 to mark the outer kinetochore. 
Interkinetochore distances were measured by the distance between CENP-A 
markers, with intrakinetochore distance measured between CENP-A and Mis12 
markers. Their findings showed that in metaphase cells, the Mis12 signal 
deviated from the pole, suggesting an increase of intrakinetochore length, 
whereas interkinetochore length changes were infrequent. These movements of 
CENP-A and Mis12 imply that kinetochores undergo repetitive extension and 
recoil or "kinetochore stretching". The second group, Maresca and Salmon, 
2009, also used fluorescent markers with the generation of a Drosophila S2 cell 
line stably expressing mCherry centromere identifier (CID, a homologue of 
CENP-A) to mark the inner kinetochore and GFP-Ndc80 as the outer 
kinetochore marker (Cheeseman et al., 2006; Salmon et al., 2005).  
The overall findings of both systems suggested a lesser importance of 
interkinetochore stretch in SAC release. Uchida et al took the approach of using 
low doses of microtubule poisons or depletion of condensin, a chromosomal 
protein complex known to confer integrity to centromeric chromatin (Gerlich et 
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al., 2006) to produce conditions in which kinetochore stretching is inhibited but 
interkinetochore stretch is retained. This would distinguish between the 
relevance of stretching kinetochores from stretching inner centromeres. It was 
observed that when treated with 7ng/ml nocodazole or depleted of condensin by 
RNAi, no obvious effect on interkinetochore stretch could be seen, yet 
intrakinetochore stretch was decreased and SAC inhibition was released.  In 
agreement with this data, (Maresca and Salmon, 2009) showed that S2 cells 
treated with low concentrations of taxol reduced interkinetochore stretch whilst 
intrakinetochore stretch remained the same as in untreated control cells and the 
SAC was satisfied. Treatment with higher doses of taxol, both inter- and 
intrakinetochore stretch was reduced, and the SAC remained on.  
Based upon the findings of both papers, it is intrakinetochore stretch and not 
interkinetochore stretch which has an effect on the SAC. Uchida et al propose a 
model by which biorientation induces stretching of centromeres 
(interkinetochore stretch). The kinetochores undergo intrakinetochore stretch 
sufficient to inactivate the checkpoint, and therefore promote SAC silencing. 
Silencing is not achieved when the intrakinetochore stretch is disturbed (by 
nocodazole or depletion of condensin), regardless of interkinetochore stretch, 
and the checkpoint remains active.  
1.6.2.2. Models of kinetochore stretch 
Two models are proposed to explain how kinetochores are stretched. The 
mechanical stretching model proposes that the stretching is caused by the 
mechanical forces between microtubules and kinetochores, with deformation 
based on an elastic property of kinetochores. The findings that centromere 
integrity is required for kinetochore stretching favour this hypothesis; however, 
intrakinetochore stretch and SAC release were observed in conditions too low 
to produce interkinetochore stretch.  The second model proposes that stretching 
may be a result of conformational rearrangements of the components of the 
kinetochore itself. In this case, intrakinetochore stretching need not reflect the 
presence of tension. (Maresca and Salmon, 2009) agree with the second model 
proposed by Uchida et al. They also hypothesise that intrakinetochore stretch is 
generated by translocation of protein elements within the kinetochore structure. 
This may be in response to the attachment of dynamic microtubules, behaving 
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like a low-tension "mechanical switch" which controls SAC silencing by altering 
the localisation of regulatory factors within the kinetochore. 
Although the mechanism by which intrakinetochore stretching occurs is 
unknown, the most likely answer would appear to lie with the conformational 
rearrangement of the kinetochore itself. Further studies into the exact 
rearrangements as well as how these translate into SAC release are essential 
in understanding the full picture with regard to SAC activation and silencing in 
response to tension.   
1.6. Checkpoint Activation: Attachment and Tension 
The primary signal that activates the SAC remains unclear. Although it is widely 
accepted that chromosomes which have failed to achieve bi-polar attachment to 
the mitotic spindle is the target of the checkpoint, a debate remains between 
models which propose lack of microtubule-kinetochore attachment as the 
checkpoint trigger and those which suggest a sensing mechanism which 
recognises lack of tension generated on the kinetochore. The fact that 
attachment and microtubule-kinetochore tension are interdependent also makes 
it difficult to determine which of these may play the larger role.  
In the presence of any misaligned chromosome, unattached kinetochores 
recruit a number of evolutionarily conserved SAC proteins; Mps1, BubR1, Bub3, 
Mad1, Mad2 and Mad3 (May and Hardwick, 2006). In metazoans these are 
accompanied by additional proteins; Aurora B, CENP-E and the Rod-Zw10-
Zwilch complex (May and Hardwick, 2006). When these SAC proteins are 
recruited close to the kinetochore it allows the formation of an inhibitory 
complex, the mitotic checkpoint complex (MCC). The MCC comprises of 
checkpoint proteins Mad2, Mad3/BubR1 and Bub3, as well as the APC/C 
activator Cdc20 (Sudakin et al., 2001). When part of this inhibitory complex, 
Cdc20 is unable to activate APC/C activity (Tang et al., 2001a; Fang et al., 
1998a), therefore preventing exit from mitosis.  
The SAC achieves inhibition of APC/C by preventing APC/C from binding its 
activator Cdc20, as well as promoting Cdc20 degradation to lower levels upon 
checkpoint activation (Chen, 2007). There are conflicting ideas about exactly 
how the APC/C is inhibited by the SAC, the most likely being a dynamic model 
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in which APC/C is regulated by Cdc20 binding by a complex comprised of SAC 
proteins, all of which have been shown to localise to, and concentrate at 
kinetochores during prometaphase (Maiato et al., 2004; Cleveland et al., 2003). 
The direct target of the SAC, therefore is Cdc20. Cdc20 is recruited to 
kinetochores independent of APC/C (Vigneron et al., 2004) from prometaphase 
to telophase (Raff et al., 2002; Kallio et al., 1998) Investigation in Xenopus 
(Vigneron et al., 2004) has shown that Mps1, Aurora B and CENP-E act 
upstream of other checkpoint proteins and are required to induce the correct 
localisation of Cdc20 during prometaphase (Kallio et al., 1998). 
1.7.  "Catalytic" model of checkpoint activation 
There are currently two models aiming to explain how unattached kinetochores 
produce a diffuse signal to prevent APC/C activation in the cytoplasm. The first 
model suggests that Cdc20 is inactivated in the cytoplasm by association of 
Cdc20 or its inhibitors with the unattached kinetochores (Kallio et al., 1998) 
(Howell et al., 2000).  In support of this "catalytic model" it has been reported, 
as is the case for other SAC proteins such as Mad2, Cdc20 associates with 
mitotic kinetochores transiently. However, the dynamic exchange of Cdc20 with 
kinetochores is thought to be four times faster than those published for Mad2 
(Kallio et al., 2002). This distinct difference in Cdc20 trafficking may be related 
to the mechanism by which the checkpoint signal is broadcast from unattached 
kinetochores and diffused throughout the cell. A current model (Kallio et al., 
2002) suggests that rapid circulation of Cdc20 at all unattached kinetochores, 
already containing high concentrations of SAC proteins such as Mad2, BubR1 
and Bub3, involves binding either directly to kinetochores or indirectly through 
another SAC protein (Eg. Bub3) (Fraschini et al., 2001). This binding is 
predicted to be via WD-40 domains of Cdc20, leaving binding domains for 
inhibitory proteins Mad2 and BubR1 free to then interact with Cdc20 and 
prevent it from activating APC/C. The rapid dynamic exchange of Cdc20 at the 
kinetochore may therefore be a mechanism allowing Cdc20 to continuously 
sample kinetochores and maintain cell-wide APC/C inhibition (Kallio et al., 
2002).  
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1.8. "Sensitisation" model of checkpoint activation  
A second model the "APC/C sensitisation model" proposes that checkpoint-
active kinetochores "sensitise" the APC/C to inhibition by the inhibitory mitotic 
checkpoint complex (Sudakin et al., 2001). This model could be achieved by 
rapid exchange of APC/C with kinetochores, however existing evidence of 
APC/C kinetochore localisation conflicts this "exchange" theory (Topper et al., 
2002). Another SAC component, the kinase Mps1, is a proposed diffusible 
signal from the unattached kinetochore, as it binds APC/C and may therefore 
sensitise it to inhibition by the MCC (Liu et al., 2003). It is however yet to be 
proven as to whether Mps1 exchanges rapidly between kinetochores as would 
be required in this model. To understand and determine the most likely 
mechanism for Cdc20 inhibition it is important therefore that we understand the 
localisation of other SAC components. 
The hypothesis that unattached kinetochores are the activator of the SAC was 
first proposed by a study in mitotic rat PtK cells, in which electron microscopy 
and live-cell imaging revealed that a single unattached kinetochore was capable 
of arresting cells at metaphase. This coupled with the finding that laser ablation 
of the centromere and associated sister kinetochores (to destroy the last 
monooriented  chromosome) relieved the SAC, allowing cells to pass into 
anaphase, provided further support for the attachment hypothesis. The study 
went on to destroy one kinetochore on a bi-orientated chromosome in the 
presence of an attached monooriented chromosome, revealing that under this 
condition anaphase continued. This suggested that the SAC signal is not 
generated by the attached kinetochore of a monooriented chromosome. Finally 
with ablation of the remaining monoorientated chromosome, the SAC was 
rendered inactive. Overall the study concluded that molecules in or near the 
unattached kinetochore of a monoorientated chromosome is the likely trigger for 
the SAC (Rieder et al., 1995). Studies have been carried out in yeast in which 
mutants defective for the four evolutionarily conserved proteins of the Ndc80 
kinetochore complex were used. The Ndc80 complex is a conserved outer 
kinetochore component required for microtubule binding (reviewed by 
(Cheeseman and Desai, 2008; Ciferri et al., 2005). Ndc80 mutant cells are 
unable to attach chromosomes to the mitotic spindle, and, in all cases were 
confirmed to be SAC defective (McCleland et al., 2003; He et al., 2001; 
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Schramm et al., 2001; Wigge and Kilmartin, 2001). In addition to this, another 
attachment hypothesis which links kinetochore-microtubule binding to the SAC 
with  regard  to  the  Ndc80  complex  introduces  the  KMN  “super  complex” 
comprised of KNL-1/AF15Q14/SPC105/Blinkin, Mis12 complex and Ndc80 
complex, shown to be a critical microtubule-binding interface on kinetochores 
and required for attachment (Emanuele et al., 2007). Two of the proteins which 
form the KMN complex, Ndc80 (Hec1 in human cells) and KNL-1 (homologous 
to human Blinkin) are microtubule interacting proteins (Buffin et al., 2007; 
Cheeseman et al., 2006), both of which have been implicated in the SAC by 
direct interaction with SAC proteins. If this is the case, competition between 
signalling and microtubule binding may exist (Burke and Stukenberg, 2008). 
The SAC protein Mps1 kinase, required for SAC and in some organisms for the 
duplication of microtubule organising centres (Winey and Huneycutt, 2002), has 
also been implicated in regulating microtubule attachment (Jones et al., 2005). 
This link between the SAC and the microtubule-kinetochore binding interface 
further supports the attachment model of SAC activation. In recent months the 
attachment model with respect to SAC linkage has been expanded upon with 
regard to unattached kinetochores catalyzing the production of an inhibitory 
complex that requires Mad2 as a template for Cdc20-BubR1 binding (Kulukian 
et al., 2009), (Li and Benezra, 1996). This study used an in vitro assay for 
Cdc20-stimulated ubiquitination of APC/C to demonstrate that unattached 
kinetochores on purified chromosomes (equating to quantities of around ten 
unattached chromosomes) generate a diffusible Cdc20 inhibitor, or possibly 
inhibit Cdc20 already bound to APC/C.  
Using molecular markers for the lack of attachment at kinetochores is another 
approach taken to support the tension hypothesis. Mad2 localisation studies 
have shown that it binds unattached kinetochores in prometaphase and is lost 
from the kinetochore in metaphase once microtubule-kinetochore attachments 
are made (Chen et al., 1996; Li and Benezra, 1996). To distinguish between the 
localisation of Mad2 to unattached kinetochores and those with reduced 
tension, micromanipulated cells and cells treated with taxol, were examined for 
Mad2 localisation. Taxol is a microtubule-stabilising treatment which results in 
sister kinetochores moving closer together (an indication of loss of tension). It 
was shown that Mad2 does not accumulate on the kinetochore under these 
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conditions, and so it has therefore been proposed that Mad2 specifically marks 
unattached kinetochores (Waters et al., 1998). There are, however, limits to the 
use of SAC proteins such as Mad2 as markers for unattached kinetochores. It 
has been argued that cells treated with taxol always show at least one 
kinetochore capable of staining with Mad2, and so the possibility exists that 
taxol alters microtubule occupancy. It has also been shown that in cells treated 
with monastrol, which blocks spindle-pole separation and results in syntelic 
attachments which are attached but lack tension, Mad2 accumulates on the 
majority of kinetochores (Kapoor et al., 2000). This indicated that Mad2 
kinetochore localisation may not be specific to unattached kinetochores. It may, 
however be due to the attachments generated by monastrol treatment not being 
at their full microtubule occupancy. It has been argued that the reduced 
microtubule occupancy may result in decreased stability of attachments that are 
not under proper tension, and therefore taxol may activate the checkpoint by 
creating unoccupied microtubule-binding sites, not lack of tension (Pinsky and 
Biggins, 2005).    
1.9. The Mitotic Checkpoint Complex (MCC) 
Both of the two presented models to account for the inhibition of Cdc20 activity 
by the SAC, the "catalytic" and "APC/C sensitisation" models, share a common 
component, the presence of an inhibitory complex, the MCC. The MCC is 
comprised of SAC proteins Mad2-BubR1-Bub3 and Cdc20 (Sudakin et al., 
2001). Other smaller complexes have also been reported in yeast, Xenopus and 
mammalian cells upon checkpoint activation including Mad2-Cdc20 and Cdc20-
BubR1-Bub3 (Chen, 2002; Millband and Hardwick, 2002). The MCC binds the 
APC/C, eliminating its ubiquitin-ligase activity on securin and cyclin B (Morrow 
et al., 2005; Poddar et al., 2005; Sudakin et al., 2001; Fang et al., 1998a). 
Although the MCC may be a key inhibitor of APC/C and therefore potentially the 
most important component of the SAC, it relies on many other SAC components 
upstream. These include Mad1, essential for the interaction between Mad2 and 
Cdc20 (De Antoni et al., 2005) and Mps1, phosphorylation of which is required 
for the localisation of checkpoint proteins including Bub1, Bub3, Mad1 and 
Mad2 (Zhao and Chen, 2006).   
23 
 
Regarded as the primary SAC effector, the MCC accumulates in mitosis and 
appears to associate with APC/C (Morrow et al., 2005; Hardwick et al., 2000). 
Within the complex both Mad2 and Mad3 are able to directly bind Cdc20, the 
interaction between Mad3 and Cdc20 requires all SAC proteins, whereas the 
only essential proteins required for the Mad2-Cdc20 interaction are Mps1 and 
Mad1 (Hardwick et al., 2000; Hwang et al., 1998). Partially purified MCC from 
mitotic HeLa cells has indicated that Mad2, Bub3, BubR1 and Cdc20 exist in 
apparently equal stochiometries (Sudakin et al., 2001) yet it is presently unclear 
as to how and when the components of the complex interact to form the MCC. 
Theories as to the location of MCC formation take two standpoints: at the 
kinetochore and in the cytosol, independent of kinetochore interaction. In order 
to fully analyse which is the more likely explanation, the localisation and binding 
capabilities of the components of the MCC must be considered. 
The least characterised MCC component is the kinase Bub3, the binding 
partner of BubR1, required for its localisation (as well as that of Bub1) (Taylor et 
al., 1998)  Although Bub3 has never been shown to bind APC/C or Cdc20 
directly, it is clearly an essential SAC component, as without it cells are unable 
to arrest in the presence of spindle damage (Lopes et al., 2005).  
1.10. Cdc20: the proposed key target for inhibition by incorporation into 
the MCC 
Cell division cycle 20 (Cdc20), the activator and substrate adaptor of APC/C, is 
a key molecule for the metaphase to anaphase transition, and is believed to be 
the primary target of the SAC in its route to APC/C inhibition (Fang et al., 
1998a; Kramer et al., 1998).  Expression of Cdc20 is regulated at several levels 
throughout the normal cell cycle. Both Cdc20 protein and RNA levels reach a 
peak during mitosis (Haugwitz et al., 2004; Morris et al., 2003; Kramer et al., 
2000; Prinz et al., 1998), with the generation of functional Cdc20 (by proper 
protein folding) aided by the CCT chaperonin in order to promote activation of 
the APC/C (Camasses et al., 2003). 
1.10.1. Normal Cdc20 activity 
In a normal cell, Cdc20 localises to the centrosomes during interphase, with 
slight exclusion from the nuclei. It then rapidly accumulates in the nuclear 
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region, localising at kinetochores and the metaphase plate, later displaying 
microtubule and centrosomal association during mitosis (Raff et al., 2002). 
Distinct domains of Cdc20 are required for its association with kinetochores 
(WD-40 repeats) and centromeres (the NH2 terminal region of Cdc20, 
containing the Mad2 binding domain) (Kallio et al., 2002).  Cdc20 associates 
with mitotic kinetochores transiently, as is the case for Mad2, but has a reported 
turnover rate four times faster than Mad2 exchange (Kallio et al., 2002). 
Kinetochore associated Cdc20 is reported to exchange with a cytoplasmic pool, 
independent of microtubules. This supports a concept whereby transient 
association of Cdc20 with unattached kinetochores maintains APC/C inhibition 
towards targets whose ubiquitination or degradation are required for anaphase 
onset (Kallio et al., 1998).  This lead to the theory that Cdc20 circulates rapidly 
at all kinetochores, binding via WD-40 repeats (potentially via another WD-40 
repeat containing SAC protein such as Bub3). The WD-40 repeat binding at 
kinetochores leaves free the NH2 terminal domain for Mad2 binding and or 
possible interaction with another SAC protein BubR1, while at the kinetochore 
Cdc20 accepts inhibitory proteins which prevent it from binding APC/C (Kallio et 
al., 2002). Cdc20 also directly binds BubR1, through a Mad3 homology domain 
of BubR1. This interaction is dependent upon SAC protein Mad2 (Davenport et 
al., 2006).  This has not yet been proven to be the case in Drosophila. 
1.11. Cdc20 phosphorylation  
Cdc20 in mammalian cells has been shown to be phosphorylated by MAPK, 
Cdc2 protein kinase Cdk1 and the SAC protein Bub1 (Tang et al., 2004a), the 
kinase activity of which is stimulated upon SAC activation. Failure of Bub1 to 
phosphorylate Cdc20 results in a defective SAC, implicating this event as 
essential in the SAC function of Cdc20 (Tang et al., 2004a). However, some 
controversy exists as to the role of phosphorylation of Cdc20 by Bub1 in the 
SAC as it has been shown that in Xenopus egg extracts depleted for 
endogenous Bub1, SAC function can be restored with the addition of a kinase-
inactive Bub1 mutant (Chen, 2002). Whether these discrepancies are the result 
of differences in SAC mechanisms between organisms or due to experimental 
limitations remains unproven.   
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A number of highly conserved sites within the N-terminal of human Cdc20 have 
been implicated as potential phosphorylation sites and can be observed over 
various species including Xenopus and Drosophila. In Xenopus laevis, four of 
these; Ser 50, Thr 64, Thr 68 and Thr 79, are believed to be required for SAC 
function. Mutation of these sites substantially decreases Cdc20 phosphorylation 
by Cdk1 in mitotic egg extracts (Kramer et al., 2000), and with their introduction 
in order to generate phosphorylation-deficient Cdc20 mutants, the SAC is 
rendered inactive (Chung and Chen, 2003). The role of these four 
phosphorylation sites in SAC function has also been investigated with regard to 
the interaction of Cdc20 with other checkpoint proteins Mad2, BubR1 and 
Cdc27. With a single mutation to any of the four implicated sites, reduction in 
the interaction between Cdc20 and Mad2 in response to unattached 
kinetochores is observed, with loss of all four sites displaying a marked 
decrease (Visconti et al., 2010; Chung and Chen, 2003). The phosphorylation of 
Cdc20 at these positions is believed to be mainly a result of Cdc2 (Cdk1) 
activity, as with inhibition of Cdk1 by high concentration p21/Cip1/Waf1, Cdc20 
phosphorylation in wild type extracts can no longer be observed (Visconti et al., 
2010). Cdk1 activity has been shown to have an effect on the interaction 
between Cdc20 and APC/C as well as Cdc20-Mad2 and Cdc20-Cdc27 in HeLa 
cells. With the inhibition of Cdk1 activity, Cdc20-Mad2 binding is greatly 
reduced, with no apparent effect on Cdc20-Cdc27 (Visconti et al., 2010).  It 
should however be considered that a noticeable decrease in Cdc20 
phosphorylation is also observed with inhibition of MAPK by U0126, suggesting 
that, although MAPK is not essential, Cdk1 and MAPK may together play a role 
in Cdc20 phosphorylation (Chung and Chen, 2003).  
Overall Visconti et al (Hagting et al., 2002), suggest a hypothesis whereby Cdk1 
may phosphorylate APC/C, a requirement of its activity, but at the same time 
phosphorylate Cdc20 to stabilise Cdc20-Mad2 interactions. This in turn lessens 
Cdc20-APC/C binding to provide a precondition for active checkpoint proteins 
such as Mad2 to interact with Cdc20 in response to unattached kinetochores. In 
this case, once correct spindle assembly is satisfied, and checkpoint proteins 
are no longer activated, APC/C-Cdc20 can begin to form.  Alternatively, Cdk1 
activity may be regulated by the checkpoint mechanism so that upon completion 
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of the mitotic spindle assembly, a drop in activity dissociates Cdc20 from other 
active checkpoint proteins allowing reactivation of APC/C-Cdc20. 
Cdc20 regulation involves changes in its abundance during the cell cycle, with 
levels negligible during G1, rising to their peak in mitosis before rapidly 
declining (Fang et al., 1998b; Weinstein, 1997). But with findings which 
implicated cell-cycle dependent Cdc20 phosphorylation, it is now believed that 
this also has a role in the regulation of Cdc20 and its ability to activate the 
APC/C. Levels of Cdc20 phosphorylation in mammalian cells have been 
reported to be maximal during G2, dropping during the G2-M phase transition, 
whilst expression of Cdc20 is actually still rising (Weinstein, 1997). This finding 
implied that Cdc20 phosphorylation actually precedes its increase in 
abundance. Subsequent investigation into conditions in which Cdc20 is 
phosphorylated suggested an association between increased phosphorylation 
and mitotic arrest, both by the microtubule depolymerising agent nocodazole 
(Kramer et al., 1998) and in Xenopus eggs naturally arrested in metaphase II by 
cytostatic factor (CSF) (Lorca et al., 1998). This lead to questions as to whether 
the phosphorylation of Cdc20 may negatively regulate the action of the APC/C, 
as the observed increase of Cdc20 phosphorylation during mitotic arrest 
corresponds with the inhibition of APC/C activity observed during the spindle 
checkpoint response. 
There are conflicting reports regarding the role of Cdc20 phosphorylation in the 
regulation of APC/C activity. At least three kinases (Cdk1, MAPK and Bub1) 
have been implicated in Cdc20 phosphorylation, with various potential 
phosphorylation sites observed across species. It is therefore plausible that 
phosphorylation of Cdc20 at different sites, by a number of different kinases, 
may have different roles in the checkpoint response. 
1.11.1. Cdc20 phosphorylation by Cdk1 
An early paper into Cdc20 phosphorylation by Cdk1/cyclin B, using bacterially 
expressed renatured Cdc20, converted it into a form capable of activating 
APC/C (Kotani et al., 1999), although subsequent attempts to replicate this 
were unsuccessful  (Kramer et al., 2000). As these initial attempts to uncover 
the role of Cdc20 phosphorylation were deemed unreliable, an in vitro system 
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was set up in order to study the differential effects of Cdc20 and Cdh1 
phosphorylation on the activity of APC/C in HeLa cells (Kramer et al., 2000). 
Here, synchronised HeLa cells were used to purify cyclosomes from different 
cell cycle stages using gel filtration chromatography. The effect of Cdc20 and 
Cdh1 on the cyclin-ubiquitin ligase activity of the cyclosomes was then 
examined. Cdh1 was shown to stimulate cyclosome activity in all cell cycle 
stages, whereas Cdc20 only stimulated its activity in samples subject to 
nocodazole arrest (M phase) or after release from nocodazole arrest (M-phase 
exit). No effect was observed in G1 or S-phase. This confirmed the previous 
correlation between Cdc20 phosphorylation and conditions in which the APC/C 
is inactive. 
This system was then used to investigate the effect of Cdh1 and Cdc20 
phosphorylation using a two-step incubation in which S-labelled proteins were 
incubated in the presence or absence of Cdk1/cyclin B in a reaction mixture 
containing MgATP. Protein kinase activity was then terminated with 
staurosporine before the addition of cyclosomes from M-phase cells and the 
cyclin-ubiquitin ligation reaction was carried out as done previously. This 
confirmed that Cdk1/cyclin B (as well as Cdh1) phosphorylation of Cdc20, 
inhibited its ability to stimulate cyclosome activity. In order to eliminate the 
possibility that Cdk1/cyclin B phosphorylation observed was not due to the 
presence of other proteins, which could potentially phosphorylate and inhibit the 
action of Cdc20, a mutant of Cdc20 in which seven out of eight potential 
Cdk1/cyclin B phosphorylation sites were converted to alanine (serine 41, 408 
and 452; threonine 55, 59, 70 and 157) was tested. It was observed that the 
phosphorylation-defective mutant Cdc20 protein was capable of stimulating 
cyclosome activity, confirming that the effect of Cdc20 phosphorylation upon 
cyclosome activation was specific. The effect of phosphorylation on binding to 
the cyclosome was then determined by co-immunoprecipitation with anti-Cdc27 
antibody, which showed an abolished Cdc20-cyclosome interaction upon 
Cdk1/cyclin B phosphorylation and a proper interaction in between the 
cyclosome and the mutant protein. Overall, this paper provided a link between 
Cdc20 phosphorylation and checkpoint control via the inhibition of APC/C 
control, yet the connection with a checkpoint-dependent control mechanism 
remained unclear.  
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Following these findings, the requirement of cyclin-dependent kinases in the 
spindle checkpoint was investigated further (D'Angiolella et al., 2003). This 
study illustrates the stabilisation of Cdk1 (as well as Cdk2) activity under 
checkpoint conditions in HeLa cells, and goes on to investigate the role of Cdks 
in the interactions between Cdc20, Mad2 and the APC/C in order to identify a 
mechanism by which Cdk phosphorylation affects the activation of APC/C.  On 
the basis that when cells are released from nocodazole arrest, activation of the 
APC/C Cdc20 requires the dissociation of Mad2 from Cdc20 (Fang et al., 1998b), 
experiments were carried out to attempt to establish whether the Cdc20 
phosphorylation by Cdk has an effect on its ability to dissociate from Mad2. For 
this they used the Cdk inhibitor Roscovitine in checkpoint arrested cells. Cdk 
inhibition was found to override checkpoint-dependent arrest in HeLa cells, with 
immunoprecipitation experiments on cells at time points after Roscovitine 
treatment showing a drastic reduction in Cdc20-Mad2 interaction, but a 
maintained Cdc20-Cdc27 (APC/C) interaction. This was consistent with 
previous data in that without Cdk1 phosphorylation, Cdc20 binds (and activates) 
APC/C (Kramer et al., 2000) but also lead to the hypothesis that Cdk activity 
restrains APC/CCdc20 activation during checkpoint arrest by stabilising the 
Cdc2—Mad2 interaction, thus preventing Cdc20 from activating the APC/C. In 
support of this hypothesis, HeLa proteins were separated on longer SDS-PAGE 
runs to visualise mobility changes of Cdc20 from checkpoint arrested cells at 
various time points after Cdk inhibition. Cdc20 mobility increased after treatment 
with Roscovitine, suggesting that it becomes dephosphorylated, with the timing 
of this dephosphorylation compatible with the timing of the increase in Cdc20-
APC/C binding and decrease in Cdc20-Mad2 binding observed in the previous 
experiment.   
Because Roscovitine inhibits both Cdk1 and Cdk2, further analysis was carried 
out to distinguish which cyclin-dependent kinase was likely to be responsible for 
this. Xenopus egg extracts, arrested in M-phase by CSF, in which Cdk1 activity 
is sustained by redundant mechanisms so that Cdk2 can be inhibited without 
affecting Cdk1 activity (Tunquist et al., 2002) were incubated with S-labelled 
Cdc20 or mutant Cdc20 (as described in (Kramer et al., 2000) which had been 
pre-treated with active Cdk1. These were treated with a low concentration of 
p21/Cip1/Waf1, which selectively inhibits Cdk2. SDS-PAGE analysis displayed 
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a normal Cdc20 gel mobility shift. In contrast with high concentrations capable 
of also inhibiting Cdk1, the mobility shift was prevented. This implied that Cdk1 
and not Cdk2 was responsible for the phosphorylation of Cdc20. 
To test whether Cdk1-dependent phosphorylation affected Cdc20 interactions 
with Mad2 and Cdc27, S-labelled wild type Cdc20 was analysed, with the non-
phosphorylatable mutant Cdc20 (Kramer et al., 2000) used as a control. Higher 
binding of Cdc27 was observed with the mutant Cdc20 than with the wild-type 
protein, with levels of Cdc20-Mad2 interaction higher in the wild type. This 
confirms previous findings that Cdk1 inhibition induces dissociation of Cdc20 
from Mad2, and a transient increase of Cdc20-APC/C. To investigate the 
significance of the observed decrease in Mad2-Cdc20 interaction with Cdc20 
phosphorylation in Mad2-dependent checkpoint arrest, pre-phosphorylated wild-
type and mutant Cdc20 proteins were incubated with a CFS-arrested extract, 
before CSF was inactivated and cyclin degradation was measured. Cyclins 
remained stable in the extract containing wild-type Cdc20, but degradation of 
cyclins was restored in the extract containing the non-phosphorylatable mutant. 
This suggested that Mad2-dependent checkpoint arrest was maintained in the 
presence of Cdk1-phosphorylated wild type Cdc20, but not in mutant protein.  
Although Cdk1 activity appears to regulate the SAC by stabilising the Cdc20-
Mad2 interaction, regulation of the mechanism by which Cdk1 phosphorylation 
of Cdc20 inhibits its ability to activate the APC/C remains largely speculative. It 
was proposed that during mitosis, Cdk1 may perform positive phosphorylations 
of APC/C (Hagting et al., 2002) but at the same time lessening the interaction 
between APC/C and Cdc20 by Cdc20 phosphorylation, and so providing a 
precondition for checkpoint proteins to interact with Cdc20 upon activation of 
the SAC. Upon satisfaction of the SAC, checkpoint proteins are no longer 
recruited and Cdc20 can go on to interact with and activate APC/C. It is, 
however, unclear at present whether the phosphorylation which has been 
implicated to maintain the interaction between Cdc20 and Mad2 is also required 
for the interaction to occur in the first place. Alternatively, the pathways that 
control Cdk1 activity (D'Angiolella et al., 2003) may be sustained by the 
checkpoint mechanism, with completion of mitotic spindle assembly leading to a 
proteolysis-dependent drop in Cdk1 activity. This would allow the interaction 
between Cdc20 and APC/C, amplified by the dissociation of other checkpoint 
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proteins from Cdc20 (D'Angiolella et al., 2003). At this point, further 
investigation into the effect of other checkpoint proteins and their Cdk1-
influenced interaction with Cdc20 would need to be investigated in order to 
implicate either hypothesis. 
The potential phosphorylation sites which were substituted for alanine in the 
mutant Cdc20 protein are conserved in human and Xenopus and all reside in 
the N-terminal of Cdc20, a region already identified as a Mad2 binding domain 
(Zhang and Lees, 2001). The previously described studies implicate the 
phosphorylation of Cdc20 by Cdk1 to be important in maintaining the interaction 
of Cdc20 with Mad2, but whether it is needed for the interaction to take place, 
and what effect it has on the binding of Cdc20 to other components of the MCC 
has yet to be investigated. Also, although these findings strongly implicate Cdk1 
in this phosphorylation, no measures to rule out or implicate any other kinases 
were carried out. 
 
 
 
Figure 1.2. Graph to illustrate Cdk1 levels during M-phase. 
 
 
After nuclear envelope breakdown (NEB), Cdk1 levels rise and remain stable 
throughout M-phase until after the metaphase to anaphase transition. Here, in 
the presence of the SAC, Cdk1 levels are high and APC/CCdc20 is the major form 
of APC/C. At the later stages of mitosis, after the SAC, Cdk1 levels drop rapidly 
and remain low as cells move into G1.  
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1.12.2.  Cdc20 phosphorylation by MAP Kinase 
Cdc20 also contains several Ser/Thr-Pro sequences that are potential targets 
for MAPK, a kinase already implicated in checkpoint signalling (Wang et al., 
1997; Minshull et al., 1994). Chen et al 2003 used a MAPK inhibitor (U0126) to 
block MAPK activity, and detected a reduced gel mobility shift in Xenopus 
extracts treated with this inhibitor. This implied that Cdc20 phosphorylation is, at 
least in part, carried out by MAPK. A mutant was then generated which made 
substitutions at the five conserved sites within the Mad2 binding domain, with 
Ser50 and Ser114 residues replaced with Ala and Thr64, Thr68 and Thr79 
replaced with Val. Mitotic egg extracts for this mutant as well as wild-type 
Cdc20 were labelled with 32P, with failure of the mutant Cdc20 to incorporate 
32P implying that these mutations prevented mitotic phosphorylation. By later 
creating single substitution mutants for the five conserved sites and repeating 
the procedure, it was shown that all single mutants apart from Ser114 displayed 
a significant decrease in 32P. It was concluded that the four sites likely to be 
involved in mitotic phosphorylation of Cdc20 were Ser50, Thr64, Thr68 and 
Thr79.  
The role of MAPK in these phosphorylations was pinpointed further with the use 
of two-dimensional tryptic phosphopeptide analysis of 32P-labelled wild-type 
Cdc20.Three major peptides were revealed, one of which disappeared and was 
replaced with a fourth peptide in U0126-treated extracts. Peptide mapping of 
the five single-mutant Cdc20 showed that this missing peptide correlated with 
undetectable phosphorylation at the Thr64 and Thr68 mutants. This suggested 
that MAPK phosphorylates either Thr64 or Thr68 of Xenopus Cdc20.  
In order to determine whether this phosphorylation was required for regulation 
of the SAC, it was observed that after incubation with sperm nuclei and 
nocodazole, phosphorylation-deficient mutants for each individual conserved 
site or mutants in which all four sites had been substituted for Ala or Val, all 
display de-condensed chromosomes indicative of failure to maintain mitotic 
arrest in response to improper or unattached kinetochores. This implies that in 
order for Cdc20 to be inhibited in response to the SAC signal, all four conserved 
sites must be phosphorylated. But what role does this phosphorylation have in 
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Cdc20 inhibition and are these sites required for Cdc20 to be inhibited by the 
MCC complex?  
To determine whether the phosphorylation-deficient Cdc20 mutants were 
capable of interacting with other checkpoint proteins, they then 
immunoprecipitated Cdc20 from metaphase extracts treated with nocodazole 
and performed immunoblot analysis to reveal that when all four phosphorylation 
sites are disturbed, levels of associated Mad2 and BubR1 are greatly reduced. 
This suggests that the phosphorylation of Xenopus Cdc20 at Ser50, Thr64, 
Thr68 and Thr79 is important for its association with BubR1 and Mad2 in 
response to unattached kinetochores. This phosphorylation can be partially 
attributed to MAPK, which is enriched at kinetochores during mitosis (Mandell et 
al., 1998; Shapiro et al., 1998), inhibition of which by U0126 reduced the 
mobility shift of Cdc20 in mitotic extracts (Chung and Chen, 2003), although the 
importance of other mitotic kinases such as Bub1 and Cdc2 and Cdk1 cannot 
be ruled out.  
The phosphorylation status of these conserved sites within the N-terminal 
region of Xenopus Cdc20, all of which overlap with the previously proposed 
Mad2 binding domain of Cdc20 (Zhang and Lees, 2001), appear to be 
unquestionably linked to the ability of Cdc20 to interact with Mad2. This would 
suggest that the formation of the MCC to activate the SAC in response to 
unattached kinetochores requires phosphorylation of Cdc20 at these sites. The 
phosphorylation of Cdc20 in order to bind the MCC and eliminate activation of 
the APC/C is a plausible hypothesis. However, the exact role of this 
phosphorylation, as well as confirmation of the kinases involved specifically in 
regulation of other MCC components and their interactions within MCC 
formation must be understood in order to combine all current proposed models 
into a more detailed understanding of the SAC mechanism.   
1.12.3. Cdc20 phosphorylation by Bub1 
The least characterised kinase believed to be involved in Cdc20 
phosphorylation is Bub1. In a 2004 study (Tang et al., 2004b) Bub1 was 
depleted in HeLa cells by RNAi in the presence of spindle damaging agent 
nocodazole. While almost all control cells arrested in mitosis, a significant 
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proportion of Bub1 depleted cells failed to undergo mitotic arrest, and exited 
from mitosis without completing cytokinesis. This implied that Bub1 was 
required for mitotic arrest of HeLa cells in response to spindle damage, as 
expected due to the essential nature of Bub1 as a SAC component.  Because 
Bub1 contains a kinase domain, they went on to test whether it phosphorylated 
Cdc20. A wild-type Bub1 and kinase-inactive Bub1 (Bub1k82A) were 
coexpressed with Bub3, shown to always associate with Bub1 in HeLa cells, 
and purified the resulting Bub1 complexes that would potentially associate with 
Cdc20. This showed that in the case of the wild-type, at a molar ratio of 
Bub1:Cdc20 of 1:10, and assuming each Cdc20 molecule was phosphorylated 
at one site on average, 74% of Cdc20 was phosphorylated. In contrast, the 
kinase-deficient mutant failed to phosphorylate Cdc20. In this study, Plk1, 
Mps1, Aurora A and B, as well as BubR1 were tested and all failed to 
phosphorylate Cdc20. As did two members of the MAPK family, p38 and 
extracellular signal-related kinase 1 (ERK1). This is inconsistent with previous 
findings by Chen et al. (2003) in Xenopus extracts. This could be due to 
differences between human and Xenopus Cdc20, or by differences in the way in 
which MAPK regulates Cdc20 phosphorylation between species, but the 
inconsistency between these studies should be noted.  
In support of the role of Bub1 in mitotic arrest, Bub1 was then shown to inhibit 
APC/CCdc20 in vitro using a reconstituted APC/C ubiquitination assay with a 
fragment of Cyclin B1 as a substrate. Again, wild-type Bub1 (plus Bub3) was 
shown to inhibit the activity of APC/C, with the kinase-deficient mutant failing to 
do the same. In an attempt to determine which sites on Cdc20 were required for 
the Bub1-dependent phosphorylation which lead to inhibition of APC/C, mass 
spectrometry was used. Endogenous Cdc20 from nocodazole-treated HeLa 
cells and protein treated with Bub1-Bub3 (already shown to phosphorylate 
Cdc20 in vitro) both identified the same six Ser and Thr residues, located in the 
N-terminal of Cdc20 (Ser41, Ser72, Ser92, Ser153, Thr157 and Ser161). These 
sites are different from the two potential phosphorylation sites which were 
identified in a 2003 study from the same species (Kraft et al., 2003). Here, two 
potential Thr residues were identified (Thr70 and Thr 146), although it was not 
determined as to which kinase was implicated in phosphorylation at these sites. 
Another factor which may have had an influence on this discrepancy is the 
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isolation method used to purify the endogenous protein, which differed between 
studies. (Kraft et al., 2003) isolated only APC/C-bound Cdc20 via the use of an 
anti-Cdc27 antibody, whereas (Tang et al., 2004a) isolated all Cdc20 within the 
cellular population via an anti-Cdc20 antibody. Why these two pools of Cdc20 
might display different sites available for phosphorylation remains unclear.  
Tang et al. then followed the route of mutating the potential Cdc20 
phosphorylation sites to alanine to test the ability of this mutant Cdc20 to be 
phosphorylated. It was observed that the recombinant mutant Cdc20 was only 
weakly phosphorylated by Bub1-Bub3 in vitro, indicating that the six sites 
identified were involved in Bub1-mediated phosphorylation of Cdc20. 
Interestingly, this recombinant Cdc20 was as efficient as the wild-type protein in 
promoting the activity of the APC/C, with Bub1-Bub3 failing to inhibit the activity 
of the APC/C-mutant Cdc20 complex. Although it cannot be ruled out that Bub1 
itself could be phosphorylating APC/C directly for its inhibition, these results 
may suggest that it is the phosphorylation of Cdc20, not other core APC/C 
subunits, that is required for inhibition of APC/CCdc20 by Bub1 (Tang et al., 
2004).  
In contrast to studies into the importance of Cdc20 phosphorylation by MAPK 
and Cdk1 on the spindle checkpoint, investigation into the effect of mutation to 
potential Bub1 phosphorylation sites had less convincing effects. Although cells 
expressing the mutant Cdc20 were observed to progress through mitosis 
without cytokinesis in the presence of nocodazole or taxol, in cells where the 
endogenous Cdc20 was depleted by siRNA, only 50% of cells expressing the 
phosphorylation mutant Cdc20 protein escaped mitotic arrest. A reduction of the 
levels of securin were also observed, indicative of cells progressing through 
mitosis. This does imply that Bub1 phosphorylation of Cdc20 has a role in the 
functional checkpoint response, although it appears that the checkpoint is only 
partially defective with a reduction in Bub1 phosphorylation.  
In support of the idea that the checkpoint is only partially defective with 
reduction in Bub1 phosphorylation, data into the interaction of Cdc20 with other 
checkpoint proteins in the absence of Bub1 phosphorylation was tested. It was 
observed that BubR1 and Mad2 were still capable of binding Cdc20 when the 
potential Bub1 phosphorylation sites were mutated. It was also observed that 
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mutant Cdc20 still localised to kinetochores, arguably in support of the idea of a 
kinetochore-dependent MCC formation in the checkpoint response. A repeat 
APC/C ubiquitination assay also identified that the mutant Cdc20 was efficiently 
inhibited by Mad2 and BubR1. This implies that the phosphorylation of Cdc20 
by Bub1 is not involved in the formation of the MCC complex. It is more likely, 
based on the findings of Tang et al., 2004. that Bub1 inhibits APC/CCdc20 
catalytically and its involvement in Cdc20 phosphorylation may be related to the 
diffusible signals of the checkpoint response, rather than the formation of the 
APC/C inhibitory complex.  
1.12. The role of Cdc20 phosphorylation in the SAC remains unclear 
The connection between phosphorylation of Cdc20 and the SAC is apparent, 
with loss of Cdk1 and MAPK phosphorylation resulting in a defective checkpoint 
and reduced association with checkpoint proteins Mad2 and BubR1 (Chung and 
Chen, 2003; D'Angiolella et al., 2003; Kramer et al., 2000), and partially 
defective checkpoint observed with the loss of Bub1 kinase activity (Tang et al., 
2004). However, with regard to the exact role of Cdc20 phosphorylation in the 
SAC response pathway, many issues remain unclear. It is most likely that 
modification by each kinase is related to a specific Cdc20 function, may take 
place at different phosphorylation sites depending on the kinase involved, and 
these phosphorylations are likely to be specific to cell cycle stage and timed in 
accordance with their function. The contribution of each kinase in the overall 
phosphorylation of Cdc20 has not yet been established, the localisation of 
checkpoint proteins when kinase activity toward Cdc20 is disrupted, and the 
various interactions which are believed to occur in order for formation of the 
SAC inhibitory mitotic checkpoint complex have not been fully explored. 
With regard to the role of phosphorylation in the inhibition of Cdc20 by the MCC, 
it has already been observed that Mad2 and BubR1 association with Cdc20 is 
disrupted when MAPK and Cdk1 phosphorylation is abolished (Chung and 
Chen, 2003; Kramer et al., 2000), but the reason behind this failure of MCC 
components to interact is not understood. Where failure of these proteins to 
interact has been observed, their localisation has not been studied and so 
opens the debate as to whether a failure of non-phosphorylatable Cdc20 to 
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localise to unattached kinetochores may contribute to disrupted MCC formation, 
resulting in an abolished checkpoint.  
Although with the loss of Bub1 phosphorylation, Cdc20 was shown to localise to 
kinetochores (Agarwal et al., 2003), in this system, checkpoint protein 
interaction remained intact and the checkpoint itself was only partially defective. 
It cannot be ruled out that the reason the checkpoint was not abolished 
completely in this case was that Bub1 phosphorylation of Cdc20 is not required 
for its localisation to unattached kinetochores, therefore allowing normal Cdc20 
localisation when Bub1 kinase activity is lost, and its subsequent interaction 
with other kinetochore localising checkpoint proteins. It would be interesting to 
see, with the loss of Cdk1 or MAPK phosphorylation of Cdc20 and subsequent 
failure of Cdc20-Mad2 and Cdc20-BubR1 interactions, whether Cdc20 is still 
observed at kinetochores. 
1.14.  Cdc20 binds directly to Bub-Related Kinase1 
Cdc20 also has binding sites on Bub-Related kinase 1 (BubR1), a central 
component of the MCC, with important roles in processes directly linked to, and 
within the SAC. As well as the role of BubR1 in SAC, it is also directly 
implicated in microtubule-kinetochore attachments (in Drosophila S2 cells) 
(Maia et al., 2007), where monooriented and unattached chromosomes are 
displayed in BubR1-depleted cells, and BubR1 is reported to dissociate from 
kinetochores upon biorientation (Skoufias et al., 2001; Taylor et al., 2001). 
Along with this observation, reports into simultaneous BubR1 and CENP-E 
depletion reveals a role for CENP-E in the rescue of the partially unattached 
kinetochore phenotype in BubR1 depleted extracts. This implies that BubR1 
and CENP-E may act antagonistically to correct inappropriate kinetochore 
attachment (Maia et al., 2007), ultimately resulting in SAC silencing.     
The essential nature of BubR1 in the SAC, and its role in the interaction of SAC 
proteins Mad2-Cdc20-Bub3 with each other and the kinetochore, has been 
shown by impaired complex formation and kinetochore localisation in BubR1 
immmunodepleted cells (Chen, 2002). BubR1 itself is present throughout the 
cell cycle (Li and Benezra, 1996) but has been shown to localise to unattached 
kinetochores, as illustrated by its outer kinetochore plate localisation in HeLa 
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cells (Johnson et al., 2004; Taylor et al., 2001), where it is reported to be 
phosphorylated (Wu et al., 2000; Chan et al., 1999; Fang et al., 1998a; Li and 
Benezra, 1996) (Wu et al., 2000). Hyperphosphorylation of BubR1 at 
unattached kinetochores has been shown to be a process directly enhanced by 
the presence of Mad1(Chen, 2002).  
The localisation of BubR1 to kinetochores requires the action of Bub1, a 
structurally related protein that binds kinetochores but dissociates upon 
microtubule attachment (as is the case for SAC components CENP-E and 
CENP-F), although repression of Bub1 is yet to have any proven negative effect 
on the function of the SAC. This implies that the localisation of BubR1 must be 
under the control of a further mechanism which overrides the loss of Bub1 and 
allows kinetochore localisation of BubR1 upon SAC activation in its absence 
(Johnson et al., 2004). This control mechanism for BubR1 localisation has a 
proposed model involving another SAC component aurora B. Repression of 
aurora kinase activity in Bub1-repressed cells, shows a dependency for Aurora 
kinase activity in the localisation of BubR1 in the absence of Bub1 (Morrow et 
al., 2005). This result could suggest two possible explanations, the first being 
that Aurora B and Bub1 may play redundant roles in a timer mechanism. The 
other, and favoured, mechanism is that the lethality observed by depletion of 
both Bub1 and Aurora B is due to the checkpoint being composed of two arms, 
one arm dependent on Bub1 and the other on Aurora B, with the common 
denominators of the two arms being BubR1 and Mad2. This provides a 
plausible explanation as to why BubR1 and Mad2 are essential to SAC function, 
yet Bub1 and Aurora B alone are not (Morrow et al., 2005).  
In checkpoint arrested cells BubR1 has been shown to have up to twelve times 
higher binding affinity with Cdc20 than Mad2, and is therefore reported to be a 
highly potent Cdc20 inhibitor (Fang, 2002). This promotes the suggestion that 
although increased levels of either Mad2 or BubR1 alone can themselves inhibit 
APC/C, they are likely to mutually promote each other’s Cdc20 binding, together 
displaying synergistic function to inhibit Cdc20-APC/C (Fang, 2002).  Although 
BubR1 is a kinase capable of phosphorylating Cdc20 directly (Wu et al., 2000), 
no evidence exists that this phosphorylation has any effect in the control of 
Cdc20 activity (Fang, 2002). 
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1.15. BubR1-Mad2 binding enables BubR1-Cdc20 interaction 
Two Cdc20 binding sites exist on BubR1, one appearing to have no effect on 
the SAC, the other being highly specific to Mad2-bound Cdc20. Mutation of this 
specific domain weakens the BubR1-Cdc20 interaction and reduces SAC 
function (Davenport et al., 2006). The fact that mutation of this binding domain 
merely weakened Cdc20-BubR1 binding rather than causing the interaction to 
be abolished lead to the suggestion that  more than one checkpoint complex 
containing the MCC components Cdc20, BubR1, Mad2 and Bub3, may exist, 
and that this may play a role in a two-step mechanism of Cdc20 inhibition 
(Davenport et al., 2006). Checkpoint inhibition in this case would require prior 
binding of Mad2 to Cdc20 in order to sensitise Cdc20 to BubR1 binding and 
inhibition. Davenport's model of the two-step inhibition of Cdc20 proposes that 
the N-terminal of Cdc20 physically blocks binding of BubR1 until it is bound by 
Mad2, at which point a conformational change of Cdc20 exposes a previously 
unavailable BubR1 binding site. This binding between the N-terminal of Cdc20 
and BubR1 is shown in this research to be the region of interaction linked to 
SAC. In this model, since evidence existed to imply that the second BubR1 
binding site of Cdc20 is not relevant to SAC function, this domain is ignored. 
Furthermore, the suggestion that the BubR1 involved in this reaction is already 
Bub3-bound is made, although this is yet to be proven. No suggestion as to 
whether the formation of the MCC complex in the two-step inhibition of Cdc20 
model requires the presence of the kinetochore is provided.  In order for the 
two-step inhibition model to be widely accepted, the relationship of other SAC 
proteins with those in the model, and the requirement of the kinetochore, 
whether direct or indirect via a protein such as Mad1, should be further 
investigated.  
1.16. SAC proteins dynamically interact with kinetochores 
Evidence does exist that Cdc20 associates transiently with mitotic kinetochores, 
along with SAC protein Mad2. The reported turnover rate for Cdc20 is four 
times faster than Mad2, implying that Cdc20 cycles rapidly on and off the 
kinetochore (Kallio et al., 2002). Cdc20 kinetochore localisation is believed to be 
via the WD-40 repeats, of which Cdc20 has seven (Kallio et al., 2002). A rapid 
exchange between kinetochores and a cytoplasmic pool of Cdc20 independent 
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of microtubules supports a previously proposed concept whereby transient 
association of Cdc20 and unattached kinetochores serves to maintain APC/C 
inhibition towards targets whose ubiquitination or degradation are required for 
anaphase onset (Kallio et al., 1998).  The addition of Cdc20 kinetics at 
kinetochores lead to a modified theory in which Cdc20 circulates rapidly at all 
kinetochores (binding via WD-40 repeats). This binding may potentially be in 
conjunction with other WD-40 repeat-containing SAC proteins, a prime 
candidate for which is Bub3. Upon binding, an N-terminal domain of Cdc20, 
believed to contain a Mad2 binding site, remains available for the Cdc20-Mad2 
interaction. This may also be responsible for association of other SAC proteins 
BubR1 and Bub3 to form the MCC complex responsible for preventing the 
activation of APC/C by Cdc20 (Kallio et al., 2002).  
1.17. Potential mechanisms for Mitotic Checkpoint Complex (MCC) 
formation 
The emerging picture of the potential mechanisms of MCC formation are in 
consensus with regard to the importance of one common interaction, Cdc20-
Mad2. Mad2 is clearly one of the key SAC proteins, conserved in all eukaryotes 
(Musacchio and Salmon, 2007; Taylor et al., 2004). Unlike SAC component 
Cdc20, Mad2 localises inside of the nucleus throughout the entire cell cycle, 
however, reason for this nuclear localisation and its role in SAC function is 
unknown. In the nucleus Mad2 is recruited to the kinetochore during mitosis 
(Taylor et al., 2004; Cleveland et al., 2003) interacting transiently, but at a 
slower rate to that of Cdc20 (Kallio et al., 2002). Mad2 has been shown to 
associate directly with the APC/C in HeLa cells upon activation of the SAC by 
nocodazole treatment (Li and Benezra, 1996). Further investigation in Xenopus 
into this association illustrates the ability of Mad2 binding to APC/C to inhibit its 
activity (Li et al., 1997), dissociating from the cyclosome with inactivation of the 
SAC. However, the biochemical mechanism promoting the Mad2-APC/C 
interaction is unknown. The most widely accepted major role for Mad2 in the 
SAC is in the formation of the MCC, with the most commonly accepted sub-
complex of MCC comprising of Mad2-Cdc20 (Taylor, Scott et al 2004). Cdc20 
has two distinct Mad2 binding domains (Mondal et al., 2006). The N-terminal 
domain of Cdc20 is the most commonly known functional Mad2 binding domain 
(Zhang and Lees, 2001). It has since been reported that the C-terminal domain 
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of Cdc20 contains at least two functional domains in the SAC, one of which is 
directly involved in Mad2 binding (Xiong et al., 2008). The contribution of a 
second Mad2 binding domain in the Mad2-Cdc20 interaction has shown to 
reflect upon interaction through the first binding site. Blocking of the C-terminal 
Mad2 binding site of full-length Cdc20 destabilises its interaction with Mad2 via 
the N-terminal binding site. This suggests that binding of Mad2-Cdc20 is optimal 
through interactions of multiple domains (Xiong et al., 2008).  
1.17.1. Mad2 adopts two distinct states 
 Mad2 itself displays three unusual properties. The first of these is that it adopts 
two distinct natively folded states (Mapelli et al., 2007; Luo et al., 2004), referred 
to as (O) open-Mad2 and (C) closed-Mad2. Secondly, these distinct states 
engage in a conformational dimer, essential for SAC function (Mapelli et al., 
2007). Finally, closed-Mad2 has been reported to form topological links with 
Mad1 and Cdc20. It has been reported that the recruitment of Mad2 to 
kinetochores requires another SAC protein Mad1, and that this recruitment is 
essential for the efficient formation of a Mad2-Cdc20 complex (Hardwick, 2005)  
1.17.2. Mad2 models: Template versus exchange 
Two models exist to explain the role of Mad1 in the formation of Mad2-Cdc20 
interaction, the "Mad2 exchange" and "Mad2 Template" models (Mapelli et al., 
2006; Hardwick, 2005; Nasmyth, 2005) (figure 1.2).  The Mad2 exchange model 
proposes that Mad1 recruits open-Mad2 at the kinetochore, changing its 
conformation to closed-Mad2, which then dissociates from the kinetochore and 
is capable of binding Cdc20. Closed-Mad2 is also formed when open-Mad2 
binds its checkpoint target Cdc20 (Nezi et al., 2006). The exchange model, 
therefore proposes that Mad1 is the catalyst in the conformational change from 
open to closed-Mad2, which is in turn required for Cdc20 binding (Luo et al., 
2004). The exchange model has been criticised by structural Mad2 studies 
which claim that Mad1 and Cdc20 bind the same Mad2 domain. If this were the 
case, Mad1 and Cdc20 would be in direct competition for Mad2 binding, 
eliminating the possibility of Mad1 activation of Mad2-Cdc20 binding (De Antoni 
et al., 2005).  Studies into Mad2 kinetics also failed to show switching kinetics of 
Mad2 which are suggested by this model (Ibrahim et al., 2008). 
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The second model, the Mad2 template model overcomes the problem of Mad1 
and Cdc20 competing for the same Mad2 binding domain. This model 
introduces the ability of Mad2 conformers (open and closed-Mad2) to bind one 
another in a conformational dimer (De Antoni et al., 2005; Luo et al., 2004). The 
presence of an open and closed-Mad2 conformational dimer was further tested 
and illustrated in S. cerevisiae (Nezi et al., 2006). The main proposals put 
forward by this model are that there is a Mad1-bound closed-Mad2 pool at the 
kinetochore and a non-exchanging pool of open-Mad2 in the cytosol. The open-
Mad2 kinetochore receptor is a tight complex between Mad1 and closed-Mad2 
(Sironi et al 2002). In this model a stable kinetochore-bound form of closed-
Mad2 is formed, and acts as a receptor for open-Mad2. The model therefore 
does not imply that Mad1 and Cdc20 compete for Mad2 binding and also 
provides an explanation for the existence of two distinct Mad2 pools previously 
identified by FRAP analysis (Shah et al., 2004).  
The implications of the Mad2 template model are that Mad1-closed-Mad2 at 
kinetochores is activated in order to trigger the conformational rearrangement of 
open-Mad2 needed for Cdc20 binding (Nasmyth, 2005). This Closed-Mad2 - 
Cdc20 would then presumably dissociate from Mad1-Mad2. In this case there 
must be a cytosolic pool of Mad1- closed-Mad2 and that this pool is unable to 
catalyse the structural rearrangement of Mad2, which should only occur in the 
presence of unattached kinetochores. It also implies that cells contain some  
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Figure 1.3. Two-state versus template model of structural Mad2 activation within 
the SAC. 
 
(A) The two-state Mad2 model. Mad2 binds to Mad1 and adopts the N2' 
conformation. Upon checkpoint activation, the Mad1–Mad2 complex is recruited 
to the unattached kinetochores. Another copy of N1–Mad2 is recruited to Mad1, 
mainly through its binding to N2'–Mad2, and is then converted to N2–Mad2. 
N2–Mad2 is either directly passed on to Cdc20 from Mad1 or dissociates from 
Mad1 to form a transient dimeric intermediate that then binds to Cdc20. 
Because Mad1 exists as a homodimer, three pathways can be envisioned for 
the transfer of N2–Mad2 from Mad1 to Cdc20: (I) the two loosely bound N2–
Mad2 molecules dissociate from Mad1 as a unit; (II) one tightly bound N2'–
Mad2 and one loosely bound N2–Mad2 dissociate as a unit; (III) the two tightly 
bound N2'–Mad2 molecules dissociate as a unit. Pathways I and III require the 
dimerization of Mad1. Pathway III is equivalent to the so-called “exchange” 
model (De Antoni et al., 2005). Only pathway I is consistent with FRAP studies 
in Ptk cells. (B) The Mad2 template model. In this model, N2'–Mad2 bound to 
Mad1 recruits N1–Mad2, which is passed on to Cdc20. The Cdc20-bound N2'–
Mad2 recruits another N1–Mad2. In this way, the N2'–Mad2–Cdc20 can self-
propagate away from the kinetochores. Taken from (Yu, 2006) 
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kind of mechanism for preventing the positive feedback loop based on Cdc20-
Mad2 in the absence of kinetochore signals. For this reason, if the template 
model is to hold, regulation of the catalytic function of closed-Mad2 must be 
tightly controlled by kinetochores (Musacchio and Salmon, 2007). Recent in 
silico investigation into the inhibition of Cdc20 by Mad2 also provides criticism, 
this time mathematical, of the template model as it stands.  Although it displays 
robust switching behaviour, the application of experimentally derived 
parameters to the template model does not predict Mad2 levels which can be 
confirmed as plausible by experimental research. This leads to the suggestion 
that Mad2 is not capable of completely sequestering Cdc20, but may do so 
alongside additional binding partners. A potential candidate for this is BubR1 
(Ibrahim et al., 2008).  
1.18. A role for Mps1 in SAC signalling 
Mps1 was first identified as a dual-specificity kinase, whose levels are 
increased in various tumour cells (Lindberg et al., 1993; Mills et al., 1992). It is 
one of the many protein kinases implicated in the SAC, with depletion of this 
protein in yeast to human cells resulting in the checkpoint being overridden 
(Fisk et al., 2004). Across these species, Mps1 has been shown to regulate 
normal mitotic progression, chromosome congression, and cytokinesis (Jelluma 
et al., 2008; Fisk et al., 2004). It has also been suggested that, alongside its role 
in the SAC, Mps1 is also required to correct chromosome attachment errors, 
phosphorylating Borealin (the chromosomal passenger complex partner of 
Aurora B). In Mps1- depleted human cells, chromosome alignment defects have 
been shown to be rescued by the introduction of a form of Borealin where 
phosphorylation sites are mutated, with partial restoration of Aurora B activity 
(Jelluma et al., 2008). This form of Borealin did not, however, restore the SAC. 
This implies that although Borealin is the Mps1 target essential to allow its 
phosphorylation and activation of Aurora B, and contribute to chromosome 
attachment correction, other targets must be important for its function in the 
SAC.  
44 
 
1.18.1. Mps1 regulation during the cell cycle 
During the cell cycle Mps1 is tightly regulated. During G1, Mps1 is diffusely 
distributed throughout the cell, relocating to the nucleus and centrosomes 
during the G2/M transition. Mps1 localises to kinetochores in prophase and 
prometaphase, or with activation of the SAC (Stucke et al., 2004; Liu et al., 
2003; Stucke et al., 2002; Friedman et al., 2001). At these times, Mps1 activity 
is dramatically increased (Kang et al., 2007; Mattison et al., 2007; Stucke et al., 
2004; Liu et al., 2003; Stucke et al., 2002). Mps1 dissociates from kinetochores 
at metaphase, or upon satisfaction of the SAC. Mps1 is believed to adopt a 
unique inactive state, with kinase activation upon Mps1 autophosphorylation 
(Xu et al., 2009). This autophosphorylation of key sites within the N-terminal 
domain of Mps1 is believed to be important, along with phosphorylation of the 
Mps1 C-terminal, for kinetochore targeting as well as SAC signalling (Xu et al., 
2009). Mps1 in human cells has been found to be required for the kinetochore 
localisation of other checkpoint proteins, Mad1 and Mad2 ((Zhao and Chen, 
2006; Vigneron et al., 2004; Abrieu et al., 2001), with Mps1 knockdown in 
SW480 cells shown to inhibit Mad2 kinetochore targeting (Liu et al. 2009). Data 
from Xenopus egg extracts suggests that Mps1 also recruits Bub1, BubR1 and 
Cenp-E (Wong and Fang, 2006; Zhao and Chen, 2006; Abrieu et al., 2001). In 
human cells, Mps1 depletion by RNAi triggers premature anaphase, often 
displaying misaligned chromosomes. A wild-type Mps1 transgene was capable 
of rescuing this phenotype, but a catalytically inactive Mps1 mutant was not 
(Tighe et al., 2008). This catalytically inactive Mps1 can restore kinetochore 
localisation of Mad1, but not Mad2. This implies that in human cells, Mps1 
catalytic activity is required for SAC function and Mad2 recruitment. With the 
essential role of Mps1 in the kinetochore localisation of various checkpoint 
proteins, Mps1 knock-down experiments could prove useful when investigating 
the formation of the MCC with regard to the requirement of direct kinetochore 
interaction. 
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1.19. A role for chemical inhibition of Mps1 
A number of groups have approached the investigation into the effect of Mps1 
on SAC function using chemical inhibition of the kinase, rather than its deletion. 
Various compounds have been identified as potent Mps1 inhibitors, and have 
been tested for their specificity to this SAC component, as well as their effect on 
other SAC proteins. This approach is becoming increasingly popular, as with 
identification of Mps1 as an essential SAC component, the loss of which leads 
to aneuploidy and cell death (Janssen et al., 2009), Mps1 has become a 
potential target for anticancer drugs.  
The earliest report of the chemical inhibition of Mps1 comes from a 2005 paper 
(Schmidt et al., 2005). Here, the previously reported c-jun amino-terminal 
kinase (JNK) inhibitor SP600125 was shown to abolish SAC function in a JNK-
independent fashion in human U20S cells. Sequence analysis revealed a 
degree of similarity between the ATP-binding pocket of JNK and the human 
Mps1 binding domain, which lead to investigation into the ability of SP600125 to 
inhibit human Mps1 kinase. This revealed that, in fact, human Mps1 kinase was 
inhibited to a greater degree than JNK. Rescue experiments using SP600125-
resistant mutants of Mps1 confirmed that this compound acts upon Mps1 to 
inhibit the SAC. Previous studies into the effect of SP600125 have implicated a 
role in the inhibition of a number of other kinases, although the only reported 
case which is believed to be involved in mitotic progression is cyclin B/Cdk2 
(Bain et al., 2003). Schmidt et al., 2005 then confirmed the relative specificity of 
SP600125-mediated Mps1 inhibition by displaying the failure of SP600125 to 
significantly inhibit Cyclin B/Cdc2, BubR1 and Aurora B, although the mild 
inhibition of these kinases could not be ignored in the disruption to SAC 
signalling in response to this compound.   
With regard to the effect on other SAC components in the presence of the 
proposed Mps1 inhibitor SP600125, the Mps1-dependent kinetochore 
localisation of BubR1 was consistent with previous reports (Liu et al., 2003; 
Taylor et al., 2001) in that BubR1 kinetochore recruitment in response to 
nocodazole and taxol treatment of cells was significantly reduced in the 
presence of the Mps1 inhibitor. This, however, was not the case for SAC protein 
Mad1, previously shown to require Mps1 for its kinetochore localisation (Abrieu 
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et al., 2001). With inhibition of Mps1 by SP600125, the localisation of Mad1 to 
kinetochores appeared largely unaffected (Schmidt et al., 2005). This finding 
lead to the proposal of a model in which the presence, but not the kinase 
activity of Mps1, is required for Mad1 kinetochore localisation. This seems 
reasonable in that all studies which deplete Mps1 (Abrieu et al., 2001) show an 
effect on Mad1 kinetochore recruitment, yet those which merely inhibit the 
activity of Mps1, for example using anti-Mps1 antibody (Liu et al., 2003) or 
chemical inhibition by SP600125 (Schmidt et al., 2005) do not.  
Although SP600125 appears to inhibit Mps1, the fact that it displays mild 
inhibition of other kinases means that more specific compounds are required for 
further investigation into Mps1 kinase activity and SAC function. A recent review 
(Lan and Cleveland, 2010) compares the more recent attempts at identifying 
potent Mps1 inhibitors, with varying inhibitory concentrations, specificities and  
sometimes conflicting results with regard to their effect on SAC components. 
Discrepancies exist between Mps1 inhibitors as to which of the SAC proteins 
require Mps1 activity for their localisation to kinetochores, potentially due to the 
nature and timing of their action.  
Three novel inhibitors of endogenous human Mps1 have been described in the 
last twelve months. Firstly, a pair of inhibitors, Mps1-IN-1 and Mps1-IN-2 were 
identified (Jelluma et al., 2010) which use a stable shRNA approach in human 
U2OS cells. Although Mps1-IN-2 remains largely uncharacterised, Mps1-IN-1 
inhibition of Mps1 was shown to inhibit the kinetochore recruitment of Mad1 and 
Mad2, as well as producing a chromosome misalignment phenotype. It does, 
however, have an effect on Aurora B kinase activity, and so the observations 
reported cannot be completely attributed to Mps1 inhibition by this compound.  
Another compound, AZ3146, described to be a more potent and specific 
inhibitor of Mps1 than Mps1-IN-1 and Mps1-IN-2, has been shown have no 
significant effect on the activity of BubR1, Cdk1 or Aurora B (Hewitt et al., 
2010). Of a screen of 50 other kinases, only four kinases were mildly inhibited 
by AZ3146, namely JNK1, JNK2, FAK and KIT.  In this study, AZ3146 was 
shown to override SAC-mediated mitotic arrest in HeLa cells blocked with 
microtubule inhibitors, thus confirming the role of Mps1 in SAC arrest, and is 
particularly interesting as it attempts to use this inhibitor to investigate the role 
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of Mps1 activity in the formation of the MCC complex at kinetochores.  The level 
of Mad2 recruitment to kinetochores was decreased by approximately 85% with 
AZ3146 inhibition, with only a partial effect on the recruitment of Mad1. This 
data is consistent with previous observations associated with loss of Mps1 
activity (Tighe et al., 2008), and so provide a basis for the relevance of AZ3146 
as a useful tool for probing Mps1 function, although questions existed as to why 
Mad1 localisation was only partially effected by AZ3146 when other Mps1 
chemical inhibitors such as Reversine show dramatic effects on Mad1 
localisation (Hewitt et al., 2010). 
It was possible that the difference in the effects of Reversine in comparison to 
AZ3146, with relation to their effect on Mad1 localisation, could be associated 
with the cell cycle stage at which the chemical inhibitor acts (Hewitt et al, 2010). 
By devising a set of experiments involving the use of MG132 and nocodazole, 
regimens were set up to test the effect of the Mps1 inhibitor when cells were 
synchronised in mitosis before AZ3146 treatment,  in comparison to cells which 
enter mitosis after the addition of AZ3146. Under conditions whereby all 
detected mitotic cells had entered mitosis before AZ3146 exposure, Mad2 
kinetochore localisation was disrupted, yet Mad1 kinetochore recruitment was 
largely unaffected. However, when cells were first treated with MG132 before 
the addition of nocodazole (so that all cells should be in mitosis with aligned 
chromosomes stripped of Mad1 and Mad2, with the addition of nocodazole 
triggering a SAC response to recruit Mad1 and Mad2 to kinetochores) the 
addition of AZ3146 showed that neither Mad1 nor Mad2 localised to 
kinetochores. When these experiments were repeated with Reversine instead of 
AZ3146, identical results were obtained. This lead to a hypothesis that it is not 
the timing of the inhibitor which lead to initial discrepancies between potential 
Mps1 inhibitors, but that Mps1 may be involved in two distinct steps within 
mitosis, possibly to recruit Mad1 to kinetochores upon mitotic entry, then to 
promote continuous Mad2 localisation (Hewitt et al., 2010). However, various 
data exists to suggest that the Mad1-Mad2 complex is very stable (Kwiatkowski 
et al., 2010; Howell et al., 2004) which conflicts with this idea. A more plausible 
explanation for the data observed by Hewitt et al (2010), attempts to uncover a 
role for Mps1 in the Mad2 template model of MCC formation, based on the 
observation that Mps1 inhibition by AZ3146 appeared to abolish all Mad2 
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kinetochore localisation, when it should have only had an effect upon ~50% of 
kinetochore-bound Mad2 levels.  
1.20. A possible role for Mps1 in the Mad2 template model of MCC 
formation 
Because a key step in SAC activation in the Mad2 template model of MCC 
formation is the recruitment of O-Mad2 to kinetochore-bound C-Mad2, Hewitt et 
al (2010) hypothesised that perhaps Mps1 activity is required for the localisation 
of O-Mad2 to Mad1-C-Mad2 complexes at the kinetochore. It was speculated 
that the antibody used to detect Mad2 may have shown it to be absent at 
kinetochores with chemical inhibition of Mps1, when actually C-Mad2 should still 
have been present. Upon testing the specificity of the anti-Mad2 antibody used 
(SM2.2 antibody) it was speculated that C-Mad2 was not being detected.  
This was further confirmed by the use of Mad2 mutants unable to adopt the 
closed Mad2 conformation in comparison to Mad2 mutants which can bind 
Mad1 but not dimerise. It was shown that in the presence of AZ3146, mutant 
Mad2 rendered unable to dimerise was unaffected by Mps1 inhibition, whereas 
the Mad2 mutant unable to adopt the closed conformation was absent from 
kinetochores. This lead to the idea that Mps1 is required during mitosis to 
recruit O-Mad2 to kinetochore-bound Mad1-C-Mad2 complexes. This inclusion 
of Mps1 in triggering the Mad2 template model of MCC formation builds upon 
previous models, but the mechanism by which Mps1 may achieve this is still 
uncertain. It is not likely to be a direct affect, as the Mad2 template mechanism 
has been investigated in vitro without the inclusion of Mps1 in the past (Vink et 
al., 2006). A more likely explanation is that Mps1 may act upon a cellular 
inhibitor in order to exert its function on this system.  
1.21. Requirement of Kinetochores in Mitotic Checkpoint Complex 
Formation  
Directly related to the localisation and binding patterns of the key SAC proteins, 
there are two basic observations derived from experimental systems in various 
species, from humans to yeast, for the role of the kinetochore in the SAC (Kim 
and Burke, 2008). The primary observation is that SAC proteins such as Mad2, 
Mps1 and BubR1 localise to unattached kinetochores (Howell et al., 2004). The 
49 
 
second observation is that a complex of SAC proteins referred to as the mitotic 
checkpoint complex (MCC) has been shown to be a potent inhibitor of APC/C. 
In this model the checkpoint proteins dynamically interact with unattached 
kinetochores, are released as the MCC which then diffuses from the 
kinetochore to inhibit APC/C (Musacchio and Salmon, 2007; Cleveland et al., 
2003).  However, the role of the kinetochore in the formation and action of the 
MCC remains incompletely described, with studies in yeast providing evidence 
that the presence of the kinetochore may not be required for the formation of 
the MCC (Nezi et al., 2006). It has also been shown that an interphase pool of 
MCC exists, indicating that the complex forms independently of unattached 
kinetochores during a normal cell cycle (Sudakin et al., 2001). 
A possible explanation of the mechanism of MCC formation is that the formation 
of a primary Mad2-Cdc20 sub-complex functions to promote the further 
recruitment of the other MCC components into the final complex (Musacchio 
and Salmon, 2007). This argument is strengthened by research in human cells 
which shows that binding of the N-terminal region of BubR1 to Cdc20 requires 
previous binding of Mad2 with Cdc20 (Davenport et al., 2006), an indication of a 
two-step Cdc20 inhibition process requiring Cdc20 to be sensitised to Mad2 by 
prior binding with BubR1. The subunit comprised of Mad2-Cdc20 itself is 
insufficient for complete sequestering of Cdc20 (Ibrahim et al., 2008). In all 
cases BubR1 is also required for full checkpoint activation (Sudakin et al., 
2001). There is also evidence to suggest that in order for Cdc20 to bind Mad2 
or BubR1, it must first be phosphorylated. Kinases implicated as important in 
this phosphorylation include Bub1, MAPK and Cdk1 (Tang et al., 2004a; Chung 
and Chen, 2003; D'Angiolella et al., 2003; Yudkovsky et al., 2000). As well as 
the mechanism of complex formation, the location of MCC formation is also 
poorly understood. Two arguments exist, that of MCC formation at the 
kinetochore, and that of kinetochore-independent cytosolic MCC formation. 
1.21.1. Kinetochore based MCC formation 
The kinetochore-based theory of MCC formation is immediately obvious due to 
the localisation of all SAC components to unattached kinetochores (Shah and 
Cleveland, 2000). A strong argument for the requirement of the kinetochore in 
MCC formation reverts back to the previously explained Mad2 template model 
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of Cdc20 binding (Nezi et al., 2006), where Mad1, which is stably kinetochore 
bound in prometaphase (De Antoni et al., 2005; Howell et al., 2004; Chung and 
Chen, 2002) binds open-Mad2 to allow its conformational change to closed-
Mad2 (Luo et al., 2004; Sironi et al., 2002). This Mad1-closed-Mad2 interaction 
does not appear to dissociate or move from the kinetochore during checkpoint 
activation (De Antoni et al., 2005; Howell et al., 2004) and accounts for the 
stable pool of Mad2 observed (Shah et al., 2004).  The strong requirement for 
the presence of the kinetochore in the formation of the Mad2-Cdc20 subunit, 
referred to as the "seed" For MCC formation (Musacchio and Salmon, 2007) 
implies that the requirement of the kinetochore in MCC formation is probable.  
Another perspective may be derived from investigation into the composition of 
the MCC complex, in order to attempt to clarify whether the MCC observed in 
interphase cells (Sudakin et al., 2001) is the same complex, the components of 
which have also been reported to preferentially bind APC/C in the SAC (Morrow 
et al., 2005; Hardwick et al., 2000; Fang et al., 1998a). Recent experiments 
subjecting salt eluate of anti-Cdc27 immunoprecipitate from checkpoint-arrested 
extracts to immunodepletion by anti-Cdc20 confirm that Cdc20, BubR1 and 
Mad2 are in a complex in mitotic cells (Braunstein et al., 2007). However it also 
indicated that MCC may only be partly responsible for APC/C inhibition, as after 
the removal of Cdc20 and accompanying complex components, inhibition of 
APC/C remained. This suggests that there are potentially other inhibitory factors 
which may be associated with the APC/C when the SAC is active, either 
enhancing or prolonging the action of the MCC. Furthermore, it was also 
observed that much less MCC components were observed to be associated 
with APC/C in cells which had exited SAC arrest (activated extracts) than in 
SAC-arrested extracts. Data suggests that the reason for these lower levels is 
due, not to the dissociation of MCC from the APC/C, but to the dissociation of a 
large part of the MCC itself (Braunstein et al., 2007).  
Although other studies have suggested MCC dissociation (Sudakin et al., 2001) 
the timing of this was not investigated and therefore somewhat cast aside. It 
may be argued that this finding implies that MCC is formed upon activation of 
the SAC and then dissembles upon SAC exit, and therefore conflict with the 
hypothesis that MCC exists outside of mitosis and that the same complex is 
involved in the SAC. It also coincides with the kinetochore-dependent formation 
51 
 
of MCC, as the MCC in this case is forming upon localisation of SAC proteins to 
the unattached kinetochore. A potential theory for this is that the requirement of 
Mad2 and BubR1 to bind Cdc20 is also needed for inhibition of APC/C Cdc20 
rather than simply to sequester Cdc20 to inhibit APC/C indirectly but until the 
mechanisms involved in causing MCC formation upon SAC activation, and the 
potential disassembly of this complex upon SAC exit are understood, this 
remains unclear.  
1.21.2. Kinetochore independent MCC formation 
The argument for MCC formation independent of kinetochore interaction is at 
first glance controversial, with such strong links between SAC proteins and 
recruitment to kinetochore presented. However, there are also arguments 
against requirement for kinetochore interaction. The first being the reported 
interphase presence of MCC. With mature kinetochores only existing in mitosis 
and MCC potentially existing throughout the cell cycle (Sudakin et al., 2001) the 
possibility of kinetochore-independent MCC formation becomes relevant. MCC 
has been detected in S. cerevisiae cells with defective SAC, in which a key 
protein for the assembly of the kinetochore, Ndc10, has been mutated (Poddar 
et al., 2005). This was also the case for normal metaphase-arrested cells. MCC 
has also been detected in HeLa cells, independent of unattached kinetochores, 
in active interphase cells. It was also shown that in this case the MCC detected 
in non-mitotic cells did not have an effect on the APC/C. This lead to the 
prediction that mitotic APC/C potentially undergoes modification allowing rapid 
interaction with a pool of MCC (Sudakin et al., 2001). This potential existence of 
MCC throughout the cell cycle, only exerting its effect in mitosis, puts forward 
the possibility that the role of the kinetochore is merely to sensitise the APC/C 
to inhibition by MCC rather than having a direct involvement in MCC formation 
(Musacchio and Salmon, 2007). This model proposes that other SAC proteins 
(uninvolved in MCC) may be important in the recruitment as well as the 
sensitisation of APC/C at kinetochores. This may be plausible as some 
evidence exists which suggest APC/C may localise to kinetochores during SAC 
activation (Acquaviva and Pines, 2006; Vigneron et al., 2004). One potential 
problem with the sensitisation model arises with studies unable to support the 
finding of interphase MCC (Morrow et al., 2005; Chung and Chen, 2002; Fang, 
2002; Chan et al., 1999). But if in fact MCC is present in interphase cells, is this 
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MCC composed of the same subunits as mitotic MCC? Could it actually be that, 
although reportedly containing the same components, they actually differ 
enough in composition for this to be the reason behind the lack of APC/C 
inhibition by interphase MCC extracts? There is a possibility that differences in 
composition between mitotic and interphase MCC exist, with only mitotic MCC 
capable of APC/C inhibition. It is yet to be tested as to whether the APC/C 
actually does undergo a conformation change which could explain this 
occurrence, or whether mitotic MCC extracts can inhibit APC/C from non-mitotic 
extracts.  
1.22. The use of Model Organisms 
A model organism is a non-human species used to investigate biological 
processes, whereby the common descent of all living organisms and 
subsequent conservation of many biological phenomenon, genetic materials 
and regulatory and developmental pathways, allows findings to provide insight 
into the workings of other organisms. They are widely used to explore causes 
and treatment of human disease, in applications deemed unethical or unfeasible 
for human experimentation, and tend to be small in size, with a short generation 
time. Other common traits which are considered when choosing a model 
organism include accessibility, manipulation, genetics and potential economic 
benefit. It must, however, also be recognised that caution must be aired when 
making generalisations about human processes based on observations within 
model systems alone.  
Particular areas of research tend to favour specific model organisms, based on 
their unique characteristics. For example, the use of the bacterium Escherichia 
coli has been used in research into molecular genetics, due to its rapid growth 
rate, simple nutritional requirements, well established genetics and completed 
genomic sequence. A second example is the use of yeast, such as 
Saccharomyces cerevisiae, in studies of the cell cycle due to the many 
similarities between human and yeast cell cycles, as well as regulation by 
homologous proteins. Another organism widely used in the study of cell cycle 
regulation and genetics is Drosophila melanogaster (Greek for dark-bellied dew 
lover – also known as the vinegar fly or fruit fly).  
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1.23. An introduction to Drosophila melanogaster 
Drosophila melanogaster has been studied as a model organism for over 100 
years, advantageous in its small size, rapid development period (Figure 1.3) 
and short (2 week) life cycle, and ability to produce large numbers of progeny 
(~50 offspring). A great deal is known about the developmental genetics of the 
fruit fly, laboratory techniques for the use of this model are well established, 
information is freely available with the establishment of websites such as 
“FlyBase” and “Interactive Fly” and the genome of Drosophila was sequenced in 
2001.  
Drosophila have four pairs of chromosomes; X-chromosome, and 
chromosomes two, three, and four. The right (R) and left (L) arms of 
chromosomes two and three, as well as the X-chromosome, are roughly 
comparable in size. Chromosome four is approximately five times smaller.  An 
important feature of Drosophila genetics is the total absence of recombination 
(the process in which DNA molecules are broken and the fragments rejoined in 
new combinations) in males. Recombination in females is still achieved, the 
control of which can be achieved by another advantageous tool in Drosophila 
genetics, balancer chromosomes. 
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Figure 1.4. The Drosophila life cycle. 
At 25⁰C, the development period from embryo to adult fly is approximately 8.5 
days. Embryos hatch approximately 12-15 h after laying, and grow for around 
four days, within which they moult at 24 h and 48 h into 2nd and 3rd instar larvae 
respectively. Larvae then encapsulate in the puparium to undergo a four-day 
metamorphosis period, after which the adult flies emerge. Image taken from: 
http://flymove.uni-muenster.de/. 
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1.23.1. The use of genetic tools in Drosophila research 
1.23.1.1 Balancer chromosomes  
The use of balancer chromosomes in the Drosophila model is one of the 
features which set it apart from that of many other organisms. Balancer 
chromosomes exploit the finding that multiply inverted chromosomes are 
unlikely to undergo exchange with their normal homologues. These 
chromosomes, which as a result of multiple breaks and rejoinings (usually by 
radiation), have scrambled gross sequences which consequently disrupt the 
synopsis between homologous chromosomes during meiotic prophase. When 
these multiply inverted chromosomes are also linked to a marker mutation, they 
become able to allow populations of flies carrying defined homozygous lethal 
mutations to be maintained as a heterozygous  or  “balanced  lethal”  stock,  as 
well as allowing segregation analysis as transmission of the homologue from 
parent to progeny can be unambiguously tracked. By suppressing the 
reproductive fitness when balancer chromosomes are carried homozygously it 
ensures that the population it is carried in does not become fixed for the 
balancer chromosome. Since the X chromosome must exist in a hemizygous 
state in males, X-chromosome balancers tend not to contain recessive lethals, 
but instead, recessive female sterility mutations. Balancer chromosomes can 
therefore be defined as possessing three main properties: they suppress 
recombination with their homologs, carry dominant markers and negatively 
affect reproductive fitness when carried homozygously.  
Many balancers exist for the X, second, and third chromosomes but are not 
required for chromosome four, as there is no exchange on this chromosome. 
The naming of balancer chromosomes tends to begin with the letter 
representing their chromosome (F for first – which is the X chromosome, S for 
second, and T for third). This is followed with an M for multiply inverted, a 
number, and often the genetic symbol for the principle marker or mutation 
carried by that balancer. An example of these are the second chromosome 
marker SM6,Cy (real name In(2LR)SM6, al2, Cy dplv1 cn2 sp2) which carries the 
dominant marker Curly and produces a phenotype in adult flies in which wings 
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are curled upward instead of lying flat to the body, and TM6BTb (real name 
In(3LR) TM6, Hu e) which carries a dominant allele of Antennapedia (Hu) and 
the additional dominant Tubby (Tb), which causes a shorter and fatter body 
shape, and is therefore a good marker for larval and pupal stages as well as 
adult flies. The tubby balancer chromosome is especially useful in the 
identification of homozygous mutant flies, in lines which are not viable to adult 
stages. In these lines, rather than investigating the introduced mutation or 
modification of interest using the most common tissue (the embryo) it is often 
the third instar larvae neuroblast cells, selected from larvae absent of the 
balancer characteristic, which are used for imaging or preparation of samples 
for biochemical analysis.  
1.23.1.2. P-elements 
Another powerful genetic tool present in Drosophila are DNA transposable 
elements. Transposable elements are genetic units that can insert into a 
chromosome, exit, and relocate, therefore altering their position within the 
genome. An example of DNA transposable elements that exist naturally in 
Drosophila, and are subsequently exploited as a tool for genetic research, are 
P-elements. P-elements were discovered as a result of the study of 
asymmetrical hybrid dysgeneisis, whereby females of laboratory fly strains were 
mated with males from the natural population. Mating of these different strains 
resulted in abnormal phenotypes manifested in the germline, such as increased 
frequency of chromosome dysjunction, higher rates of mutation, and sterility, 
phenotypes which did not occur when laboratory strain males were mated with 
natural females. This phenomenon was later investigated with flies divided into 
P strains (paternal contributing) and M strains (maternal contributing), whereby 
any P strain male can induce dysgenesis in a cross with an M strain female but 
not vice versa. This is believed to be due to the ability of wild type females to 
produce a transposase inhibitor. Construction of recombinant chromosomes 
showed several regions within the P chromosome were able to cause 
dysgenesis. The nature of these P-specific sequences were first identified by 
mapping the DNA of w mutant flies, which carry mutations as a result of DNA 
insertions at the w locus which inactivate the gene and result in a white-eye 
phenotype, found amongst the dysgenic hybrids, and the inserted sequence 
was named the P-element.  
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P-element insertions form a classic transposable system, whereby individual 
elements vary in length but are homologous in sequence. P-elements contain a 
gene, composed of four exons and three introns, that encodes transposase (the 
enzyme that binds to the ends of a transposon and catalyzes it’s  relocation  to 
another part of the genome). Each contains a 31bp inverted repeat at each 
terminus, and generate direct repeats of target DNA of 8bp upon transposition 
(Muster et al., 1983). Transposition requires ~15bp of terminal DNA. The 
transposase binds to 10bp sequences adjacent to the 31bp inverted repeats 
and inserts the P-element by a non-replicative  “cut  and  paste”  mechanism. 
Insertion of the P-element may cause mutation to the new site, and have a 
deletion effect at the donor site. These P-elements are transcribed in both 
germline and somatic tissues, but only activated in the germline. This tissue 
specificity is believed to be conferred by a change in splicing pattern, in which 
within somatic cells the first two introns are excised and a protein which 
represses transposase activity is transcribed, or in the germline where an 
additional splicing event occurs to remove the third intron and connect all 
reading frames to translate transposase.    
The mobility of these elements can be exploited in Drosophila genetics to mark 
the position of genes and to facilitate gene cloning. As P-elements inserted into 
genes in vivo disrupt genes randomly, they create mutants with different 
phenotypes, marking the presence of the mutation. These can subsequently be 
selected for cloning of the mutant gene by way of transposon tagging, in which 
the mutant gene is cloned with the use of P-element segments as a probe. P-
elements can also be used to insert genes, which may be generated to carry a 
specific point mutation or be fused to a marker or tag such as green fluorescent 
protein (GFP). This would then allow for the inserted fusion protein to be 
visually tracked within cells, to study localisation of that protein as well as any 
phenotype it may cause.  
1.23.1.3. The use of P-elements to insert genes 
This use of P-elements to insert donor genes into the germline was first 
demonstrated by a procedure designed by Rubin and Spralding in 1983 (Rubin 
and Spradling, 1983). The recipient genotype is homozygous for a given 
mutation, for example rosy (ry-) which confers a characteristic eye colour 
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phenotype. Embryos from this line are collected at around cycle nine when it 
still exists as a single multinucleated cell. At this stage, the nuclei destined to 
form germ cells are clustered at one end of the embryo. As P-elements mobilise 
only in germ cells, embryos at this stage are injected with two types of DNA, the 
first being a bacterial plasmid carrying a defective P-element into which the 
wild-type gene (for example ry+) has been inserted. This deleted element is not 
able to encode transposase, and is therefore unable to transpose without the 
help of a second injected DNA, or helper plasmid, containing a full element. The 
resulting flies are phenotypically still rosy mutants, but their offspring will include 
large numbers of ry+ flies. The presence of stable Mendelian inheritance of the 
ry+ gene suggests that it is located on a chromosome.  
The gene of interest can be generated to contain point mutations, with the use 
of PCR site-directed mutagenesis in the construction of the P-element, and as 
mentioned previously, can also be designed to express the protein of interest 
tagged to a second protein, such as a fluorescent marker.  
1.24. The relevance of Drosophila as a model organism     
With all of this considered, use of Drosophila genetics is often an elegant 
means by which to study a wide array of cellular processes. Even though the 
human genome is almost four-fold larger than that of the fly, they carry 
comparable numbers of gene families and there is a remarkable conservation 
between human and Drosophila genes. Many genes involved in human disease 
can be directly linked to orthologues in flies, enabling the use of genetic 
techniques in Drosophila to establish their function in humans, and thus develop 
treatments. This is particularly true of genetic and developmental diseases, due 
to the wide understanding of these processes in flies.  
Many genes involved in cell cycle regulation, including those which make up the 
mitotic spindle assembly checkpoint, are also orthologous between human and 
Drosophila. With the use of described genetic techniques, fly lines can be 
generated to study the effects of modification to these genes including deletion, 
overexpression and functional domain mutation, and the effect this has on cell 
progression and checkpoint functionality. Localisation of tagged proteins can be 
easily visualised throughout the cell cycle in embryo and neuroblast cells, with 
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the rapid life cycle of flies allowing easy sample collection for this as well as 
biochemical analysis. 
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1.25. Aims and objectives 
The series of events leading to inhibition of Cdc20 in the SAC response has 
been widely studied, and a general consensus exists as to the importance of 
the formation and incorporation of Cdc20 into a mitotic checkpoint complex in 
order to inhibit its function as an APC/C activator. The conditions required in 
order for this MCC to form is the subject of much debate, with the requirement 
of direct kinetochore interaction, and therefore the kinetochore localisation of 
SAC proteins, one of the key questions remaining.   
A number of conserved domains across various SAC proteins have been 
identified and deemed important in the interaction between MCC components, 
but many of these have never been confirmed in Drosophila, and the role of 
these domains in the kinetochore localisation of SAC proteins is often largely 
overlooked. To be able to visualise the localisation patterns of Cdc20 and other 
SAC components in Drosophila models, whereby potential functional motifs and 
domains have been removed, or upstream players in the SAC response 
omitted, could provide a useful tool in building our understanding of factors 
essential for SAC protein interactions, and the resulting effect on their 
kinetochore localisation and subsequent ability to be incorporated in the MCC.  
The main aims of this project were to generate working systems with which we 
could investigate the role of specific conserved residues or upstream SAC 
proteins in kinetochore-based MCC formation within Drosophila. Specifically: 
 To confirm the role of specific residues within Cdc20 which are 
potentially involved in its phosphorylation using transgenic approaches, 
and to investigate a potential requirement of this phosphorylation in 
Cdc20 kinetochore localisation and MCC formation. 
 To develop bacterial and yeast three hybrid systems which will allow us 
to confirm a role for the BubR1 KEN box motif on its ability to bind 
Cdc20 in the presence and absence of Mad2. 
 To use transgenic approaches to develop a model whereby the 
requirement of Mps1 in the localisation of other SAC proteins can be 
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investigated, and the effect on the ability of cells to elicit a SAC 
response under these conditions. 
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Chapter 2. Materials and Methods 
 
2.1 Reagents and Buffers 
2.1.1 Fly Food (1L) 
 100g Polenta maize meal 
 50g Brown sugar 
 25g Yeast 
 12.5g Agar 
 0.4g Sorbic acid 
 2g Benzoic acid 
 0.9g Nipagen 
H2O up to 1L 
The mixture was heated to dissolve components, aliquoted into vials and 
allowed to set. 
 
2.1.2 Apple Juice Agar 
 30% Apple Juice 
 70% H2O 
 3% Agar 
 
2.1.3 50x TAE (Tris-Acetate-EDTA) Buffer 
 2M Tris 
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 1M Acetic acid 
 50mM EDTA 
 pH adjusted to 8.5 with NaOH and autoclaved to sterilise. 
 
2.1.4 6x DNA Loading Dye 
 10mM Tris-HCl (pH 7.6) 
 0.03% Bromophenol Blue 
 0.03% Xylene cyanol FF 
 60% Glycerol 
 60mM EDTA 
 
2.1.5 10x PBS 
 Dulbecco’s Phosphate Buffered Saline Buffer from Sigma. 
 
2.1.6 1x PBS-T 
 1x PBS (Sigma) 
 0.1% Tween-20 
 
2.1.7 1x Protein Sample Loading Buffer 
 2% w/v SDS 
 5% v/v 2-mercaptoethanol 
 60mM Tris (pH 6.8) 
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 Bromophenol Blue 
 10% Glycerol 
 
2.1.8 20 x Protein Gel Running Buffer  
 NuPAGE® MOPS SDS Running Buffer from Invitrogen. 
 
2.1.9 Transfer Buffer for Western Blotting 
 25mM Tris 
 192mM Glycine 
 20% Methanol 
 
2.1.10 Blocking Buffer for Western Blotting 
 Odyssey Blocking Buffer from Li-Cor. 
 
2.1.11 2x YT Medium 
 10g Tryptone 
 10g Yeast extract 
 5g NaCl 
 De-ionised H2O up to 1L 
 pH adjusted to 7.4 with NaOH and autoclaved to sterilise. 
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2.1.12 LB Agar medium 
 10g NaCl 
 10g Tryptone 
 5g Yeast extract 
 20g Agar 
 De-ionised H2O up to 1L 
 pH adjusted to 7.0 with NaOH and autoclaved to sterilise. 
 
2.2. DNA Purification Buffers 
  
2.2.1. Wizard® Plus SV Minipreps DNA Purification System 
  Cell Lysis Solution: 
  0.2M NaOH 
  1% w/v SDS 
 
  Cell Resuspension Solution: 
  50mM Tris-HCl (PH 7.5) 
  10mM EDTA 
  100µg/ml RNase A 
 
  Neutralisation Solution: 
  4.09M Guanidine hydrochloride 
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  0.759M Potassium acetate 
  2.12M Glacial acetic acid 
  Final pH ~ 4.2 
 
  Column Wash Solution: 
  162.8mM Potassium acetate 
  22.6mM Tris-HCl (pH 7.5) 
  0.109mM EDTA (pH 8.0) 
  Plus 95% ethanol as directed. 
 
2.3.DNA  Gel Extraction Buffers 
 QIAquick® Gel Extraction Kit from Qiagen. 
 
 200mM Tris (pH 7.4) 
 200mM NaCl 
 1mM EDTA (pH 7.4) 
 10mM 2-mercaptoethanol  
 
2.4. Inhibitors 
 
 1mM phenylmethylsulfonyl fluoride (PMSF) 
 2µg/ml Leupeptin 
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 2µg/ml Aprotinin 
 2µg/ml Pepstatin 
 100µM Benzamidine 
  
 
2.5.Kinase Assay Buffers 
 
2.5.1. Basic Homogenisation Buffer 
Both Homogenisation buffers A+B have the same basic components: 
 
5ml basic mix: 
20mM Tris (pH 7.5)  - 100µl of 1M stock  
2mM EGTA         - 50µl of 200mM stock 
2mM DTT  - 10µl of 1M stock 
100mM NaCl  - 125µl of 4M stock 
 
A) Contains protease inhibitors only: 
10µg/ml Aprotonin 
10µg/ml Leupeptin 
100µM PMSF 
1mM Benzamidine 
 
B) Contains both protease and phosphatase inhibitors: 
10µg/ml Aprotonin 
10µg/ml Leupeptin 
100µM PMSF 
1mM Benzamidine 
 
50mM NaF 
0.1mM NaVO4 
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10mM β Glycophosphate 
 
 
2.5.2. Kinase Wash Buffer 
 
  50mM Tris (pH 7.5) 
10mM MgCl 
1mM EGTA 
 
2.5.3. Kinase Reaction Mix (70µl – sufficient for 7 reactions) 
 
Made up in kinase reaction buffer: 
50mM Tris (pH 7.5) 
10mM MgCl2 
1mM EGTA 
1mM DTT 
Plus: 
100µM cold ATP 
245ng CDK1/CycB (35ng per reaction) 
Finally: 
0.5µCui/µl ATP32P (35µCui total activity) 
 
 
2.6. S. cerevisiae media 
   
2.6.1. YPD media 
1% (w/v) Bacto-yeast extract 
2% (w/v) Bacto-peptone 
2% (w/v) glucose 
20mg/L adenine hemisulphate 
69 
 
10mg/L L-histidine 
20mg/L  L-leucine 
10mg/L L-tryptophan 
8mg/L uracil 
10mg/L methionine 
To make solid YPD, 2% (w/v) Bacto-agar was added.  
 
2.6.2. Minimal SD media 
1% (w/v) Bacto-yeast nitrogen base 
2% (w/v) glucose 
To make solid SD, 2% (w/v) Bacto-agar was added. 
 
2.7. Fly Methods 
 
2.7.1. Drosophila Stock Maintenance 
Unless otherwise stated, stocks can be maintained by periodic mass transfer of 
adults onto approximately 5ml fresh fly food in a 20ml vial. A small amount of 
baker’s yeast is sprinkled over the surface of the fly food within the vial before 
use. To transfer, vials are tapped to bring flies away from the plug before it is 
removed.  The vial is then rapidly inverted over one containing fresh food and 
tapped to bring flies to the base of the new vial before plugging. General stocks 
are maintained at 18⁰C at which temperature generation time from egg to adult 
is approximately 19 days. These stocks are transferred every three weeks. The 
temperature for normal experimental conditions is 25⁰C. At this temperature the 
generation time is around 21 days, and stocks must be transferred every two 
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weeks for maintenance, or every day if flies are required for embryo harvesting, 
up to five days prior to use.  
2.7.2. Embryo Harvesting 
Flies are transferred into a fresh vial containing either general fly food as before, 
or to encourage laying, into vials containing 30% apple juice agar. In either case 
a  tiny amount  of  baker’s  yeast  is  sprinkled onto  the  surface of  the  food/agar, 
and the vial inverted and tapped to remove excess before transferring flies as 
before. Flies are kept at 25⁰C for the appropriate amount of time for laying. This 
will depend upon the application for which embryos will be used. After this time, 
flies are transferred to a fresh vial, 1xPBS-T (0.1%) is added to the vial 
containing the embryos, and using a soft paintbrush, embryos are carefully 
dislodged from the surface of the food/agar. Embryos are then collected and 
washed three times with 1xPBS-T (0.1%) using a vacuum manifold to remove 
food and debris.   
2.7.3. Drosophila Viability Studies 
Well fed flies were transferred to fresh vials containing 30% apple juice agar 
and left for up to 3h. Embryos were harvested as described in section 2.7.2. and 
transferred  onto  3%  agar  plates  supplemented  with  a  spot  of  baker’s  yeast 
paste as food once hatched. Plate lids were modified to incorporate a ventilation 
hole, plugged with sponge.  One hundred embryos per plate, in ten groups of 
ten embryos were transferred, all of which were collected from the same 
embryo harvest. Plates were sealed with parafilm to avoid escape, and left at 
25⁰C for development.  This was replicated five times per line. Once hatched, 
first instar larvae were counted and monitored to third instar stages where they 
were counted again and transferred into general food vials for development into 
pupae. The number of third instar larvae which developed into pupae stages 
was recorded, and vials were left for further development and hatching into 
adult flies.  
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2.7.4. Embryo Dechorionation – Manual Method 
For applications such as live imaging of embryos and microinjection, embryos 
must be dechorionated manually.  To manually dechorionate embryos, normal 
harvesting is carried out and embryos transferred onto a microscope slide 
prepared with double-sided tape. This adhesive surface holds the embryos in 
position to allow the chorion to be removed manually. Fine forceps are then 
used to gently massage the chorion to separate it from the embryo. Once 
separated, forceps can be used to remove the top part of the chorion, and the 
embryo can then be lifted away, leaving the remaining chorion adhered to the 
slide.  
2.7.5. Embryo Dechorionation – Bleach Method 
For applications such as heptane/methanol fixation and immunostaining, 
embryos were dechorionated using the bleach method. Embryos were left in the 
vacuum manifold after harvesting and 60% thin bleach was added for two min 
with regular agitation. The bleach was then drawn away and embryos washed 
three times in 1xPBS-T (0.1% tween) followed by once in dH2O.  
2.7.6. Preparation of Living Syncytial Embryos for imaging 
Well fed adult flies were transferred into a fresh vial (fly food or apple agar) and 
left for 45-60 min. Embryos were harvested (as in 2.7.2) and manually 
dechorionated as described in section 2.7.4. A thin strip of glue was placed onto 
a coverslip and left for 3 min before the dechorionated embryos were placed 
onto and adhered to the glue strip, and immediately immersed in Voltalef 10S 
oil (a 5:1 mixture of Holocarbon 700 oil and 27 oil, Sigma) to prevent 
dehydration. The living embryos were then visualised using confocal 
microscopy.  
2.7.7. Heptane/Methanol Fixation of Embryos 
Embryos were harvested as normal and dechorionated using the bleach 
method. Embryos were then transferred to a 1.5ml eppendorf tube and 500µl 
heptane was added to permeabilise the vitteline membrane. An equal volume of 
cold methanol was added immediately and the tube shaken vigorously for one 
min. Embryos were left to settle to the bottom of the tube and for the heptane 
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and methanol to separate. The heptane and methanol were carefully removed. 
Any old, and therefore unsuitable, embryos will float between the heptane and 
methanol layers and were also removed. Embryos were then washed three 
times in cold methanol. At this point they can be stored at 4⁰C, or the methanol 
can be removed before use.  
2.7.8. Formaldehyde Fixation of Embryos 
In cases whereby embryos express a transgenic fluorescent protein signal, and 
the retention of this signal is desired, heptane/methanol fixation is unsuitable. In 
these cases formaldehyde fixation was carried out. Embryos were harvested 
and dechorionated using 60% bleach as before, transferred into a 1.5ml 
eppendorf tube and incubated with 750µl 3.7% formaldehyde in 1xPBS for 30 
min at room temperature with gentle rotation. With proteins now preserved, the 
formaldehyde was carefully removed and replaced with 500µl cold methanol 
and incubated at -20⁰C for 15 min for further fixation. At this point embryos can 
be stored at -20⁰C or the methanol removed before use.  
2.7.9. Preparation and Imaging of Third Instar Larval Neuroblasts 
Drosophila late third instar larvae were removed from vials and washed in 1x 
PBS to remove food debris and placed in a drop of 1xPBS on a clean 
microscope slide for dissection. Brains were isolated by holding the larval body 
and mouth parts with fine forceps and pulling in opposite directions. The 
adjacent tissue was carefully removed and the isolated brain placed in a fresh 
drop of 1x PBS on a clean coverslip. Once 2-5 brains were isolated in this way, 
they were covered and lightly flattened with a second coverslip, each brain into 
a disc of approximately 2mm in diameter. Excess liquid was removed using filter 
paper and the flattened brains were observed under a dissecting microscope to 
ensure adequate spread of the brain tissue. The coverslip was sealed around 
the periphery, leaving a small unsealed area for ventilation, using 10S oil. When 
prepared this way, brains were flattened to provide clear protein localisation 
images, although cells were non-viable under these conditions. Images were 
recorded using a spinning disc confocal microscope. 
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2.7.10. Preparation and Imaging of Live Third Instar Larval    
Neuroblast 
Drosophila late third instar larvae neuroblasts were dissected as described in 
2.7.9. A coverslip was prepared, using a fine paintbrush to create a well in the 
centre of the coverslip using grease. The fresh brain was mounted into a drop of 
Drosophila S2 culture medium containing penicillin and streptomycin, plus any 
appropriate drugs/inhibitors within the well. A piece of breathable standard 
membrane was cut to size and lowered onto the sample, using a soft paintbrush 
to flatten the sample and seal the membrane onto the grease well. Neuroblasts 
were gently flattened using a soft paintbrush, allowing excess culture medium to 
escape from the grease well to leave a minimal layer of media around the 
partially flattened neuroblasts. The slide was then visualised using a spinning 
disk confocal microscope. Using the appropriate settings, cells in these 
conditions were viable for up to three h.  
 
 
 
 
 
Culture medium 
   
 
 
.  .  . 
   
Standard membrane 
Grease well 
Coverslip Neurobasts 
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2.7.11. Imaging TF4;B4-2 Neuroblast cells 
Imaging settings were optimised for the TF4 and TF4;B4-2 fly lines to allow the 
highest quality image capture whilst still allowing cells to be viable. The settings 
used in all cases were as follows: 
 
Bit-scale enabled: Yes 
Laser: 22% 
Exposure: 150ms 
 
2.7.12. Imaging TM2-413;B4-2 Neuroblast cells 
Imaging settings were optimised for the TM2-413 and TM2-413;B4-2 fly lines to 
allow the highest quality image capture whilst still allowing cells to be viable. 
The settings used in all cases were as follows: 
 
Bit-scale enabled: Yes 
Laser: 17% 
Exposure: 150ms 
2.8. Molecular Biology 
2.8.1. Polymerase Chain Reaction (PCR) 
The DNA insert fragments used to generate all constructs, including those used 
in antibody production and purification, were amplified from cDNA plasmids or 
genomic DNA using PCR. In these instances, HotStarTaq® DNA Polymerase 
(Qiagen) was used. A typical reaction mixture using the HotStarTaq®kit had a 
total volume of 100µl per reaction, assembled as follows: 
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 Component   Volume  Final Concentration 
10x PCR Buffer     10µl   1x 
 dNTP Mix (10mM of each)     2µl   200µM of each dNTP 
 Sense primer (50µM)     1µl   0.1-0.5µM   
 Antisense primer (50µM)     1µl   0.1-0.5µM 
 Template DNA      Variable  1µg maximum 
 HotstarTaq® polymerase     0.5µl  2.5 units 
 Distilled water     up to 100µl  - 
 
For amplification of DNA templates used in reverse transcription reactions to 
generate DNA, GoTaq® HotStart Polymerase (Promega) was used. A typical 
100µl reaction mix was assembled as follows: 
 
 Component   Volume  Final Concentration 
 GoTaq® Flexi Buffer       20µl  1x 
 MgCl2 Solution (25mM)       4µl  2.0mM 
 PCR nucleotide mix (10mM)    1µl   0.2mM each dNTP 
 Sense primer (50µM)       1µl  0.1-0.5µM 
 Antisense primer (50µM)       1µl  0.1-0.5µM 
 Template DNA        Variable            1µg maximum 
 GoTaq®HotStart Polymerase   0.5µl  2.5 units 
 Nuclease-free water        up to 100µl  - 
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Variations in reaction mixture depended on the length DNA being amplified and 
the primers used. In all cases the PCR reaction was carried out on a Hybaid 
PCR Sprint Thermal Cycler (Thermo Scientific, SPRT001).  A typical program is 
as follows: 
 
  
Initial activation step:    5 min    95⁰C 
 3-step cycling (25 Cycles): 
‐ Denaturation   1 min   94⁰C 
‐ Annealing   1 min   55⁰C (Tm) 
‐ Extension   1 min   72⁰C 
Final extension:   5 min   72⁰C 
Hold:                   -   4⁰C 
 
The annealing temperature was calculated according to primer sequence length 
using the following formula: Tm = 2AT + 4GC. The extension time was varied 
according to the length of the target fragment, for both HotstarTaq® polymerase 
and GoTaq®HotStart Polymerase 1 min per 1Kb of DNA to be amplified was 
allowed. All oligonucleotides were purchased from Sigma-Genosys (details of 
primers can be found in table 2.1).  PCR products were analysed by agarose 
gel electrophoresis (see 2.11.3), and bands of expected size were excised and 
purified using QIAquick® Spin Gel Extraction Kit (Qiagen). 
 
2.8.2 Restriction Digest 
All restriction enzymes (Promega) were used with their optimal buffer and 
incubated at their optimal temperature, usually 37⁰C (in accordance with the 
77 
 
Promega Life Sciences catalogue 2008) for a minimum of 1.5 h.  A typical 
digest was be performed in a volume of 20µl on 0.2-1.5µg of substrate DNA, 
assembled in the following order: 
 
 Component   Volume 
 Sterile water    Variable 
 10x Buffer   2µl 
 Acetylated BSA  0.2µl 
 DNA    Variable  
 Mix by pipetting, then add: 
 Restriction enzyme  0.5µl 
 
For applications such as sub-cloning, whereby DNA fragments generated were 
to be purified or vectors cut and ligated, this was scaled up to a 100µl final 
reaction volume in order to allow higher yields of DNA fragments to be isolated 
for use. All digests were analysed by agarose gel electrophoresis (see section 
2.8.3).   
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Table 2.1. Primers used within this thesis. 
Primer 
name 
 Details Sequence Enzyme 
site 
B A C T H     
JY424 
 
5’ BubR1 N-
terminal WT 
fragment 
GTCGACTATGGACTTTGACAATG
CGAAAGAGAACATTCAGCG 
SalI 
JY425 5’ BubR1 N-
terminal KEN-
AAA mutant 
fragment 
GTCGACTATGGACTTTGACAATG
CGGCAGCGGCCATTCAGCCG 
SalI 
JY426 3’ BubR1 N-
terminal fragment 
GAGCTCTGAGGCCTGTTCTTGGCC
ACAAAGTTTGTCGGAAAT 
StuI 
JY427 5’ BubR1 Kinase 
domain fragment 
CATATGATTGCCTCGTTT NdeI 
JY428 3’ BubR1 Kinase 
domain fragment 
GAGCTCGGTTTCTGCAATATCGTG
TTA 
SacI 
JY435 5’ pUT18 adaptor 
oligo 
CTGCAGGCTCGAGTGGTACCAGG
CCTCATATGGAATTCGAGCTC 
SphI 
JY436 3’ pUT18 adaptor 
oligo 
AATTGAGCTCGAATTCCATATGA
GGCCTGGTACCACTCGAGCCTGC
AGCATG 
EcoRI 
JY453 5’ P25N adaptor 
oligo 
(phosphorylated) 
CGATATGAGCGGATAACAATTTC
ACACAGGAAACAGCTGCGGCCGC
ACTAGTGCATGCAT 
ClaI 
JY454 3’ P25N adaptor 
oligo 
(phosphorylated) 
CGATGCATGCACTAGTGCGGCCG
CAGCTGTTTCCTGTGTGAAATTGT
TATCCGCTCATAT 
ClaI 
JY457 5’ Mad2 fragment 
for BTH 
GCG GCGGCC GCATGTCAA 
CTGCCCAGGCGA C 
NotI 
JY458 3’ Mad2 fragment 
for BTH 
GCG GCA TGC TTA AGT GCT CAT 
CTT GTA GTT GAC 
SphI 
Y T H     
JY472 5’ BubR1 N-
terminal WT 
AA TAT AAC CCG GGG ATG GAC SmaI 
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fragment  TTT GAC AAT GCG 
JY473 5’ BubR1 N-
terminal KEN-
AAA mutant 
fragment 
A TAT AAC CCG GGG ATG GAC 
TTT GAC AAT GCG GCA GCG GCC 
ATT CAG CCG 
SmaI 
JY474 3’ BubR1 N-
terminal fragment 
AT AAT TGC TAG CCG TCG CTC 
GTT AAG TTC C 
NheI 
JY475 5’ BubR1 Kinase 
domain fragment 
for Y2H 
TTA TAT CAT ATG ATT GCC TCG 
TTT ATG AAA G 
NheI 
JY476 3’ BubR1 Kinase 
domain fragment 
TTA TAT GTC GAC CTA TTT CTG 
CAA TAT CGT G 
SalI 
JY477 5’ Fizzy fragment AA TAT AAC CCG GGG ATG TCG 
CAG TTC AAT TTT GTG 
SmaI 
JY478 3’ Fizzy fragment TTA TAT GTC GAC CTA ACG GAT 
GCT CTG TCG GAA C 
SalI 
JY481 5’ Adaptor oligo for 
use in pBridge 
MCSII 
C ATG GCG CGG CCG ATG CAC 
GGA 
NcoI 
JY482 3’ Adaptor oligo for 
use in pBridge 
MCSII 
G ATC TCC GTG CAT CGG CCG 
CGC 
BglII 
JY489  Mad2 fragment 
for MCSII of 
pBridge 
TTAAATGCGGCCGCATGTCAACT
GCCCAGGCG 
NotI 
JY480 3’ Mad2 fragment 
for MCSII of 
pBridge 
AT 
ATACCATGGTTAAGTGCTCATCTT
GTAGTTG 
NotI 
JY490  pBridge MCSII 
adaptor oligo 
GGCCAATTTTACGACCATGGGGA
TTAA 
NotI 
JY491  pBridge MCSII 
adaptor oligo 
CGTTAAAATGCTGGTACCCCTAAT
TCTAG 
BglII 
A ntibody     
JY437 5’ BubR1-MBP 
fusion 
GAATTCATGGACTTTGACAATGC
G 
EcoRI 
JY438 3’ BubR1-MBP 
fusion 
GTCGACAATCGGAATATTTCCCTC
A 
SalI 
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JY439 5’ Fizzy-MBP 
fusion 
GAATTCTCCGGCGATAAGTCCGA
T 
 
EcoRI 
JY440 3’ Fizzy-MBP 
fusion 
GTCGACCCCCTCCTGGATCCACG
A 
 
SalI 
JY441 5’ Mps1-MBP 
fusion 
GAATTCGATAGCATAAGCTTCTCC 
 
EcoRI 
JY442 3’ Mps1-MBP 
fusion 
GTCGACAGGAAGGTTGGTGGTGT
A 
 
SalI 
dsRN Ai     
JY467 5’ Fizzy 3'UTR + 
T7 Promoter 
GCGTAATACGACTCACTATAGtatg
ctcagacctttagaactgtt 
- 
JY468 3’ Fizzy 3’UTR + 
T7 Promoter 
GCG 
TAATACGACTCACTATAGtcagaatgt
caagcattttattta 
- 
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2.8.3. DNA Gel Electrophoresis 
Typically 0.8% agarose gels in 1x TAE running buffer were used for analysis, 
unless otherwise stated. After dissolving with heat, the gel was cooled and 
ethidium bromide (CLP®) was added to a final concentration of 0.5µg/ml before 
pouring. DNA samples were mixed with 1x DNA loading dye before gels were 
run in a DNA running tank (Minnie the gel cicle, Hoefer).  In each case a 1Kb 
DNA ladder (New England Biolabs) was run alongside DNA samples in order to 
determine the size of DNA fragments.  Gels were run at a constant voltage of 
100V for 20-40 min in 1x TAE running buffer. Visualisation of bands by 
integrated ethidium bromide (under UV light) was photographed by BioGene 
BV2040 gel documentation system using Grabber 3.00D software.  
 
2.8.4. DNA Extraction from Agarose Gels 
For extraction of DNA fragments 70bp-10Kb, bands of interest were excised 
from agarose gels following electrophoresis and DNA was extracted using the 
QIAquick® Spin Gel Extraction Kit (Qiagen), according to standard protocol 
(including optional steps). In cases where concentrated DNA was required, like 
samples were pooled and run through a single spin column to ensure maximum 
binding, with elution in 30µl buffer EB, applied directly to the centre of the 
column membrane and incubated for 1-2 min before spinning.  
 
2.8.5. Ligation of DNA fragments into Vectors 
Ligation was performed in a sterile 0.5ml eppendorf tube in a final reaction 
volume of 10µl. Reactions were set up with a Vector Plasmid concentration to 
insert DNA concentration of 1:9, together with 1U T4 DNA Polymerase in 1x 
ligase buffer (Roche). The ligation was carried out on a Hybaid PCR Sprint 
Thermal Cycler (Thermo Scientific, SPRT1001) for 16-20 h at 16⁰C.  
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2.8.6. Transformation of DNA constructs into Bacteria 
Unless otherwise stated, Escherichia coli NovaBlue strains (Novagen and lab) 
were used for amplification of all plasmids. Escherichia coli BL21 strains 
(Novagen) were used for the expression and purification of proteins. 5µl of the 
ligation reaction (see section 2.8.5) were added to 50µl of competent cells in a 
1.5ml eppendorf tube and incubated on ice for 30 min, briefly vortexing after 15 
min. Cells were then heat shocked for 45 sec at 42⁰C before being returned to 
ice for a further 2 min. 500µl of S.O.C (Super Optimal broth with Catabolite 
repression) medium (Novagen) or LB was added to the cells and incubated with 
shaking at 37⁰C for 1 hour.  Transformed cells were plated onto 2% LB agar 
containing the appropriate antibiotic. For constructs allowing blue/white 
selection, X-gal  (final  concentration  40µg/ml)  and  IPTG  (Isopropyl  β-D-
Thiogalactopyranoside) (final concentration 120µg/ml) were added. Plates were 
inverted and incubated overnight at 37⁰C.  
 
2.8.7. Plasmid DNA Preparation 
Single colonies were picked from plates using sterile tips and grown in 7-9ml LB 
medium, containing the appropriate antibiotic, in a 50ml falcon tube overnight at 
37⁰C with 200rpm shaking in an orbital incubator (Gallenkamp, Sanyo). 
Overnight cultures were spun at 10000xg for 5 min, supernatant was poured off 
and inverted tubes blotted on a clean paper towel to remove excess media. The 
plasmid DNA was then extracted using the Wizard® Plus SV Minipreps DNA 
Purification System, according to standard centrifugation protocol (see Promega 
technical bulletin for Wizard® Plus SV Miniprep DNA Purification System).  The 
final plasmid DNA was eluted from the spin column in 60µl nuclease free water, 
applying the water to the column membrane and incubating for 2-5 min before 
elution.  
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2.8.8. DNA Sequencing 
Routine sequencing was performed to verify the correct insert sequence within 
each construct generated.  Miniprep samples, prepared using the Wizard® Plus 
SV Minipreps DNA Purification System (Promega), were diluted so that 15µl 
contained approximately 200ng/µl DNA and were subsequently sent to The 
Sequencing Service, College of Life Sciences, University of Dundee. 
Sequencing primers were dependent upon the vector used. Common primers 
include T3/T7 and SP6 (for vectors such as pGEM-T and pCAL-n).  
 
2.9. Biochemical Methods 
 2.9.1. SDS-PAGE Gel and Western Blotting 
Protein samples were prepared in 1x protein sample loading buffer, at a 
concentration which allowed optimal loading of 10-20µl per sample.  Samples 
were boiled for 10 min at 95⁰C and spun at 1300rpm for 30 sec to remove 
debris before loading onto a NuPAGE® 10% or 12% Bis-Tris pre-cast gel 
(Invitrogen). To separate proteins, the gel was run at 200V for around 60 min 
(variable depending on the size of the protein of interest) in NuPAGE® MOPS 
SDS Running Buffer (Invitrogen), within a Novex Mini-Cell gel tank (Invitrogen). 
For gels run longer than 90 min, gel tanks were packed with ice to avoid 
overheating. Proteins were then transferred onto a 0.2µm reinforced Cellulose 
Nitrate Membrane (Schleicher & Schuell) in transfer buffer at 70V using a 
Trans-Blot Cell (BioRad). Membranes were blocked at room temperature for 1 
hour with shaking in Odyssey Blocking Buffer (Li-Cor). Primary antibodies were 
prepared in 1:1 Odyssey Blocking Buffer (Li-Cor): PBS-T (0.1%) at a dilution of 
1:500, and incubated overnight at 4⁰C with shaking. Following primary antibody 
incubation, membranes were washed three times for 10 min in PBS-T (0.1%) 
with shaking. Infrared-labelled secondary antibodies, Alea Flour 680 goat anti-
rabbit IgG (Molecular Probes) and IRDye 800 donkey anti-mouse IgG 
(Rockland), were added at a dilution of 1:5000 in 1:1 Odyssey Blocking Buffer 
(Li-Cor): PBS-T (0.1%) and incubated away from light for 1 hour at room 
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temperature with shaking. The membrane was washed three times in PBS-T as 
before, then a final time for 5 min in PBS to remove excess Tween-20. 
Membranes were then scanned using the Odyssey® Infrared Imaging System 
(Li-Cor). The fluorescence intensity of bands of interest was quantified using 
TINA (version 2.09) software.  
 
2.9.2 Antibody Preparation and Purification 
2.9.2.1. Generation of pMalc2x constructs, and protein expression  
BubR1, Mad2 and Mps1 full length fragments were generated by PCR (see 
primer table 2.1) and subcloned into EcoRI –SalI of pMalc2x expression vector 
(see 2.8.5). Constructs were transformed into BL21 cells (see 2.8.6.) and the 
protein expression induced with IPTG. Inductions for pMalc2x and pCal BubR1, 
Fizzy and Mps1 constructs were set up by inoculating a single transformed 
colony into 4ml of 2XYT broth with appropriate antibiotic and grown overnight at 
37⁰C with shaking (200rpm). 100µl of each culture were diluted into 1L 2XYT 
media supplemented with 2g glucose, and grown overnight at 16⁰C. The 
following day, once the OD of the cultures had reached approximately 0.9nm, 
cultures were induced with 0.2mM IPTG and grown at 20⁰C at 200rpm for five 
h. Cultures were spun at 4000g for 20 min and pellets resuspended in 50ml 
column buffer + inhibitors, ready for column purification.  
 
2.9.2.2. Affinity Column Antibody Purification 
Affinity columns were prepared as described by the AminoLink Plus Coupling 
Gel protocol. Approximately 30 mg of antigen were coupled per 2.5 ml of beads 
(5.0 ml 50% slurry).  Sera were defrosted at room temperature before being 
transferred to 50 ml Falcon tubes and placed on ice. Storage buffer was drained 
from the affinity column before washing with 2.5 ml PBS. The sera was drawn 
through the column, with flow through collected in a 50 ml Falcon tube on ice. 
This was repeated several times to ensure all antibody was removed. After the 
final sera step, the column was drained before adding 2.5 ml PBS and allowing 
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this to drain into the collection tube. The column was then washed with 50 ml 
(20 column volumes) of 0.5M KCl (in PBS), then drained and washed with 25 ml 
(10 column volumes) of PBS. After the last traces of PBS were drained from the 
column, 10 x 1 ml of 0.1M Glycine were sequentially added to the column to 
elute the antibody in 1 ml aliquots  into 1.5 ml eppendorf tubes containing 100 µl 
of 1.0M Tris-HCI (pH 8.8). As the fractions were eluted, the tubes were placed 
on ice. 10 µl of each fraction was added to 200 µl of Bradford reagent to assess 
which fractions contained the eluted protein. The peak fractions (typically 
fractions 3-5) were combined in another tube, with final antibody concentration 
determined by measuring the OD at 280 nm.   
 
2.9.3. Cdc20 in vitro Kinase Assay 
2.9.3.1. Drosophila Embryo Collection and Storage 
Flies were kept in large collection vials on 30% fruit juice agar, supplemented 
with liquid and dry yeast, for 2 days to achieve optimal laying.1-4h embryos 
were harvested. Using a vacuum manifold, embryos were washed 3x in (1X) 
PBS-T 0.1%, 2x in (1X) PBS-T, then 1x in dH2O. Embryos were de-chorionated 
in 60% thin bleach for 2min with agitation, then washed again 3x in (1X) PBS-T 
0.1%, 2x in (1X) PBS-T, then 1x in dH20. Embryos were transferred to a clean 
1.5ml tube before being snap frozen in liquid nitrogen before being stored at      
-80⁰C until use. From this point, embryos were not allowed to thaw. 
2.9.3.2. Cross-linking GFP Antibody to DYNAL Dynabeads 
The protocol described is for 100µl of Dynabead slurry= 50µl pure beads. (This 
is sufficient for 5x kinase samples/reactions @ 20µl per sample). 100µl of 
resuspended slurry was transferred to a clean 1.5ml tube before being placed 
on a magnetic separator for 1-2min, and the supernatant removed. Beads were 
washed by fully re-suspending in 500µl of 0.1M Na-Phosphate buffer (pH 8.1), 
before being returned to the magnet for 1-2min and the supernatant removed. 
This wash step was repeated 3x further. After the final wash, beads were 
returned to their original volume (in this case 100µl) of Na-Phosphate buffer (pH 
8.1) including 10µl of the GFP-serum (Abcam Rabbit polyclonal to GFP –ab290) 
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(90µl Na-Phosphate buffer, 10µl serum). Beads were incubated at room 
temperature, with rotation, for 50min.The beads were then washed in 500µl Na-
Phosphate buffer (pH8.1) x4 as described previously. After the final wash, 
beads were re-suspended in the original volume (100µl) of Na-Phosphate 
buffer. Beads were now ready for use, or could be stored at 4⁰C (with 0.1% 
azide) until use. 
2.9.3.3. Drosophila Embryo Extract Preparation  
One kinase assay sample (one lane of final input gel) = 0.07g of embryos 
(prepared as above). A pestle and mortar was stood in a small tray filled with 
liquid nitrogen and 0.07g of frozen embryos were ground into a powder using 
the frozen pestle and mortar. The powder was then transferred to a clean 1.5ml 
tube (also standing in liquid nitrogen to prevent thawing of sample). 100µl of ice 
cold homogenisation buffer A was added to the powder and the powder allowed 
to dissolve on ice with gentle agitation. The sample was left on ice for a further 
10min to allow lysis to occur (flicking tube to agitate after the first 5min, then 
returning to ice for the final 5min). The sample was centrifuged at max speed for 
30min at 4⁰C, and the supernatant transferred to a clean tube (x2), before being 
spun at max speed for 15min at 4⁰C and the supernatant removed and 
transferred to a clean tube as before (x2). The final cleared lysates were 
transferred to a clean 1.5ml tube, ready to be used in the immunoprecipitation 
experiment (IP).  
 
2.9.3.4. Immunoprecipitation 
GFP-Dynabeads were equilibrated in homogenisation buffer A by placing beads 
on a magnetic separator for 1-2min, removing supernatant, and re-suspending 
in 500µl of homogenisation buffer A (x3). Beads were resuspended in 
homogenisation buffer A to their original volume (in this case 100µl). For each 
sample, 20µl of equilibrated GFP-Dynabeads (equivalent to 10µl pure beads) 
were added to the cleared lysate/embryo extract (equivalent to 0.07g of 
Drosophila embryos). The samples were incubated overnight with rotation at 
4⁰C.  
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The following day, the beads/samples were placed on a magnetic separator for 
1-2min and the supernatant removed (but not discarded – used in post-IP 
blot).The beads were then washed (using the magnetic separator as before) x4 
in 500µl homogenisation buffer B (containing both phosphatase and protease 
inhibitors). The beads were now ready for use in the kinase reaction. 
2.9.3.5. The Kinase Reaction: 
The beads were washed (using the magnetic separator as before) in 500µl 
kinase wash solution (x5). After the final wash, beads were re-suspended in 
100µl kinase wash buffer and stored on ice until use. At this point, 3µl of beads 
from each sample were taken, added to 27µl of 2x protein sample buffer (SB) 
and boiled 5-10min to be later run on a western blot as the loading control for 
the kinase gel. The kinase reaction mix (without ATP32P) was prepared, 
sufficient for all samples. ATP32P was added to the appropriate amount of 
prepared kinase reaction mix (in accordance to its current activity) to a final 
activity of 50µCui/100µl. Beads were isolated from supernatant using a 
magnetic separator. 10µl of the complete kinase reaction mix were added to 
each bead sample, before samples were placed at 30⁰C for 30min to allow the 
kinase reaction to occur. 10µl of 2xSB was added to each bead sample and 
boiled at 95⁰C for 5min. Samples were placed briefly on ice before the beads 
were again separated from the supernatant using the magnetic separator. The 
supernatant was transferred to a clean tube for loading onto the kinase gel (a 
pre-cast 4%-15% gradient gel). Full samples were loaded in each case, and the 
gel run at 200V until the smallest protein of interest (in this case histone) and 
the largest protein (in this case GFP-Fizzy) were at appropriate positions on the 
gel according to the size marker. After running, the gel was washed in 5% TCA, 
1% Na Pyrophosphate for 1 h with shaking. The wash was changed and left 
overnight with shaking. The following day, the 5% TCA, 1% Na Pyrophosphate 
wash was changed and the gel incubated for a further hour. The gel was placed 
in Safe Stain for 2h, then washed and dried between gel-drying films in 1% 
glycerol. After drying (1-2days), the gel was exposed to phospho-image plate 
for around 5-6 h and analysed.  
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2.10. S. cerevisiae techniques 
2.10.1. Y190 strain and growth conditions 
The S. cerevisiae strain Y190 (genotype: MATa gal4-542 gal80-538 his3 trp1-
901 ade2-101 ura3-52 leu2-3,112 URA3::GAL1-LacZ Lys2::GAL1-HIS3cyhr) as 
used in the yeast three hybrid experiments in this thesis. Cultures were grown 
at 30⁰C in either rich YPD or minimal SD media. SD media was supplemented 
(as appropriate) with adenine hemisulphate (20mg/L), L-histidine (10mg/L), L-
leucine (20mg/L), L-methionine (10mg/L), L-tryptophan (10mg/L) and uracil 
(8mg/L) (All supplied by Sigma Aldrich). When making solid media, 2% (w/v) 
Bacto-Agar was added. 
2.10.2. Lithium acetate transformation of S. cerevisiae cells 
To account for all 14 samples, 300ml mid-log-phase-growing (OD660 nm 0.4; 
5x106 cells/ml) Y190 cells were split into 3 x 100ml aliquots, each of which were 
pelleted by centrifugation, washed with 1ml LiAc/TE (0.1M LiAc pH 7.5, 10mM 
Tris-HCI pH 7.5, 1mM EDTA pH 8.0) and resuspended in 1ml LiAc/TE. 200µl of 
cells were mixed with 20µg denatured salmon sperm DNA (Stratagene), 1-10ng 
of plasmid DNA and 1.2ml PEG/LiAc/TE (0.1M LiAc pH 7.5, 10mM Tris-HCI pH 
7.5, 1mM EDTA pH 8.0, 40% (w/v) PEG 4000), and incubated with shaking for 
30min at 30⁰C. Cell suspensions were heat shocked at 42⁰C for 15min, then 
pelleted at 6,000 rpm for 30 sec. Cells were washed with 1ml dH2O and plated 
onto selective SD agar plates which were incubated at 30⁰C for 3-4 days. 
2.10.3. β-galactosidase filter assay 
Colonies were transferred onto Whatman #3 filter paper by placing the filter 
across the surface of the plate, and peeling away. The filters were then placed 
in liquid nitrogen for 30sec and then allowed to thaw at room temperature on a 
flat surface. 3 ml Z-buffer (60 nM Na2HPO4.7H2O, 40 mM NaH2PO4.H2O, 10 
mM KCl, 1mM MgSO4.7H2O),  8.1  µl  β-mercaptoethanol and 40 µl X-gal 
(20mg/ml in dimethylformamide) was added to the lid of a petri dish and 
Whatman #50 filter paper was placed into the lid and allowed to absorb the 
buffer. The thawed #3 filter was then carefully placed on top of the #50 filter, 
89 
 
colony side up. Plates were incubated at 37⁰C until the development of blue 
colour. 
90 
 
Chapter 3: Investigating the role of Cdc20 phosphorylation by 
Cdk1 in Cdc20 localisation and its incorporation into the MCC 
upon SAC activation 
3.1. Introduction 
Cdc20 regulation involves changes in its abundance during the cell cycle, with 
levels negligible during G1, rising to their peak in mitosis, before rapidly 
declining (Weinstein, 1997). But with findings which implicated cell-cycle 
dependent Cdc20 phosphorylation, it is now believed that this also has a role in 
the regulation of Cdc20 and its ability to activate the APC/C. Levels of Cdc20 
phosphorylation in mammalian cells have been reported to be maximal during 
G2, dropping during the G2-M phase transition, whilst expression of Cdc20 is 
actually still rising (Weinstein, 1997). This finding implied that Cdc20 
phosphorylation actually precedes its increase in abundance. Subsequent 
investigation into conditions in which Cdc20 is phosphorylated suggested an 
association between increased phosphorylation and mitotic arrest, both by the 
microtubule depolymerising agent nocodazole (Kramer et al., 1998) and in 
Xenopus eggs naturally arrested in metaphase II by cytostatic factor (CSF) 
(Lorca et al., 1998). This lead to questions as to whether the phosphorylation of 
Cdc20 may negatively regulate the action of the APC/C, as the observed 
increase of Cdc20 phosphorylation during mitotic arrest, corresponds with the 
inhibition of APC/C activity observed during the spindle checkpoint response. 
There are conflicting reports regarding the role of Cdc20 phosphorylation in the 
regulation of APC/C activity. At least three kinases (Cdk1, MAPK and Bub1) 
have been implicated in Cdc20 phosphorylation, with various potential 
phosphorylation sites observed across species. It is therefore plausible that 
phosphorylation of Cdc20 at different sites, by a number of different kinases, 
may have different roles in the checkpoint response. Whether the MCC forms at 
unattached kinetochores with recruitment of individual components, or already 
exists as subunits which come together upon checkpoint activation to form the 
complex as a whole, is still a topic for debate. If MCC subunits such as Cdc20-
Mad2 exist outside of the checkpoint response and in non-mitotic cells, 
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potentially only forming the complex as a whole upon checkpoint activation, 
would these too be affected by the inability of Cdc20 to be phosphorylated? 
Could the phosphorylation of Cdc20 by kinases who’s activity peaks at mitosis 
or upon activation of the checkpoint, be involved in the difference between 
checkpoint protein complexes which are formed at kinetochores during the SAC 
response and those which already exist?  
The experiments in this chapter were designed to establish a Drosophila 
working model, in which the potential effect of disturbing the potential 
phosphorylation of Cdc20 by Cdk1 could provide a system for studying MCC 
formation in which Cdc20 kinetochore localisation is perturbed. If this were to be 
successful, the requirement of direct kinetochore interaction with Cdc20 in the 
formation of the MCC could be established, providing a new and insightful 
method for investigating the formation of inhibitory complexes upon SAC 
activation in Drosophila.  
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3.2. Results: 
3.2.1 Drosophila Fizzy carries three potential Cdk1 consensus 
phosphorylation sites on Thr63, Thr78 and Thr82 within the N-terminal of 
the protein.  
The Drosophila homologue of Cdc20 (Fizzy) contains an N-terminal Mad2-
binding domain, as observed in humans and Xenopus (Fig 1A). To identify 
whether the N-terminal of Drosophila Cdc20 also contains potential sites for 
Cdk1 phosphorylation, the protein sequence of Fizzy was analysed using a 
bioinformatic motif scan website (http://scansite.mit.edu/motifscan_seq.phtml), 
which performs proteome-wide prediction of cell signalling interactions using 
short sequence motifs (Kraft et al., 2005).  
Scansite analysis highlighted three potential consensus sequences for Cdk1 
phosphorylation, all of which reside within the N-terminal region, the predicted 
Mad2 binding region of Fizzy. The residues implicated for phosphorylation were 
Thr63, Thr78 and Thr82. These residues are consistent with the conserved 
phosphorylation sites observed in human and Xenopus.  
3.2.2 Generation of transgenic fly lines for the study of Fizzy Thr63, Thr78 
and Thr82 as potential phosphorylation sites. 
In order to study the relationship between the phosphorylation on these three 
potential Cdk1 sites (Thr63, Thr78 and Thr82) and their relevance on the SAC 
function of Fizzy, previous lab members point-mutated these residues to alanine 
singly, doubly or all three together by site-directed mutagenesis PCR. These 
mutated plasmid DNA constructs were then fused with a GFP-tag at each of 
their  5’end,  at  the  beginning  of  the  open reading frame (ORF). These fusion 
DNA constructs were then subcloned into a P-element-mediated transgenic 
expression vector (pWRubq vector, from Nick Brown, Cambridge University) as 
described in materials and methods.  Transgenic fly lines were generated by 
standard P-element-mediated transgenic procedure (Salmon and Ahluwalia, 
2009) to express either a wild-type GFP-tagged Fizzy protein (TF4 line in stock) 
or a potential phosphorylation defective mutant protein (TF41) in which Thr63, 
Thr78 and Thr82 were all substituted for Ala using PCR-site-directed 
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mutagenesis (Figure 3.1B) (performed by G. Morley, microinjection performed 
by M. Pal). In order to study the effect of the potential phosphorylation site 
mutations on the localisation of Fizzy on the mitotic apparatus (particularly the 
kinetochores) as well as the interaction with other SAC components, a 
Drosophila line null for endogenous Fizzy protein was needed. In this case, 
once the GFP-Fizzy fusion protein is introduced, the only Fizzy protein present 
would be that of the GFP-fusion proteins. This would allow comparison between 
ectopically expressed GFP-tagged wild-type and mutant Fizzy, in the absence 
of endogenous protein. The absence of endogenous protein avoids the potential 
of masking the effects of the mutation on the GFP-fusion proteins. 
Three fizzy mutant alleles were found to be available from Flybase, within the 
Bloomington stock centre. They are fzy1, fzy3 and fzyEP1028. fzy1 and fzy3 alleles 
are embryonic lethal but the phenotypes could not be rescued by insertion of 
the wild-type GFP-fzy transgene, and are suspected to contain additional point 
mutations (Laine et al., 2009). These lines were deemed unsuitable for use in 
this particular study. The fzy EP1028 is a weak allele as it still expresses around 
20% endogenous protein, with homozygotes viable (although sick).  Therefore, 
this line was chosen for use in this study, and the transgenes were introduced 
into wild-type flies as a control (in the presence of endogenous Fizzy) and also 
in the fzyEP1028 mutant background. This would allow for analysis of the mutant 
GFP-fusion protein to be performed in the relative absence of the endogenous 
protein.  
After introduction of tf4 and tf41 transgenes into the fzyEP1028 background, 
although the wild-type and mutant GFP-fusion proteins were successfully 
expressed, unfortunately, levels of endogenous Fizzy were unexpectedly 
detected at normal levels (data not shown). The reason for this is unknown, with 
the potential of mistakes during genetic crosses unlikely (although not 
impossible) due to these genetic recombinations being repeated twice.  We 
therefore failed to express the GFP-fusion in a fizzy mutant background, in that 
only the TF4 and TF41 flies which express mutant Fizzy in the presence of wild-
type levels of endogenous Fizzy were successful (data not shown). 
94 
 
 
A 
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Figure 3.1. Potential regions of interest within Drosophila fzy, and subsequent 
constructs, for use in generating potential phosphorylation-site mutant fly lines. 
 
A) Diagram to highlight the conserved potential Cdk1 phosphorylation sites in 
human and Xenopus Cdc20 in comparison to Drosophila fizzy. Threonine at 
positions 63, 78 and 82 of the Drosophila sequence are consistent with 
evolutionarily conserved sites within the human and Xenopus sequences. B) 
Diagram to represent the P-element constructs used to generate the TF4 GFP-
Fizzy control and TF41 GFP-Fizzy phosphorylation site mutant transgenic lines. 
Constructs were generated using PCR for the wild-type TF4 and by PCR site-
directed mutagenesis to substitute threonine 63, 78, and 82 of Fizzy for alanine 
in the mutant TF41 line. P-element constructs were then used to insert the wild-
type GFP-tagged Fizzy protein or the mutant GFP-Fizzy protein into a 
background potentially null of endogenous Fizzy.  
 
T63A     T78A   T82A 
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Single mutants for these lines were also generated, with either Thr63, Thr78 or 
Thr82 substituted for Ala in the presence of endogenous Fizzy. If these sites are 
targets for phosphorylation, some sites may be specific to phosphorylation by a 
specific kinase, be it a single site or all three sites combined. For this reason, it 
was decided to focus upon the TF41 mutant line, carrying all three mutated 
sites.  
 
 
 
Figure 3.2. In the presence of endogenous Fizzy, the TF41 mutant GFP-fusion 
protein localises to kinetochores. 
The TF41 GFP-fusion protein displays normal localisation patterns in the 
presence of endogenous Fizzy (bottom panel), as shown by time-lapse imaging 
in embryos. This is comparable with that observed in the TF4 line (top panel) 
throughout mitosis.  
 
3.2.3 In the presence of endogenous Fizzy, the triple mutant Fizzy GFP-
fusion protein localises normally throughout the cell cycle. 
To determine whether the mutant Fizzy protein was capable of localising to the 
kinetochore in the TF41 fly line, GFP was visualised in syncytial embryos using 
a Leica confocal microscope. It was also visualised in the wild-type TF4 control 
line for comparison. Fizzy was clearly localised to the kinetochore during 
metaphase. Wild-type localisation patterns were observed throughout the cell 
cycle, with Fizzy absent from the interphase nucleus, moving from cytosol to 
nucleus during prophase. Fizzy was then observed to remain associated with 
the mitotic spindle throughout anaphase and telophase (Fig. 2). These data 
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suggest that in the presence of endogenous Fizzy, Thr63, Thr78 and Thr82 are 
not required for proper localisation of the GFP-fusion protein throughout the cell 
cycle in syncytial embryos.  
 
A 
 
 
Figure 3.3.  In vitro kinase assay results show a role for T63, T78 and T82 in 
Cdk1 phosphorylation of Drosophila Fizzy.  
A) Cdk1 in vitro kinase assays were carried out to determine the 
phosphorylation status of the mutant and wild-type GFP-fusion proteins. 
Embryos from a YFP-only line were used as a negative control. 
Immunoprecipitation to Dynal Dynabeads cross-linked to anti-GFP antibody 
(Abcam) was carried out using 0-4hour embryo extracts, to isolate the fusion 
proteins and YFP control. These were then subject to an in vitro kinase assay 
and incorporated P32 isotope activity was visualised using a phospho-image 
plate. Experiments were carried out in triplicate. It was observed that the TF41 
mutant line has a significant decrease in incorporated P32 (top panel), implying 
that the phosphorylation of this fusion protein is decreased in comparison to 
wild-type fusion protein. B) Quantification using TINA software revealed a 
decrease in Cdk1 phosphorylation in the TF41 mutant GFP-fusion protein of 
69% compared to that of the TF4 wild-type fusion protein. Error bars represent 
standard deviation. 
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3.2.4 Thr63, Thr78 and Thr82 of Drosophila Fizzy are phosphorylated by 
Cdk1 in vitro.  
Cdk1 was found to phosphorylate Xenopus and human Cdc20 (refer to 
introduction 1.12.) at residues conserved across both species as well as 
Drosophila. Because Scansite analysis of Drosophila Fizzy revealed that Thr63, 
Thr78 and Thr82 are predicted phosphorylation sites with Cdk1 recognition 
motifs, it was decided that analysis of the TF41 mutant GFP-fusion protein 
should be analysed with regard to the effect of these mutations on 
phosphorylation by Cdk1. 
An in vitro kinase assay was performed on the triple mutant GFP-Fizzy fusion 
protein, isolated from TF41 embryos, as well as on the wild-type GFP-Fizzy 
fusion protein isolated from TF4 embryos as a control. 0-4 hour embryos were 
collected and homogenised over liquid nitrogen, with cleared lysate subjected to 
co-immunoprecipitation with anti-GFP antibody to isolate the GFP-fusion 
proteins. A Cdk1/Cyclin B kinase assay was performed on the isolated fusion 
proteins in the presence of ATP32P, with levels of incorporated ATP detected 
using a phospho-image plate. 
It was observed that in the absence of intact Thr63, Thr78 and Thr82 residues, 
phosphorylation of Drosophila Fizzy by Cdk1/Cyclin B was reduced by 69% 
(Figure 3.3). This implies that these residues are involved in the 
phosphorylation of Fizzy, and that a proportion of this phosphorylation can be 
attributed to Cdk1/Cyclin B.  
3.2.5 Mutation of Thr63, Thr78 and Thr82 of Drosophila Fizzy does not 
affect its interaction with the APC/C. 
After establishing that Thr63, Thr78 and Thr82 are phosphorylated by 
Cdk1/Cyclin B in vitro, the next step was to identify whether loss of 
phosphorylation at these sites had any effect on the ability of Fizzy to associate 
with the APC/C. Samples from the anti-GFP immunoprecipitation used to isolate 
the wild-type (TF4) and triple mutant (TF41) GFP-fusion proteins for the 
previous kinase assay, were probed by western blot for Cdc27, a subunit of 
APC/C. The levels of Cdc27 found to associate with the triple phosphorylation 
mutant Fizzy protein were comparable to the association of Cdc27 with wild- 
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Figure 3.4. Western blot analysis to show levels of associated checkpoint 
proteins with wild-type TF4 and mutant TF41 fusion proteins in non-
synchronised 0-4hour embryo extracts. 
(Representative of extracts used for the in vitro kinase assay in fig. 3.3).  
Immunoprecipitation with anti-GFP antibody (Abcam) shows that Mad2 and 
BubR1 association with GFP-Fizzy is reduced with the mutation of Cdk1 
phosphorylation sites (as shown in the TF41 samples).  Quantification of 
associated proteins when standardised as a percentage of that observed in 
wild-type GFP-Fizzy TF4 samples (as displayed in the bar chart to the right) 
shows that binding of wild-type and mutant GFP-Fizzy fusion proteins to 
endogenous Fizzy is consistent with one another, as is binding to the APC/C 
subunit Cdc27. Cyclin B affinity is increased four-fold in the TF41 fusion protein 
compared to wild-type. Experiments were carried out in triplicate, imaged using 
the Li-Cor Odyssey® infrared imaging system, with protein levels quantified 
using TINA software and samples from TF4 and TF41standardised against one 
another using GFP-Fizzy loading as reference. Error bars represent standard 
deviation. 
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Wild type GFP-Fizzy (Fig.3.4). This suggests that within this IP, mutation at 
these sites may cause a 69% decrease in Cdk1/Cyclin B phosphorylation, but 
does not affect the ability of Fizzy to associate with the APC/C.  
3.2.6. Mutation of Thr63, Thr78 and Thr82 of Drosophila Fizzy has an effect 
on its ability to interact with other checkpoint proteins, implicating a role 
for Cdk1 phosphorylation in MCC formation. 
To address the effect of the potential role of Cdk1 phosphorylation of Drosophila 
Fizzy on the interaction between mutant GFP-Fizzy and other SAC proteins, the 
anti-GFP immunoprecipitation samples were probed with anti-BubR1, anti-
Mad2, anti-Cyclin B antibodies (Fig. 3.4). It was observed that 80% less Mad2 
protein associated with the triple mutant GFP-fusion protein than with the wild-
type GFP-Fizzy fusion protein. The ability of the mutant protein to interact with 
BubR1 was also decreased, with less than 50% BubR1 protein observed in the 
TF41 blot in comparison to the TF4 wild-type sample. This suggests that 
Cdk1/Cyclin B phosphorylation of Drosophila Fizzy at Thr63, Thr78 and Thr82 is 
likely to be required for efficient formation of the MCC.   
With regard to the association of Fizzy with mitotic the cyclin, cyclin B, probing 
the immunoprecipitation samples with anti-Cyclin B antibody revealed a 
dramatically increased association of cyclin B with the triple mutant fusion 
protein (approximately four-fold), in comparison to that associated with the wild-
type fusion protein (Fig. 3.4). This implies that Cdk1 phosphorylation of Fizzy is 
involved in its interaction with cyclin B, although how a decrease in Cdk1 
phosphorylation would result in this increased association is not yet understood.  
In order to assess the potential contribution of endogenous Fizzy in the results 
observed, the previously described immunoprecipitation samples were also 
probed with anti-Fizzy antibody (Fig. 3.4). Although the association of 
endogenous Fizzy with the triple mutant fusion protein appeared to be reduced 
in comparison to wild-type, this reduction was not significant. This implies that 
endogenous Fizzy is capable of associating with the mutant protein, and that 
phosphorylation of Fizzy at Thr63, Thr78 and Thr82, is likely to have no 
involvement in any interaction between Fizzy molecules. This should be taken 
into consideration when subsequently discussing these data. 
100 
 
 
3.2.7. GFP-Fizzy fusion proteins extracted from mitotically synchronised 
embryos display similar, but not identical, patterns of association with 
APC/C and checkpoint proteins.  
The previous immunoprecipitation results were carried out on non-synchronised 
0-4 hour syncytial embryos. Within a non-synchronised cell population, it has 
been previously determined within the lab, the mitotic index is approximately 
4%. MG132 treatment of Drosophila embryos has been shown previously within 
the lab to result in approximately 80% of cells arresting in mitosis. In order to 
see whether the association between Fizzy and other checkpoint proteins 
observed in the previous experiments, and therefore representative of the  
 
 
Figure 3.5. Western blot analysis to show levels of associated checkpoint 
proteins with Wild-type (TF4) and reduced phosphorylation mutant (TF41) in 
mitotically synchronised (MG132-treated) 0-4hour embryo extracts.  
Immunoprecipitation with anti-GFP antibody (Abcam) shows that BubR1 binding 
is again reduced in the mutant extracts, as is the association of GFP-Fizzy with 
Mad2, although to a lesser extent.  Binding of wild-type and mutant GFP-Fizzy 
fusion proteins to endogenous Fizzy appears less than in non-synchronised 
extracts, with association of the mutant GFP-fusion protein and endogenous 
Fizzy 50% less than that of wild-type GFP-Fizzy. Cdc27 is again consistent 
between samples, with Cyclin B affinity dramatically increased in the TF41 
fusion protein compared to TF4 wild-type. Experiments were carried out in 
triplicate, imaged using the Li-Cor Odyssey® infrared imaging system, with 
protein levels quantified using TINA software and TF4 and TF41 samples 
standardised against one another by GFP-Fizzy loading controls. Error bars 
represent standard deviation. 
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general cell cycle, were consistent with embryos synchronised in mitosis, 0-
4hour TF4 and TF41 embryos were treated with MG132 before repeating the 
anti-GFP immunoprecipitation experiment as before.  
The general pattern of association between checkpoint proteins, Cyclin B and 
APC/C subunit Cdc27 with the triple phosphorylation site mutant and wild-type 
GFP-Fizzy fusion proteins, remains consistent with those observed in non-
synchronised samples (Fig. 3.5). The association between Fizzy and APC/C 
displayed no significant difference between wild-type and mutant protein, whilst 
the association between Fizzy and Cyclin B significantly increased with the loss 
of Thr63, Thr78 and Thr82 in the triple mutant protein. Consistent with the non-
synchronised extracts, the interaction between Fizzy and Mad2, as well as that 
between Fizzy and BubR1, are reduced in the TF41 mutant sample. This 
supports the finding that phosphorylation by Cdk1 at Thr63, Thr78 and Thr82 
appear to be required for efficient association of checkpoint components. 
Interestingly, although Mad2 and BubR1 interaction with Fizzy show the same 
decrease in interaction, it appears that the extent of this decrease differs in the 
mitotic samples in comparison to the fusion proteins extracted from non-
synchronised embryos (Figs. 3.4 & 3.5). Whereas the levels of BubR1 detected 
in the anti-GFP immunoprecipitation from non-synchronised embryos was 
reduced by around 55% in the mutant line compared to wild-type, this decrease 
was far more dramatic in the western blot analysis of fusion proteins from 
mitotically synchronised embryos. Here, levels of BubR1 were reduced to less 
than 10% of the levels observed in wild-type. In contrast, the decrease in Fizzy-
Mad2 interaction in the phosphorylation mutant GFP-fusion protein samples 
compared to that of wild-type, appears less in the samples from mitotically 
synchronised embryos. It is unclear as to whether these differences are 
significant. 
With regard to the interaction between GFP-Fizzy fusion proteins and 
endogenous Fizzy, it appears that although on average the triple mutant GFP-
fusion protein from mitotic samples showed decreased levels of associated 
endogenous Fizzy in comparison to wild-type, whether this slight difference has 
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any significance on the data is unlikely, but is yet to be investigated further 
(Figs. 3.4 & 3.5).    
3.3. Discussion 
The contribution of Cdk1 to the overall phosphorylation of Drosophila Cdc20 
(Fizzy) has never been specified. With potential conserved Cdk1 sites identified 
within Fizzy, there is a possibility that Cdk1 may phosphorylate Fizzy in order to 
promote its function within the SAC response. With questions into the role of 
kinetochore localisation of SAC proteins in MCC formation, and studies yet to 
establish a system whereby Cdc20 or Drosophila Fizzy localisation can be 
perturbed, we set out to test whether these phosphorylation sites may affect the 
ability of Fizzy to localise to the kinetochore upon SAC activation. If this were to 
prove to be the case, interactions between Fizzy and other SAC components 
could be investigated in the absence of Fizzy kinetochore localisation, thus 
providing a Drosophila working model which will allow more of an insight into 
the requirements for MCC formation. 
With the use of generated transgenic fly lines, it has been possible to isolate 
GFP-tagged wild-type and potential phosphorylation-deficient mutant Fizzy 
fusion proteins from syncytial embryos, in order to analyse their phosphorylation 
by Cdk1. These data suggest that Thr63, Thr78 and Thr82 of Drosophila Fizzy 
are phosphorylated in vitro, and that approximately 70% of this phosphorylation 
could be attributed to the activity of the mitotic cyclin dependent kinase Cdk1 
(and cyclin B). The three residues tested all reside within the N-terminal of 
Fizzy, consistent with conserved phosphorylation sites observed in Xenopus 
and human Cdc20.  
Previous studies of Cdk1 phosphorylation of Cdc20 linked this to the role of 
Cdc20 in the spindle checkpoint, with inhibition of Cdk1 activity resulting in a 
defective checkpoint response, believed to be attributed to the finding that non-
phosphorylatable Cdc20 is capable of binding APC/C in the presence of SAC 
triggers. Although the effect of the triple phosphorylation-site mutant Drosophila 
Fizzy in the presence of checkpoint-arresting agents was not tested directly in 
syncytial embryos, it was observed that removal of Thr63, Thr78 and Thr82 of 
Fizzy, had no effect on its binding to APC/C subunit Cdc27 in both mitotic and 
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non-synchronised embryo extracts (Figs. 3.4 & 3.5). This could potentially imply 
that Drosophila Fizzy is likely to behave in the same fashion, although at 
present it is not possible to reliably test this directly.  
Originally, we anticipated examining the functions of the GFP-tagged Fizzy 
fusion proteins in a fizzy weak allele genetic background in which the 
endogenous Fizzy protein levels were significantly reduced. Unfortunately, the 
efforts of introducing the TF4 and TF41 transgenes into the fizzy weak allele 
(fzyEP1028) genetic background failed. The resulting fly lines expressed the wild-
type GFP-fusion protein or the triple mutant GFP-fusion protein in the presence 
of wild-type levels of endogenous Fizzy. For this reason, they are not suitable 
for use in testing the behaviours of the ectopically-expressed GFP-tagged wild-
type or triple phosphorylation-deficient Fizzy under conditions which should 
trigger the SAC, as the endogenous protein present would likely satisfy the 
checkpoint response, and arrest cells regardless of whether phosphorylation of 
the fusion protein occurred.    
If we were to assume that phosphorylation of Fizzy by Cdk1 is required to block 
its association with APC/C in the checkpoint response, by allowing it to localise 
and subsequently associate with other checkpoint components as part of the 
MCC, we might expect that the triple mutant protein would display reduced 
interaction with MCC components such as Mad2. Previous studies in humans 
and Xenopus have shown that with mutation of potential Cdk1 phosphorylation 
sites, there is a decreased association with checkpoint proteins Mad2 and 
BubR1. Consistent with this, immunoprecipitation experiments to isolate the 
complexes associated with the GFP-tagged phosphorylation-deficient mutant 
and wild-type Fizzy fusion proteins revealed that this is also the case in 
Drosophila Fizzy (Fig. 3.4). Fizzy-associated Mad2 levels were decreased by 
over 80% in the phosphorylation-deficient mutant sample, compared to that of 
wild-type, Similarly, a reduction of over 50% BubR1 associated with Fizzy was 
detected in the phosphorylation mutant sample. These results were obtained 
using extracts made from non-synchronised embryos. In a non-synchronised 
population, only approximately 4% of Drosophila syncytial embryos are in 
mitosis (unpublished results, carried out by another member), and past studies 
from other systems have implied that Cdc20 can form sub-complexes of the 
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MCC (such as Cdc20-Mad2) outside of mitosis. Hence, it was not known 
whether our data were representative of the interactions of Fizzy specifically in 
mitosis. In the non-synchronised population, TF41 Fizzy has reduced ability to 
associate with Cdc27, BubR1 and Mad2 but increased ability to bind with cyclin 
B.  
To test whether these results would also be observed in mitotic extracts, similar 
co-immunoprecipitation experiments were performed to isolate the complexes 
that associated with GFP-tagged Fizzy fusion proteins from MG132-treated 
mitotically-synchronised embryos. These experiments revealed a similar pattern 
of GFP-Fizzy-Mad2 and GFP-Fizzy-BubR1 interaction in that, with the mutation 
of Thr63, Thr78 and Thr82, the association of these checkpoint proteins is 
decreased. This implies that the patterns observed are representative of the 
mitotic behaviour of Fizzy, and so it is not unreasonable to link the decreased 
association with defective formation of the MCC complex. In order to test this 
further, it would be interesting to probe for the presence of associated Bub1 and 
Bub3 (other predicted MCC components), to verify whether the phosphorylation 
of Fizzy is required for specific interactions, or formation of the MCC as a whole. 
Unfortunately no Bub1 or Bub3 antibodies were available during the course of 
this study. Interestingly, a coomassie stain of a gel on analysing  
immunoprecipitation samples for the TF4 and TF41 proteins isolated for the 
kinase assay displayed numerous differences in visible bands, representing 
associated proteins, between the wild-type and mutant samples (Fig. 3.5). The 
predicted positions of Mad2 and BubR1 can account for two bands observed in 
the wild-type samples which appear to a far lesser extent in the mutant 
samples, but the other proteins which display differences between the TF4 and 
TF41 isolated fusion protein immunoprecipitation samples are yet to be 
identified. 
Although the significance of the differences in the extent of the decreased 
association between Fizzy-Mad2 and Fizzy-BubR1 in non-synchronised and 
mitotic extracts is questionable, it cannot be ruled out that it could have some 
potential significance. Levels of associated BubR1 were seen to decrease more 
dramatically in mitotically-derived fusion protein samples, whereas Mad2 levels 
decreased to a lesser extent in protein extracted from mitotically-synchronised 
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embryos than with protein extracted from non-synchronised embryos (figs 3.4 & 
3.5). It could be speculated that the interaction of Fizzy with Mad2 when forming 
sub-complexes outside of mitosis, may be affected more by lack of Cdk1 
phosphorylation than the Fizzy-Mad2 interaction which occurs in the formation 
of the MCC. Further research into the differences between the interactions of 
Fizzy-Mad2 outside of mitosis would need to be carried out. However, with past 
studies questioning the presence of Mad2 in the MCC itself (Nilsson et al., 
2008), and a recent paper from our own laboratory implicating that BubR1, but 
not Mad2, is required for recruitment of Fizzy to the kinetochore in Drosophila 
(Cheeseman, 2009), this notion cannot be completely dismissed at present.  
A recent publication by our lab also highlights the greater significance of BubR1 
in the MCC than that of Mad2 (Li et al., 2010). By inserting a GFP-Fizzy 
transgene into the Mad2 EY21687 fly line, characterised as null for endogenous 
Mad2 by western blot analysis and proven to be unable to induce a SAC 
response, it was shown that in the absence of Mad2, Fizzy is still capable of 
normal kinetochore localisation. In contrast, with insertion of the GFP-Fizzy 
transgene into a BubR1-null line (obtained from the Bloomington stock centre), 
it was observed that in the absence of BubR1, Fizzy was unable to localise to 
kinetochores in mitosis, even when the SAC is potentially induced by treatment 
with colchicine. Alongside this data, the fact that the EY21687 Mad2-null line is 
viable, whereas the BubR1-null line is homozygous lethal at the larval/pupal 
stage, indicates a more prominent role for BubR1 than for Mad2 in the 
sequestration of Fizzy within the SAC response. This also suggests that in 
Drosophila Mad2 and BubR1 are likely to form complexes with Fizzy 
independently of one another. This data is supportive of that of Pines et al 
(2008), who claimed that Mad2 may not be a component of the MCC complex, 
but rather, has a role in retaining the localisation of Cdc20/Fizzy once the SAC 
is activated. 
In addition to analysis of associated APC/C and checkpoint proteins, 
immunoprecipitation samples were probed for the association of Cyclin B. In 
both non-synchronised and mitotically-derived samples, the association of 
Cyclin B with the mutant GFP-fusion protein was significantly increased in 
comparison to wild-type. It is known that Cdc20 targets Cyclin B, and that for 
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normal mitotic progression this associated Cyclin B must dissociate. At present 
it is not known why the reduction in Cdk1 phosphorylation of Fizzy would result 
in a greater association with Cyclin B. However, two possible scenarios which 
could be investigated in the future are whether this is a result of the 
phosphorylation mutant protein being rendered constitutively active, or whether 
Cdk1 phosphorylation of Fizzy is required to allow cyclin B dissociation, thus 
resulting in the observed excess. At present the effect of Cdk1 phosphorylation 
of Cdc20 on its association with mitotic cyclins in other organisms has not been 
investigated.  
One aspect of these data which must be taken into consideration, is the fact 
that the fly lines generated for analysis contained wild-type levels of 
endogenous Fizzy. The checkpoint is likely to be effective in these cells as a 
result of this, and so in vivo analysis of the mutant GFP-fusion protein is not 
reliable due to the masking effect of endogenous Fizzy. It is possible that, 
because the mutant GFP-fusion protein is capable of interacting with the 
endogenous protein (as shown in Figs. 3.4 & 3.5), the normal localisation of this 
protein throughout the cell cycle (Fig 3.2) could be attributed to this association. 
For this reason, the localisation of Fizzy when Thr63, Thr78 and Thr82 are 
mutated, as well as whether this mutant Fizzy is capable of a checkpoint 
response, can only be investigated reliably in the absence of the endogenous 
protein.  
Unfortunately, the re-generation of transgenic lines in a Fizzy-null background 
was too time consuming to consider as part of this study, as was the generation 
of constructs allowing for transfection into a stable cell culture line, such as 
Drosophila S2 cells, allowing for subsequent dsRNAi depletion of endogenous 
protein. In an attempt to create an environment whereby the wild-type and triple 
mutant Fizzy GFP-fusion proteins exist in an environment free of endogenous 
Fizzy  protein,  dsRNA  to  the  3’UTR  of  Fizzy was generated for microinjection 
into TF4 and TF41 syncytial embryos. This would target endogenous Fizzy, but 
not the transgenic protein, thus allowing localisation of the triple mutant GFP-
Fizzy protein to be analysed in the absence of endogenous Fizzy. It could also 
help verify the effect of disruption of 
107 
 
sites on SAC arrest and kinetochore localisation of GFP-Fizzy in the absence of 
endogenous Fizzy. 
Previous studies microinjected dsRNA into syncytial embryos to successfully  
deplete mitotic Cyclin B (McCleland et al., 2009), possibly due to the fact that  
 
 
 
 
 
Figure 3.6. GFP dsRNAi injection into TF4 and TF4-221 embryos is unable to 
provide a phenotype to suggest GFP levels are depleted at the site of injection. 
 
No visible reduction in GFP signal was observed over time at the site of GFP-
dsRNA injection (highlighted in green) in either the original TF4 line or a 
derivative line which carries TF4 plus RFP histone (TF4-221). The pattern of the 
mean fluorescence amplitude only fluctuates with changes in cell cycle stage, 
presumably as Cdc20 localisation patterns change, but the overall presence of 
the GFP signal was unaffected. No obvious decrease in GFP signal was 
observed. This implies that the dsRNAi injection was unable to inhibit GFP 
turnover in embryos. Injections were carried out on more than five TF4 and 
TF4-221 embryos.  
 
 
 
Cyclin B is a rapid turnover protein. Fizzy/Cdc20 is also a rapid turnover protein 
targeted by APC/C-mediated ubiquitination, supported by the presence of a 
destruction box and KEN box motif, although in Drosophila embryos it has not 
been confirmed that Fizzy is completely degraded every cell cycle. Therefore, 
there is a good possibility that Drosophila may be suitable for dsRNAi in 
embryos too. If this is the case, it would provide an alternative means to 
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conditionally knockout the endogenous Fizzy from TF4 or TF41 embryos so the 
experiments discussed above could be performed. 
As a control to assess whether dsRNAi injection of embryos has a global or 
localised effect, dsRNA for GFP was produced and injected into TF4 nuclear 
division cycle 5 stage embryos and TF4-221 embryos, which carry the TF4 
transgene as well as RFP-tagged histone as a DNA marker. If successful, this 
would cause a drop in GFP fluorescent intensity signals monitored by confocal 
microscope in areas where the dsRNA had been microinjected and effective. If 
this effect sustained long enough, injected embryos could be collected for 
western blot analysis to verify the knockout. If only a local effect of the dsRNAi 
depletion of the fluorescent signals was observed, any potential effects on the 
mitotic progression caused by depleting the endogenous Fizzy would need to 
observe the presence of any altered cell phenotypes locally around the injection 
site. Unfortunately, multiple attempts failed to produce any visible drop in GFP 
fluorescent intensity signals with the microinjection of dsRNA against the GFP 
mRNA. We have also microinjected  dsRNA  against  the  3’UTR  region  of  the 
fizzy gene nonetheless, with the intention of attempting to deplete the 
endogenous Fizzy from TF41 syncytial embryos. This also failed to yield any 
visible or interpretable results from multiple microinjection attempts (Fig. 3.6). 
For this reason, the dsRNAi approach in embryos was deemed too unreliable 
for use.  
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Chapter 4.The Drosophila BubR1 KEN-box motif is required for 
its interaction with Cdc20 (Fizzy). 
4.1. Introduction 
BubR1 has been shown in various systems to bind to Cdc20, alone or as part of 
the MCC, in order to sequester the activity of Cdc20 and prevent it from 
activating the APC/C. Two BubR1 Cdc20 binding sites were identified within 
BubR1, one in the N-terminal of BubR1 and the other in the C-terminal 
(Davenport et al., 2006). A previous report from the same group, illustrated that 
the N-terminal half of BubR1 was sufficient for SAC function (Harris et al., 
2005). This leads to speculation that the N-terminal Cdc20 binding site of 
BubR1 was likely to be relevant in SAC signalling. 
Whether any other domains within the N-terminal region of BubR1 carry 
importance in its ability to bind Cdc20 in the SAC response remained unclear 
until research into conserved KEN box motifs, which are conserved from yeast 
to humans. In other systems, two KEN box motifs exist, whereas only the N-
terminal KEN box is present within Drosophila BubR1. Previous research into 
their importance revealed that in yeast, the N-terminal KEN box is required for 
SAC signalling ((Sczaniecka et al., 2008; Pfleger and Kirschner, 2000)  (Zich 
and Hardwick, 2010), whereas the second KEN box motif is not. This is 
consistent with reports into the ability of the BubR1 N-terminal region to be 
sufficient for SAC signalling (Malureanu et al., 2009).  
With regard to Drosophila, it had previously never been tested as to whether the 
single N-terminal KEN box behaves in a similar fashion to that observed in 
yeast Mad3. The single KEN box of Drosophila BubR1 may have a conserved 
function, or may possibly carry out additional roles due to the lack of a second 
KEN box. If Drosophila was to be used as a model for the study of the BubR1 
KEN box in SAC function, it would first need to be established as to whether 
mutation of the BubR1 KEN box disrupted the interaction between BubR1 and 
Cdc20. We speculated that, as in other systems, the BubR1 KEN box will be 
essential for the BubR1-Cdc20 interaction, but whether Mad2 will be required 
for this interaction is questionable. In order to test this, a bacterial three-hybrid 
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experiment was designed to confirm the roles of both Mad2 and the BubR1 
KEN box in the BubR1-Cdc20 interaction.  
Whether the single KEN box of Drosophila BubR1 behaves in the same way to 
human and yeast N-terminal KEN boxes remains unknown. In these systems, 
although the second KEN box is not required for MCC formation, it is required 
for the checkpoint to remain active. Since Drosophila BubR1 lacks this second 
KEN box motif, it would be interesting to determine whether the single N-
terminal KEN box has additional roles in checkpoint signalling to those 
observed in other systems, potentially compensating for the lack of a second 
KEN box motif. Understanding the role of the Drosophila BubR1 KEN box in 
SAC signalling in comparison to other systems may help to uncover the role of 
the second KEN box observed in humans and yeast. It may also provide a 
greater understanding of the formation of the MCC complex in this system, 
should the interaction between Drosophila BubR1 and Cdc20 be reliant upon 
this motif, and whether or not this interaction is dependent upon Mad2 as 
observed in other models.   
Within this chapter we establish bacterial and yeast three hybrid systems, 
whereby the KEN-box-dependent manner of Drosophila BubR1 and Cdc20 can 
be investigated, in the presence and absence of Mad2. It is observed that the 
single N-terminal KEN box of Drosophila BubR1 has a similar SAC role to that 
conserved across other species, in that is required for the BubR1-Cdc20 
interaction. This implicates the potential importance of the Drosophila BubR1 
KEN box in the formation of the MCC.  
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4.1.1  Principle of the Bacterial Two Hybrid System 
The bacterial three hybrid system used in this thesis is modified from the 
reconstituted signal transduction pathway based two hybrid protocol, supplied 
by Euromedex (Karimova et al., 1998). Here, a bacterial two hybrid system was 
established which allowed in vivo screening of functional protein-protein 
interactions, based on reconstitution of a signal transduction pathway which 
exploits the positive control exerted by cAMP. 
Previous studies had shown that B. pertussis produces a calmodulin-dependent 
adenylate cyclase toxin, encoded by the cyaA gene, the catalytic domain of 
which exhibits high activity in the presence of calmodulin, and very low activity 
in its absence (Karimova et al., 1998). It was observed that this catalytic domain 
could be cleaved into two complimentary fragments (T25 and T18) which 
remain associated in a fully active ternary complex in the presence of 
calmodulin (Munier et al., 1991). In the absence of calmodulin the two 
fragments did not exhibit detectable activity, due to physical separation. 
Karimova et al. (1998) reasoned that if these complimentary fragments were 
fused to putative interactive proteins and expressed in an E. coli strain deficient 
for calmodulin or calmodulin-related proteins, the interacting proteins would be 
brought into close proximity and lead to re-association of complimentary 
fragments, resulting in cAMP synthesis. As cAMP is responsible for regulation 
of various genes, including those involved in catabolism of carbohydrates such 
as maltose(A., 1983), the restoration of the catalytic domain and its expression 
under the control of lacZ, would provide sufficient calmodulin-independent 
residual activity to restore the ability of the strain to ferment maltose. This could 
then be scored by plating onto maltose or X-gal plates.  
The plasmids used by (Karimova et al., 1998) were constructed by modifying 
pACYC184 and pBluescript II KS to express either the T25 or T18 fragment of 
CyaA respectively. A multicloning site was fused to the C-terminal of T25 to 
facilitate construction of fusions with foreign protein, similarly the T18 fragment 
was fused  in  frame with αlacZ of pBluescript II KS, downstream of its multiple 
cloning site. To test the reliability of the system, first they co-transformed the 
two plasmids (pT25 and pT18) alone (empty of any interacting proteins) as well 
as a control plasmid which contained the full catalytic domain into a calmodulin 
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lacking bacterial strain. When plated onto agar supplemented with maltose, 
cells transformed with independently expressed fragments remained white, 
whereas those transformed with the full catalytic domain were red. This proved 
that without interacting proteins, the two fragments were incapable of contact 
and subsequent formation of a full catalytic domain.  
Next, positive control plasmids were constructed in which sequences encoding 
interacting proteins were inserted into the multiple cloning sites of the pT25 and 
pT18 vectors. These control plasmids, pT25-zip and pT18-zip, contained DNA 
sequence that encodes a leucine zipper derived from yeast transcriptional 
activator GCN4. When pT25-zip and pT18-zip were co-transformed as before, 
the resulting colonies were red. This showed that functional complementation of 
T25 and T18 was as a result of interaction between the inserted leucine zipper 
motifs. As a negative control, pT25-zip was co-transformed with pT18, and 
pT25 with pT18-zip. In support of previous results, colonies were white, and so 
no functional complementation of the T25 and T18 fragments was observed.  
The designed bacterial two hybrid system was proven capable of providing an 
effective means by which to detect protein-protein interactions in a bacterial 
model. The proteins tested were derived from yeast, indicative of its ability to 
analyse eukaryotic proteins. Because this system involves the generation of a 
regulatory molecule (in this case cAMP) it is possible to spatially separate the 
physical association of the interacting proteins from the transcriptional activation 
events which are dependent upon cAMP synthesis. This allows analysis of 
interactions which do not take place in the vicinity of the transcriptional 
machinery and so could be particularly useful in the study of proteins in the 
cytosol, or for co-localisation of two given proteins. This is not the case in yeast-
based two hybrid systems. Along with this, the bacterial transformation protocol 
is quick and does not require any specialist knowledge, as it follows standard 
transformation protocol as used in the preceding molecular cloning steps.   
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4.2. Results 
4.2.1 Creating a bacterial based three hybrid system, derived from pT25 
and pT18 vectors, to test the interaction between Cdc20 and BubR1 in the 
presence of Mad2. 
Due to the extensive restriction sites found within Drosophila bubr1, standard 
pT25 and pT18 vectors were unsuitable for use without prior modification of the 
MCS. As well as this, these vectors are only designed for a traditional two-
hybrid approach. In order to accommodate the third protein (Mad2), a second 
MCS under the control of its own promoter was inserted into pT25. 
Replacement and additional multiple cloning sites were synthesised as adaptor 
oligos (Sigma Aldrich) which, after excision of the original MCS sequence, were 
inserted into the expression vectors to create the modified plasmids (named 
p25NJY and pUT18JY respectively) (Figs. 4.1 & 4.3). The various constructs 
generated for analysis in the bacterial three hybrid assay are listed in table 4.1. 
BACTH vectors were a kind gift from Richard Daniel (University of Newcastle). 
 
4.2.2 Bacterial Three Hybrid Analysis was unable to detect interaction 
between BubR1 and Cdc20, even with the inclusion of Mad2. 
With the use of bacterial strain BTH1001 as a host, none of the constructs 
generated, including wild-type full length BubR1 combined with both Cdc20 and 
Mad2, displayed the reporter phenotype of blue colonies in the presence of 
IPTG and X-gal. All colonies were white, showing that the T18 and T25 
fragments had not been brought together as a result of interaction between 
hybrid proteins. This was also, as expected, observed in all negative control 
transformations. Co-transfection of the positive control constructs, pT18-zip and 
pT25-zip, displayed blue colonies indicative of an interaction between inserted 
proteins. This confirmed that the protocol and experimental conditions were 
suitable for reporting the interaction between hybrid proteins (Fig. 4.5).   
 
 
114 
 
 
4.2.3 The bacterial Three Hybrid system appears unsuitable for 
investigating the BubR1-Cdc20 interaction. 
In order to verify whether the co-transfected constructs of interest had actually 
been expressed in the BTH1001 host strain during experimental conditions, 
colonies were inoculated in liquid LB from double transformants containing all 
three proteins of interest, full-length BubR1, Cdc20 and Mad2, and induced in 
the presence of IPTG at 37⁰C for 1 h. Protein samples were collected from 
these cells and subject to western blot analysis. A sample prepared from 
Drosophila S2 cells was also run, to act as a comparison for indication of the 
band sizes of the three proteins. It was observed that bands were detectable 
which corresponded to the Cdc20 band, but bands in the expected positions of 
full-length BubR1 and Mad2 was not detected. This implies that the bacterial 
cells were not expressing the full length BubR1 protein (Fig. 4.6). The western 
blot itself was subject to excess background noise, likely to be due to the fact 
that the protein generated to raise the antibody was purified from a bacterial 
host too, this however, did not alter the fact that not all of the proteins of interest 
could be detected. It can be assumed that the co-transformation of the two 
constructs was successful, as they confer different antibiotic resistance and so 
without both constructs, cells could not grow on selective plates containing both 
antibiotics.  
Because it could not be confirmed that the host strain could express all of the 
proteins of interest, it was decided that the system was unsuitable for use in the 
investigation of the interaction between BubR1 and Cdc20. Although previous 
studies implied that this system was suitable for the expression of eukaryotic 
protein, only fairly short proteins were tested. BubR1 is significantly larger, and 
it cannot be ruled out that this caused the failure of its expression in full. In order 
to determine whether the BubR1 KEN box is required for its interaction with 
Cdc20 in the absence or presence of Mad2, a yeast three hybrid system was 
employed.  
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Figure 4.1. Schematic diagram to show the modification of pUT18 vector to 
pUT18JY.  
The SphI-EcoRI region of the pUT18 MCS was excised and replaced with a 
custom adaptor to include the required restriction sites for generation of the final 
constructs. This adaptor was produced by annealing two complimentary 
oligonucleotides, designed to ligate into the SphI-EcoRI  region. The resulting 
vector, pUT18JY, with adaptor MCS restriction sites is illustrated.  
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Figure 4.2. Diagram to show the sub-regions of BubR1 used to generate 
pUT18JY-BubR1 constructs to be analysed using the bacterial three hybrid 
system. 
pUT18JY vector contains restriction sites suitable for insertion of three BubR1 
fragments. N-terminal and kinase domain regions were modified by PCR to 
incorporate the mutations to the KEN box and the desired restriction sites. The 
mid-region was excised directly from BubR1 cDNA clone LD23835 between 
StuI and NdeI (B). Constructs containing full length SalI-SacI, kinase deletion 
SalI-NdeI, or N-terminal SalI-StuI BubR1 were generated, containing either an 
intact or mutated KEN box motif (C).  
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Figure 4.3. Schematic diagram to show the modification of p25N vector to 
p25NJY.  
 
The PstI-EcoRI region of the p25N MCS was excised and replaced with a 
custom adaptor to include the required restriction sites for generation of the final 
constructs. This adaptor was produced by annealing two complimentary 
oligonucleotides, designed to ligate into the PstI-EcoRI  region. The resulting 
vector, p25NJY, with adaptor MCS restriction sites is illustrated.  
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Figure 4.4. Schematic diagram to show the insertion of fizzy into p25NJY and 
the subsequent modification to include a second MCS under the control of its 
own promoter, for the insertion of mad2. 
(A) Full length fizzy was modified by PCR to incorporate the required restriction 
sites and inserted into KpnI-EcoRI of p25NJY. This is the protein which will be 
expressed as a T25-fusion. (B) In order to incorporate a third protein into the 
assay, a second multiple cloning site was created within the ClaI site which 
exists after the T25 motif. An adaptor was created by annealing two 
complimentary oligonucleotides which encode a stop codon to end Fizzy-T25 
translation, and a plac promoter sequence to drive a second MCS into which 
mad2 will be inserted. This adaptor was phosphorylated at both 5’ and 3’ ends 
so that the construct could be treated with alkaline phosphatase to prevent 
religation in the absence of the adaptor. (C) Full length mad2 was modified by 
PCR with required restriction sites at either ends. This mad2 fragment was 
designed to also carry its own stop codon. (D) mad2 was inserted into NotI-SphI 
sites of the newly generated MCSII. (E) The resulting construct contained full 
length fizzy in MCSI for the expression of a Fizzy-T25 fusion protein, and full 
length mad2 in MCSII of p25NJY for the expression of Mad2 as a third and 
separate hybrid protein under the control of its own promoter.  
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Table 4.1. Bacterial Three Hybrid constructs 
 
 
Modified Vector 
Name 
 
 
Original Vector 
 
Modification information 
 
pUT18JY 
 
pUT18 
(Euromedex) 
 
MCS of pUT18 (SphI-EcoRI) replaced with 
adaptor oligo for the insertion of a 
replacement MCS. 
 
 
p25NJY 
 
P25N 
(Euromedex) 
 
MCS of p25N (PstI-EcoRI) replaced with 
adaptor oligo for insertion of replacement 
MCS.  
 
 
   
Construct Name Insert Information Restriction 
Sites 
 
 
pUT18JY N-terminal 
BubR1-StuI WT 
 
 
N-terminal WT BubR1 (Pstn 1-1147) in pUT18JY   
 
SalI-StuI 
 
pUT18JY N-terminal 
BubR1-StuI KEN-AAA 
 
   
N-terminal KEN-AAA BubR1 (Pstn 1-1147) in 
pUT18JY   
 
SalI-StuI 
 
pUT18JY BubR1-NdeI 
WT 
 
 
WT BubR1 (Pstn 1-2295) in pUT18JY 
 
 
 
SalI-NdeI 
 
pUT18JY BubR1-NdeI 
KEN-AAA 
 
 
KEN-AAA BubR1 (Pstn 1-2295) in pUT18JY 
 
 
 
SalI-NdeI 
 
pUT18JY Full Length 
BubR1 to SacI WT 
 
 
Full length WT BubR1 (Pstn 1- 4452) in pUT18JY 
 
SalI-SacI 
 
pUT18JY Full Length 
BubR1 to SacI KEN-AAA 
 
 
Full length KEN-AAA BubR1 (Pstn 1- 4452) in 
pUT18JY 
 
SalI-SacI 
 
P25NJY-Fizzy 
 
 
 
Full length Fizzy (Pstn 1-1578) in p25NJY 
 
KpnI-EcoRI 
 
P25NJY-Fizzy-Mad2 
 
 
 
Full length Fizzy (Pstn 1-1578) in p25NJY. 
Construct then modified to introduce MCSII into 
ClaI site using adaptor oligos. Once modified, full 
length Mad2 (Pstn1-624) was inserted into MCSII. 
 
 
KpnI-EcoRI 
NotI-SphI 
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Figure 4.5. Bacterial three hybrid analysis failed to provide information on the 
requirement of the BubR1 KEN box in the BubR1-Fizzy interaction, either in the 
presence or absence of Mad2.  
 
(A) The interaction between the BubR1 N-terminal to StuI fragment, (B) as well 
as that of BubR1 to NdeI kinase deletion (C) and full length BubR1 to SacI (C) 
with Fizzy were co-transfected in host strain BTH1001 in the absence (left 
panels) and presence (right panels) of Mad2. The only combination of 
constructs which produced a positive interaction, indicated by blue colonies in 
the presence of X-gal, is the positive control pKT25-zip plus pUT18C-zip 
transfection. As even full-length wild type BubR1 does not produce a positive 
interaction, no information can be obtained from these data. The combinations 
used in the assay are numbered, and listed in the key. Bold print indicates those 
experiments which were designed to test the effect of mutation of the KEN box 
domain in the interaction between BubR1 with Fizzy in the presence and 
absence of Mad2. Control experiments are listed in normal font.  
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Figure 4.6. Western blot analysis of transfected BTH1001 cells reveal that only 
Cdc20 can be detected.  
 
The right hand lane shows bands detected in an S2 cell extract when probing 
with anti-BubR1, anti-Fizzy (Cdc20) and anti-Mad2 antibodies. The extracts 
probed from bacteria co-transfected with pUT18JY containing full length WT or 
KEN-AAA BubR1 and p25NJY containing Cdc20 and Mad2 respectively. The 
only protein which shows a clear band at the correct position is Cdc20. It 
appears that full length BubR1 (WT or mutant) and Mad2 may not be expressed 
by host cells, or may be very unstable.   
 
124 
 
4.2.4 Principle of the Yeast Hybrid System 
Yeast two and three-hybrid analysis systems are widely used to investigate 
protein-protein interactions, and are available commercially. The yeast three 
hybrid experiments carried out in this thesis uses an activation domain 
containing vector,  pGBKT7,  from  Clontech’s  Matchmaker™ Gold Two-Hybrid 
system, alongside a modified version of the Clontech binding domain containing 
three-hybrid  vector,  pBridge™.    When  used  together,  these  vectors  allow 
investigation of ternary protein complexes, whereby the interaction of two 
proteins of  interest may  require  the presence of a  third protein  to  “bridge”  the 
interaction, be it physically or by modification to one or both proteins of interest.  
The Matchmaker™ system is a GAL4-based three hybrid assay, in which a bait 
protein is expressed as a fusion to the GAL4 binding domain of pBridge™ and 
the prey protein is expressed as a fusion to the GAL4 activation domain (Fields 
and Song, 1989)  (Chien et al., 1991) of pGBKT7. The third or “bridge” protein is 
expressed  from  a  second  multiple  cloning  site  of  pBridge™.  pBridge™  is  a 
shuttle vector which replicates autonomously in S.cerevisiae and carries the 
TRP1 nutritional marker. The bait protein within MCSI of pBridge™ is expressed 
by yeast host cells from the constitutive ADH1 promoter, with termination of this 
transcription by an ADH1 termination signal. This hybrid protein is targeted to 
the yeast nucleus by nuclear localisation signals which are an intrinsic part of 
the GAL4 DNA-binding domain(Osborne et al., 1995). The additional gene of 
interest is cloned into MCSII, located downstream of another nuclear 
localisation sequence and an HA epitope. This “bridge” protein is conditionally 
expressed from the MET25 promoter in response to methionine levels within the 
growth medium. This enables the expression of the bridge protein to be 
switched on and off by replica plating of the host colonies. pGBKT7 expresses 
the bait protein fused to the DNA-binding domain of GAL4. Fusion proteins are 
highly expressed from the constitutive ADH1 promoter. 
When bait and prey proteins interact, they bring together the activation and 
binding domains in order to activate the transcription of four reporter genes 
(AUR1-C, HIS3, ADE2 and MEL1). These allow detection of protein-protein 
interactions in different ways, and can be used in combination to reduce 
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background activity. AUR1-C encodes a drug reporter, HIS3 can be used to 
screen for  
 
 
Figure 4.7. The mechanisms of the yeast three-hybrid system. 
pBridge expresses both the DNA-BD fusion and the third, or bridging protein. 
The activation domain fusion is expressed from a separate vector (in the case 
of this thesis, pGBKT7). The conditionally expressed bridging protein can play 
either a structural role (left), a modifying role (middle) or an inhibitory role (right) 
in the interaction between the two hybrid proteins of interest, which restores 
reporter  gene expression.  (Taken  from Clontech pBridge™ vector  information 
sheet, protocol No: PT3212-5).   
 
 
interactions in yeast strains unable to synthesise, and therefore grow, in the 
absence of histidine, as when bait and prey proteins interact, Gal4-responsive 
His3 expression and allows the host strain to grow on histidine-deficient 
medium. ADE2 works in the same fashion, but enables strains unable to 
synthesise adenine to grow on medium lacking adenine in the presence of an 
interaction. Finally, MEL1 encodes α-galactosidase, which in the presence of a 
bait-prey interaction, is expressed and secreted by the yeast cells, causing 
them to turn blue in the presence of X-α-Gal. These reporter genes are under 
the control of three independent Gal4 responsive promoter elements (G1, G2 or 
M1). The protein binding sites within these promoters are different but each is 
related to the 17-mer consensus sequence in the UAS region which is 
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recognised by Gal4 (Giniger and Ptashne, 1988; Giniger et al., 1985). This 
ensures that any prey proteins which interact with unrelated sequences 
flanking, or within the UAS (false positives) are automatically screened out. (All 
information regarding Matchmaker™  and  pBridge™  is  taken  from  the 
Matchmaker™  Gold  Yeast  Two-Hybrid System User manual 2010, and 
pBridge™ vector information sheet, respectively).  
4.2.5 Generation of pGBKT7 and modified pBridge constructs for three 
hybrid analysis of the BubR1-Cdc20 interaction in the presence and 
absence of Mad2. 
Before bubr1 or fizzy were subcloned into pBridge, it was first modified for the 
insertion of the mad2 fragment. MCSII of pBridge was removed and replaced 
with an adaptor oligo containing an NcoI site between NotI and BglII. The Mad2 
fragment was then inserted into NcoI-NotI of the modified vector, pBridgeJY. 
BubR1 was again cloned in three separate fragments, with the N-terminal 
fragment either coding for wild-type protein or with the KEN box substituted for 
AAA. This was inserted into SalI-SmaI sites of pBridgeJY and XhoI-SmaI sites 
of pGBKT7, a kind gift from Rachel Davies (University of St Andrews). fizzy was 
inserted as a single fragment into the same SalI-SmaI or XhoI-SmaI sites of 
JYpBridge-Mad2 or pGBKT7 respectively (figure 4.8).   
Final plasmid DNA constructs were subjected to restriction digest and gel 
electrophoresis for confirmation of appropriate band pattern, and DNA 
sequence analysis was carried out (University of Dundee Sequencing and 
Services) to verify the presence of the PCR site-directed point mutation of the 
KEN box motif to AAA (figure 4.10).  
 
4.2.6 The BubR1 KEN box is required for its interaction with Cdc20, and 
BubR1- Cdc20 appear to interact in the presence and absence of Mad2 in 
Y190. 
Wild-type BubR1 interacts with Cdc20 (Fizzy) in the presence of Mad2, when 
expression from MCSII of pBridgeJY is switched on. This was displayed by 
positive blue colonies in the three hybrid X-Gal assay. In contrast, with mutation 
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of the BubR1 KEN box to AAA, negative white colonies were observed. This 
suggests that the Drosophila BubR1 KEN box is required for its interaction with 
Fizzy, in the presence of Mad2. In order to determine whether Mad2 was 
required in this interaction, the transfected Y190 strains, a kind gift from Jeremy 
Brown (University of Newcastle), were re-streaked onto plates containing 
methionine in order to switch off the expression of Mad2 from MCSII of 
pBridgeJY. Under these conditions, wild-type BubR1 still seems to interact with 
Fizzy, again indicated by the positive blue colonies of the three hybrid X-Gal 
assay. 
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Figure 4.8. Schematic diagram to show the modification of pBridge™ vector to 
pBridgeJY.  
(A) The NotI-BglII region of pBridge MCSII was excised and replaced (B) with a 
custom adaptor to include an NcoI site. This adaptor was produced by 
annealing two complimentary oligonucleotides,  designed to ligate into the NotI-
BglII  region. (C) Full length mad2 was modified by PCR with required restriction 
sites at either ends and ligated into NotI-NcoI of pBridgeJY MCSII. (D) This 
generated the pBridgeJY-Mad2 construct into which either bubr1 or fizzy will be 
inserted later.                                                   
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Figure 4.9. Diagram to show how full length bubr1 and fizzy were constructed 
for insertion into yeast three hybrid vectors. 
(A) Full length wild-type and KEN box mutant bubr1 were constructed in three 
fragments within pGEM-T cloning vector, and subsequently cut and ligated into 
either pGBKT7 or pBridgeJY-Mad2 vectors. (B) Full length fizzy was modified 
by PCR. Constructs were inserted into pGBKT7 or pBridgeJY-Mad2 using SmaI 
– XhoI or SmaI – SalI sites respectively. Oligos used for generation of the 
various fragments can be found in table 2.1. 3 and 4 represent 5’ primers for wt 
bubr1 and KEN mutant bubr1, with 5 representing the 3’ reverse primer for this 
fragment. Oligos 6 and 7 are the forward and reverse primers for the bubr1 
kinase domain fragment. Oligos 8 and 9 represent the forward and reverse 
primers used to generate the fizzy fragment. 
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Figure 4.10. pBridge vector based yeast three hybrid plasmid DNA constructs 
were verified using both DNA sequence analysis and restriction digest. 
 
pBridge-BubR1 was sequenced in the wild-type and KEN-AAA mutant 
constructs to ensure that the N-terminal KEN box was intact in the wild-type, 
and substituted for AAA in the mutant. The resulting chromatograms verify that 
the region containing the KEN box motif is correct in each case (left). Following 
sequence analysis of constructs, they were subject to restriction digest and gel 
electrophoresis to confirm that they display the expected band patterns (right). 
In each case, the band patterns corresponded with those expected (which are 
described in table 4.2). 
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Table 4.2. Yeast Three Hybrid Constructs 
 
Modified Vector 
Name 
O riginal 
Vector 
Modification information 
 
pBridgeJY1 
(Ampr ) 
 
 
pBridge 
(Clontech) 
(Ampr ) 
 
 
MCSII of pBridge (NotI-BglII) replaced with 
adaptor oligo for the insertion of MCSII 
containing NcoI (NotI-NcoI-BglII). 
 
 
 
Construct 
Name 
 
 
Size 
 
Insert Information 
 
RE 
Sites 
used 
 
Test 
Digest:  
 
Ref 
 
pBridgeJY1-
Mad2 
(Ampr ) 
 
 
 
7.1Kb 
 
Full length Mad2(Pstn1-
624) in pBridgeJY1 (MCSII) 
 
NotI- NcoI 
 
 
 
Data not shown 
 
pBridgeJY1-
BubR1(WT) -
Mad2 
(Ampr ) 
 
 
11.5Kb 
 
Full length Wild-type 
BubR1(Pstn1-4392) in 
pBridgeJY1 (MCSI) plus 
Mad2 (Pstn1-624 (MCSII))  
 
 
SmaI- 
SalI 
 
NotI-NcoI 
 
 
 
Cut XhoI: 
Expect: 
6.7Kb, 
4.8Kb 
 
Fig 
4.10 
Lane2 
 
 
pBridgeJY1-
BubR1(KENAAA) 
-Mad2 
(Ampr ) 
 
 
11.5Kb 
 
Full length KEN-AAA 
mutant BubR1(Pstn1-4392) 
in pBridgeJY1 (MCSI) plus 
Mad2(Pstn1-624 (MCSII)) 
 
 
SmaI- 
SalI 
 
NotI-NcoI 
 
Cut XhoI: 
Expect: 
6.7Kb, 
4.8Kb 
 
Fig 
4.10 
Lane 3 
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pBridgeJY1-
Cdc20-Mad2 
(Ampr ) 
 
 
8.7Kb 
 
Full length Cdc20 (Pstn11-
1578) in pBridgeJY1(MCSI) 
plus Mad2 (Pstn1-624 
(MCSII)) 
 
 
SmaI- 
SalI 
 
NotI-NcoI 
 
 
 
Cut XhoI: 
Expect: 
4.79Kb, 
3.32Kb, 
0.59Kb 
 
Fig 
4.10 
Lane 4 
 
 
pGADT7-
BubR1(WT) 
(Ampr ) 
 
 
12.38Kb 
 
Full length Wild-Type 
BubR1(Pstn1-4392) in 
pGADT7 
 
SmaI-SalI 
(XhoI) 
 
 
 
Cut BglII: 
Expect: 
7.6Kb, 
2.3Kb, 
1.7Kb, 
0.7Kb 
 
 
Fig 
4.10 
Lane 5 
 
 
pGADT7-
BubR1(KENAAA) 
(Ampr ) 
 
 
12.38Kb 
 
Full length KEN-AAA mutant 
BubR1 (Pstn1-2392) in pGADT7 
 
SmaI-SalI 
(XhoI) 
 
 
 
Cut BglII: 
Expect:7.6Kb, 
2.3Kb, 1.7Kb, 
0.7Kb 
 
 
Fig 4.10 
Lane 6 
 
 
pGADT7-Cdc20 
(Ampr ) 
 
 
9.56Kb 
 
Full length Cdc20 (Pstn1-
1578) in pGADT7 
 
SmaI-SalI 
(XhoI) 
 
 
 
Cut BglII: 
Expect: 
4.4Kb, 
2.44Kb, 
1.7Kb, 
0.9Kb 
 
 
Fig 
4.10 
Lane 7 
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Table 4.3. Yeast Three Hybrid Results 
Co-transfected constructs Expressed 
proteins 
% positive 
colonies 
Int Image of membrane 
 
A 
pBridgeJY1-
Cdc20-Mad2 
 
pGADT7-
BubR1(WT) 
 
BubR1 (WT) 
Mad2 
Cdc20 
 
96 
 
+ 
 
 
 
B 
pBridgeJY1-
Cdc20-Mad2 
 
 
pGADT7-
BubR1(KENA
AA) 
 
BubR1KENAAA 
Mad2 
Cdc20 
 
1 
 
- 
 
 
 
C 
pBridgeJY1-
Cdc20-Mad2 
 
pGADT7 
(empty) 
 
 
Mad2 
Cdc20 
 
0 
 
- 
 
 
 
D 
pBridgeJY1-
Mad2 
 
pGADT7 
(empty) 
 
 
Mad2 
 
0 
 
- 
 
 
 
E 
pGADT7-
BubR1(WT) 
 
pBridgeJY1-
Mad2 
 
 
BubR1 (WT) 
Mad2 
 
1 
 
- 
 
 
 
F 
pGADT7-
BubR1(KENA
AA) 
 
pBridgeJY1-
Mad2 
 
 
 
BubR1KENAAA 
Mad2 
 
0 
 
- 
 
 
pGADT7  - - No growth 
pBridgeJY1-
Mad2 
- Mad2 No growth 
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Co-transfected constructs Expressed 
proteins 
% positive 
colonies 
Int Image of membrane 
 
G 
pBridgeJY1-
BubR1(WT) -
Mad2 
 
pGADT7-
Cdc20 
 
 
BubR1 (WT) 
Mad2 
Cdc20 
 
85 
 
+ 
 
 
 
H 
pBridgeJY1-
BubR1(KENA
AA) -Mad2 
 
pGADT7-
Cdc20 
 
BubR1KENAAA 
Mad2 
Cdc20 
 
3 
 
- 
 
 
 
I 
pBridgeJY1-
BubR1(WT) -
Mad2 
 
pGADT7 
(empty) 
 
BubR1 (WT) 
Mad2 
 
 
1 
 
- 
 
 
 
J 
pBridgeJY1-
BubR1(KENA
AA) -Mad2 
 
pGADT7 
(empty) 
 
BubR1KENAAA 
Mad2 
 
 
0 
 
- 
 
 
 
K 
pBridgeJY1-
Mad2 
 
pGADT7 
(empty) 
 
 
Mad2 
 
0 
 
- 
 
 
 
L 
pBridgeJY1-
Mad2-Cdc20 
 
pGADT7 
(empty) 
 
 
Mad2 
Cdc20 
 
0 
 
- 
 
 
pGADT7 
(empty) 
- - No growth 
pBridgeJY1-
Mad2 
- Mad2 No growth 
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Figure 4.11. Without expression of Mad2, Wild-type BubR1 but not KEN-AAA 
mutant BubR1, is capable of interacting with Cdc20. 
When the transfected Y190 colonies (see table 4.3. for transfection 
combinations) were streaked, then patched onto plates which contained 
methionine in order to silence expression of Mad2, wild-type BubR1 still 
appears to interact with Cdc20, as indicated by the blue colonies in the three 
hybrid X-gal assay. The interaction between BubR1 and Cdc20 is destroyed 
with mutation of the KEN box domain, as indicated by white colonies. 
Fizzy 
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4.3 Discussion 
Although it is unclear as to why the bacterial three hybrid system was unable to 
efficiently express all of the proteins of interest, this results in its use in this 
particular study of the interaction between Drosophila BubR1 and Cdc20 
unreliable. Whether the proteins of interest failed to express at all, or were not 
folded correctly when expressed in a bacterial system, is not certain. However, 
preliminary western blot analysis suggested that bands to represent the full-
length BubR1 protein of interest appeared absent (Figure 4.6).  
However, using the yeast three hybrid system, these data provide evidence 
that, as in other systems, the BubR1 KEN box is required for the interaction 
between BubR1 and Fizzy in Drosophila. Without an intact BubR1 KEN box, 
BubR1 and Cdc20 appear unable to interact. It could be suggested that the 
BubR1 KEN box has its primary function in the interaction of BubR1 with Cdc20 
within the MCC complex, rather than as a mitotic degron, although further 
investigation would be required in order to fully confirm this.  
A previous study by Davenport et al, (2006) studied the interaction of human 
BubR1-Cdc20 in the absence and presence of Mad2 using the Clontech yeast 
three hybrid system. They showed that the human BubR1-Cdc20 interaction 
required the N-terminal of BubR1, and that Mad2 was required for this 
interaction to take place. Although this paper used pBridge vector to incorporate 
Mad2 as a bridging protein, when analysing the BubR1-Cdc20 interaction in the 
absence of Mad2 pBridge was not employed. Instead pGADT7 was used in 
combination with pGBKT7 vector in the traditional two hybrid system, with only 
BubR1 and Cdc20 fragments present, rather than utilising pBridge throughout  
by exploiting the MET25 promoter which controls expression of the bridging 
protein and switching Mad2 expression on and off with replica plating onto 
methionine- and methionine+ plates, respectively. Why this study chose not to 
be consistent in their use of vectors is unclear. Perhaps the inclusion of Mad2 
as a three hybrid system was introduced after the traditional two hybrid vector 
combination with only BubR1 and Cdc20 failed to produce a positive result? 
This should be taken into consideration when analysing the Drosophila three 
hybrid data, as it cannot be ruled out, without the use of western blot, that even 
in the presence of methionine, Mad2 may still be expressed. 
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Although the yeast three hybrid assay appears to have provided data consistent 
with other systems, the limitations of this system must still be taken into 
consideration. As is the case for the bacterial three hybrid assay, it is unclear as 
to whether all eukaryotic proteins expressed by yeast will be correctly folded, 
thus allowing interaction of true binding partners. It seems unlikely that the 
negative results observed in these data are due to false negatives incurred by 
such issues, as although BubR1 is expressed as either wild-type or to contain 
point mutations to the KEN box motif, it has not been implicated that this minor 
modification would lead to differences in protein folding in comparison to wild-
type. Two hybrid experiments in mammalian cells have been established to 
attempt to overcome problems with eukaryotic protein folding, however at 
present, no commercial vector kits are available for mammalian three-hybrid 
analysis, and the effect of point mutations in protein folding will remain an issue 
as long as any hybrid technique is employed. In addition to this, it may be 
argued that the effect of the fusion of proteins of interest with transcription 
factors may affect their ability to interact with true binding partners. This should 
not be problematic within the yeast three hybrid assay used to obtain these 
data, again, due to the fact that wild-type BubR1 is shown to interact with Cdc20 
as would be expected.  
Because the proteins of interest (BubR1 and Cdc20) have been shown 
previously to interact by co-immunoprecipitation experiments (including those 
observed in chapter 3), and these data relate to the ability of these proteins to 
interact with introduction of a point mutation to the BubR1 KEN box motif, other 
limitations of the yeast three hybrid system such as binding of proteins which 
would not exist in the same cellular compartment and would never therefore 
interact in their natural environment, are not relevant. This is supported by the 
fact that BubR1 and Cdc20 are known to co-localise to kinetochores during 
mitosis. It can therefore be assumed that the positive interaction observed 
between wild-type BubR1 and Cdc20 in the yeast three-hybrid assay is a true 
interaction, relevant to events which occur within Drosophila cells.  
By employing a three hybrid technique rather than the traditional two hybrid 
assay, problems incurred by the absence of additional proteins required for 
modification of interacting proteins, or to act as a bridge between interacting 
proteins, is minimised. By introducing Mad2 to the assay, which was previously 
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shown by Davenport, (2006) to be required for the BubR1-Cdc20 interaction, 
this issue is overcome. Most positive clones will activate all reporters, however 
it is possible that a particular prey fusion-protein may be inaccessible to a 
specific UAS, causing the failure of that reporter to activate even in the 
presence of a positive interaction. Again, a Clontech yeast strain is available 
which can be used for any one of the reporters, or if combined with total dropout 
media, all four at once. Unfortunately this strain was not available for use in this 
study, hence the use of Y190. 
Taking system limitations into consideration, it is not unreasonable to consider 
the data obtained a reliable indicator that the BubR1 KEN box is required for the 
BubR1-Cdc20 interaction within Drosophila. Now that this has been verified, the 
effect of this mutation to the spindle checkpoint as a whole should be 
investigated within the Drosophila model. It would be interesting in the future to 
examine exactly how the lack of intact BubR1 KEN box would affect the 
formation of the MCC as a whole, and whether the kinetochore localisation of 
BubR1 or Cdc20 would be disturbed as a result. In order to study this further, 
other group members have attempted to create transgenic fly lines to express a 
fluorescently-tagged mutant BubR1 protein in a BubR1-null background. If 
successful, this would allow the study of BubR1 localisation as well as the study 
of the ability of these lines to display mitotic arrest in the presence of 
checkpoint-inducing agents such as colchicine when an intact KEN box motif is 
absent. If a different fluorescent tag such as RFP (Red Fluorescent Protein) 
was fused to Cdc20, and this was able to be incorporated into this line, study of 
Cdc20 localisation, as well as co-immunoprecipitation experiments to determine 
which MCC components were capable of interacting with Cdc20 or BubR1 
could also be investigated. Another approach would be to create stably 
transfected Drosophila cell culture lines (such as S2) to express the mutant 
BubR1 protein, removing endogenous protein by dsRNAi. With the use of cell or 
embryonic fixation and immunostaining techniques, the microtubule structure 
and chromosome morphology could be investigated in relation to checkpoint 
defects caused by the removal of the BubR1 KEN box, with the use of α-tubulin 
and histone H3 antibodies, respectively.  
In addition to this, these lines could be potentially useful in the investigation of 
BubR1 turnover. It would be interesting to see exactly how much of an effect the 
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loss of an intact KEN box would have of BubR1 proteolysis, to provide evidence 
of whether the BubR1 KEN box is involved in protein degradation as well as 
interaction, and which function of this motif is likely to be the most prominent. 
These would both be time consuming projects, but could provide some 
important insights into the role of BubR1 in the MCC and checkpoint signalling 
as a whole.  
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Chapter 5: Drosophila Mps1 is required for the SAC, and is 
involved in Mad2, but not Cdc20 localisation. 
 
5.1. Introduction 
Mps1 protein kinase has been implicated in various mitotic processes, and 
plays an essential role in the SAC response (Howell et al., 2004). Its role in the 
SAC is believed to be related to recruitment of key SAC proteins BubR1 and 
Mad2 as well as Mad1 and Bub1, as shown in human and Xenopus (Zhao and 
Chen, 2006; Howell et al., 2004; Vigneron et al., 2004; Liu et al., 2003; Martin-
Lluesma et al., 2002; Abrieu et al., 2001). The effect of Mps1 depletion on the 
localisation of Cdc20 has not been reported in these systems, and no studies 
exist to confirm the SAC role of Mps1 in Drosophila.  
As Mps1 is implicated in the kinetochore recruitment of MCC components, and 
questions still exist into the requirement of the kinetochore localisation of SAC 
proteins in the formation of the MCC, a model whereby some or all checkpoint 
proteins are not capable of localising to unattached kinetochores, could provide 
a useful tool in the future investigation of the SAC response.  
A study by the Gilliland lab which carried out a germline clone screen for meiotic 
mutants in Drosophila, identified a lethal mps1 allele with rare escapers, which 
could be potentially useful in the study of the role of Mps1 in the SAC (Page et 
al., 2007). This allele, aldB4 (referred to as B4-2 from hereon in) was recovered 
on chromosome 3R, failed to compliment the meiotic phenotype of the wild-type 
ald1 allele, and could be rescued by the presence of the P{ald+} construct, which 
contains a functional copy of ald+. Sequencing analysis revealed that the B4-2 
contains an early T to C nonsense mutation, which changes glutamine at 
position 48 to a stop codon. For these reasons, it was speculated that B4-2 line 
was null for Mps1, although characterisation of this line was never carried out. 
 
In this chapter we characterise the Mps1 B4-2 Drosophila line, and confirm that 
it has dramatically reduced levels of Mps1 in comparison to wild-type levels. It 
was therefore deemed suitable for use in establishing a Drosophila system for 
the study of GFP-Cdc20 and GFP-Mad2 localisation in a background 
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significantly depleted for Mps1, in order to verify its role in SAC response and 
the kinetochore localisation of these SAC components in living neuroblast cells. 
It is observed that a significant decrease in Mps1 expression renders 
Drosophila lines non-viable, and unable to elicit a checkpoint response. Whilst 
Cdc20 localisation appears unaffected by the decrease in Mps1 expression, 
Mad2 kinetochore recruitment is dramatically affected.  
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5.2. Results 
5.2.1. Generation of Drosophila lines incorporating GFP-Fizzy or YFP-
Mad2 into the Mps1 B4-2 weak allele background.  
Fly lines already available in the lab, which express GFP-Fizzy (TF4) or YFP-
Mad2 (TM2-20) in a normal wild-type background, were crossed into the B4-2 
background, on the third chromosome (J. Huang). This line was previously 
shown to have only 4% viability and to be rescued by wild-type Mps1, therefore 
likely to be null for Mps1 (Gilliland lab), although Mps1 levels within this fly line 
had never before been confirmed by western blot. The resulting fly lines, 
referred to as TF4;B4-2 and TM2-20;B4-2, were maintained as a heterozygous 
stock using the TM6-Tubby balancer chromosome.  
5.2.2. Introduction of GFP-Fizzy or GFP-Mad2 into the mps1 weak allele 
background further reduces viability of B4-2 flies. 
Viability studies analysing the progression of development of homozygotes of 
the original B4-2 fly line was consistent with previous reports by Gilliland et al, in 
that although approximately 16% of flies hatched, only around 4% survive to 
viable adult flies (Fig. 5.1). The remaining 12% died upon hatching, with wings 
still folded. With the incorporation of either GFP-Fizzy or YFP-Mad2 into the B4-
2 weak allele background, the viability of B4-2 homozygotes was reduced, with 
the resulting flies being non-viable. The TF4;B4-2 and TM2-20;B4-2 lines can 
survive no later than pupae stages (Fig. 5.1 & 5.2). 
5.2.3. The TM2-20;B4-2 fly line was deemed unsuitable for use in 
identifying Mad2 kinetochore localisation in the B4-2 background, 
whereas in the TF4-B4-2 line kinetochore localisation of Cdc20 was clearly 
observed. 
Using spinning disk confocal microscopy to image TF4 and TM2-20 third instar 
larvae neuroblasts, in the wild-type background, YFP- Fizzy can be observed at 
what can be assumed to be kinetochore – like localisation during mitosis. The 
protein is seen congregating at the centre of the cell at metaphase, becoming 
tightly organised before the cell moves into anaphase. This localisation is also 
observed in the TF4;B4-2 line. In the TM2-20 control line, as well as the TM2-
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20;B4-2 line, the high expression of the YFP-Mad2 fusion protein, and its 
nuclear localisation appears to mask any kinetochore localisation in metaphase. 
Other Mad2-fusion protein lines have been shown to display kinetochore 
localisation of Mad2 in a wild-type background (Kindly provided by Roger 
Karess). It is for this reason that the TM2-20 YFP-Mad2 fusion is unsuitable for 
such studies, as this distinct kinetochore localisation of YFP-Mad2 cannot be 
visualised. For this reason, another fly line had to be generated, in which the 
Mad2-fusion protein was expressed from its endogenous promoter was 
generated. 
 
 
Figure 5.1.  Full viability data for TF4;B4-2 and TM2-20;B4-2 Mps1-Null 
Drosophila lines.  
The original B4-2 Mps1-null line has 1.6% viability, in-keeping with initial 
characterisation (of 2% viability) by the Gilliand lab. With the addition of the 
fizzy-GFP transgene (TF4;B4-2) into the Mps1-null background, this phenotype 
is enhanced and flies are non-viable. This is also the case with the addition of 
the mad2-YFP transgene (TM2-20;B4-2). Both lines have improved viability as 
compared to the B4-2/- line up to 3rd instar larvae, particularly with 
overexpression of Mad2, but are unable to develop past this point. Viability was 
recorded in groups of 20 embryos-flies, repeated ten times to count 200 
embryos-flies in total. Error bars represent standard deviation. 
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Figure 5.2.  Mps1-reduced Drosophila Line Phenotypes.   
The B4-2/- Mps1-reduced line suffers a large proportion of embryonic death 
with viability at 3rd instar stages lower than with overexpression of Mad2-YFP or 
Fizzy-GFP (see Fig. 5.1). Many 3rd instar larvae show signs of tissue 
abnormalities throughout the larvae, resulting in lethality (top panel A). With 
overexpression of Mad2, less severe and more localised tissue abnormalities 
which appear as dark patches can be observed (middle panel A and B). This is 
similar to the phenotype observed with Fizzy-GFP overexpression (bottom 
panel B). Over half of the TM2-20;B4-2 and TF4;B4-2 3rd instar larvae die in the 
late stages (bottom panel A), with surviving larvae capable of reaching pupae 
with relatively normal phenotypes (compare top panel B with C in middle and 
bottom panels). The original B4-2 line has 4.4% hatching, 2.8% of which are 
extremely sick and die within hours (top panel D) leaving1.6% hatch as healthy 
viable adults (top panel C).   
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Figure 5.3.  Preliminary data suggests that in the Mps1 B4-2 background Fizzy-
GFP is still able to localise to the kinetochore in the TM2-20;B4-2 Mad2YFP 
line, the nuclear localisation of Mad2 appears normal. However, the kinetochore 
localisation of Mad2 is undetectable in both wild-type control and mutant lines.  
In the wild-type background Fizzy-GFP localises to the kinetochore during 
metaphase (indicated by red arrows, top left panel) in third instar larvae 
neuroblast cells. The same pattern of localisation can be observed when Fizzy-
GFP exists in the Mps1-reduced background (red arrow, top right panel). Under 
wild-type conditions, Mad2 is localised to the nucleus (bottom left panel). In the 
Mps1-reduced background Mad2-YFP cannot be observed on the kinetochore 
in either control (bottom left panel) or mutant background (bottom right panel). 
Nuclear localisation appears lessened (bottom right panel), although this has 
not been fully quantified. As the kinetochore localisation of Mad2 is not visible in 
either line, they are unsuitable for use in the investigation of the effect of Mps1 
knockdown on the kinetochore localisation of Mad2-YFP.  A minimum of 10 
neuroblasts per line were analysed in order to draw these conclusions. 
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5.2.4. Generation of GFP-Mad2 fly lines, expressing the Mad2-fusion 
protein from its endogenous promoter, is suitable the insertion into the 
B4-2 background and allow subsequent analysis of Mad2 localisation. 
The TM2-413 GFP-Mad2 line, with the transgenic insertion on the third 
chromosome, under the control of its native promoter was obtained from R. 
Karess, and was previously shown to be able to display Mad2 kinetochore 
localisation. TM2-4-13 expresses a GFP-Mad2 fusion protein from the 
endogenous Mad2 promoter. Unfortunately, B4-2 is also on the third 
chromosome and is homozygous lethal. This makes the TM2-413 line 
unsuitable for recombination with the B4-2 line, for use in the above study. In 
order to overcome this problem, a new transgenic line, derived from the TM2-
413  line,  was  generated  (J.  Huang)  using  a  (Δ2-3)  G6B  (α  immobilisable 
transposase C transgene construct) based genetic hopping technique. This 
inserted the transgene on the X-chromosome.  In this line, kinetochore 
localisation of GFP-Mad2 in neuroblast cells can be observed using spinning 
disk confocal microscopy. This localisation was not as striking as that observed 
in the TF4 or TF4;B4-2 line, but is very apparent when the TM2-413 control line 
is treated with colchicine and cells are arrested at metaphase (data not shown). 
Genetics techniques were used to introduce this line into the B4-2 background, 
resulting in the TM2-413;B4-2 line (carried out by J. Huang and T. Leung) in 
which the GFP-Mad2 fusion protein, deemed suitable for identification of 
potential kinetochore localisation, exists in the B4-2 background. 
5.2.5. Generation of an anti-Mps1 antibody for use in confirming the 
reduced levels of endogenous Mps1 in the B4-2 and B4-2-derived fly lines. 
An anti-Mps1 antibody was raised in rabbit against full-length Drosophila Mps1. 
The Mps1 sequence of interest was generated by PCR and subcloned into 
pMal-c2x expression vector, for IPTG induction in BL21 cells (see materials and 
methods). The protein was purified and separated by SDS-PAGE before being 
stained using SafeStain and excised from the gel. The protein was sent for 
immunisation by Cambridge Bioscience, with serum purified by affinity column. 
The resulting antibody was tested for band-specificity in Drosophila S2 cell 
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samples, and displayed a specific band at 71KD, the expected position of 
endogenous Mps1 (Figure 5.4). 
 
 
 
 
Figure 5.4. Generation and characterisation of a polyclonal antibody to 
Drosophila Mps1 (ald).  
(A) Position 745 – 1302 of the Drosophila Mps1 (ald) nucleotide sequence was 
subcloned into pMal-C2x MBP-fusion protein plasmid using EcoRI –SalI, for the 
generation of Mps1-MBP fusion  protein used for immunisation. (B) Elisa tests 
(pre-final bleed) against Mps1 protein (without MBP tag) show that all 
immunised rabbits have generated anti -Mps1 antibody in response to the 
fusion protein. All rabbits display detectable antibody at an absorbance of 1.5 
(405nm) at a serum dilution of between 1:10000 (observed in rabbit 3902) and 
1:50000. Antibody from the serum of rabbit 3902 was affinity-purified for use. 
(C) Western blot analysis of S2 cell samples show a clear detectable band of 
71KD, the size of the Drosophila Mps1 (ald) protein, implying that this antibody 
is specific.  
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5.2.6. Western blot analysis to characterise the B4-2 and B4-2-derived fly 
lines displays significantly reduced levels of endogenous Mps1 as well as 
incorporation of GFP-fusion proteins of interest. 
Western blot analysis carried out on samples prepared from dissected third 
instar larvae neuroblasts confirmed that the B4-2 fly line carried dramatically 
reduced Mps1 expression, of approximately 16%. This reduction in Mps1 
expression is retained when the B4-2 line was used to generate TF4;B4-2 and 
TM2-20;B4-2 lines. The TM2-413;B4-2 line also displays the reduction of 
endogenous Mps1. Western blot analysis also confirmed that the TF4-B4-2 line 
carries the GFP-Fizzy fusion protein, and that the TM2413-B4-2 line carries the 
GFP-Mad2 fusion protein. This confirms that the localisation patterns observed 
when analysing these lines represents GFP-Fizzy in the TF4;B4-2 line and 
GFP-Mad2 in the TM2-413;B4-2 line (Fig. 5.5).  
5.2.7. With an 84% reduction in endogenous Mps1 expression, Fizzy 
kinetochore localisation is not perturbed, but Mad2 kinetochore 
recruitment appears significantly reduced in third instar larvae 
neuroblasts. 
Quantification of kinetochore-like localisation patterns of GFP-Fizzy in TF4;B4-2 
neuroblast cells, compared to that of the TF4 control line,  confirmed that with 
an 84% reduction in Mps1 expression, there is no affect on the amount of Fizzy 
recruited to kinetochores (Fig. 5.6). This is not the case for GFP-Mad2, which 
shows very weak kinetochore-like localisation at metaphase (Fig. 5.7) (also 
previously observed by T. Leung). When neuroblast cells were treated with 
10µM colchicine, the GFP-Mad2 control line showed an active SAC, with cells 
arresting at metaphase, displaying strong and persistent GFP-Mad2 
kinetochore localisation. In the B4-2 background, GFP-Mad2 localisation under 
the same conditions was reduced by approximately 80% (Figure 5.7). Although 
some Mad2 was recruited to kinetochores, the SAC was not activated in the 
presence of colchicine, and cells progressed into anaphase.  
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Figure 5.5. Western blot analysis indicates a dramatic decrease in endogenous 
Mps1 levels in the B4-2 background, as well as the success of incorporated 
Mad2 and Fizzy GFP-fusion proteins. 
In comparison to wild-type neuroblasts, the TF4;B4-2 fly lines have had GFP-
Fizzy successfully inserted into the B4-2 background, showing a clear band 
detected by anti-Fizzy antibody at the position of GFP-Fizzy and only displaying 
approximately 17.1% endogenous Mps1. A similar level of Mps1 remaining in 
the TM2-413;B4-2 line (approximately 16.5%), with this line clearly producing a 
band representing GFP-Mad2, as detected by anti-Mad2 antibody. The original 
B4-2 line displayed an average of 15.5% endogenous Mps1.  Beta actin was 
used as a loading control. Western blot analysis was carried out in triplicate, 
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with band intensities quantified using TINA software. Error bars represent 
standard deviation. 
5.2.8. Although GFP-Fizzy is recruited to kinetochores at normal levels, 
and GFP-Mad2 can be weakly detected in the absence of 84% endogenous 
Mps1, the spindle assembly checkpoint is defective. 
With colchicine treatment of third instar neuroblast from both TF4 GFP-Fizzy 
and TM2-413 GFP-Mad2 control lines, cells arrest at metaphase with strong 
kinetochore localisation of fusion proteins, indicative of a functional spindle 
assembly checkpoint with their expression in a wild-type background. When the 
fusion proteins are expressed in the B4-2 background, as TF4-B4-2 and 
TM2413-B4-2, colchicine treatment of third instar neuroblasts failed to arrest 
cells at metaphase (Fig. 5.8). Instead, cells progress through metaphase but fail 
to divide properly. The striking GFP-Mad2 kinetochore localisation observed 
with colchicine treatment of the TM2-413 control line is not observed when the 
fusion protein is expressed in the B4-2 background. Failure of cells to arrest at 
metaphase in the presence of colchicine indicates that with an 84% reduction of 
endogenous Mps1, even though Fizzy localises to kinetochores properly, and 
some GFP-Mad2 localisation can be detected, the spindle checkpoint fails to 
produce an anaphase-wait signal and so can be considered defective. 
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Figure 5.6. The level of kinetochore localisation of Fizzy during metaphase is 
not affected by reduction in Mps1 (ald) expression. 
(A) During metaphase, Fizzy in Mps1-mutant third instar larvae neuroblasts is 
localised to kinetochores. (B) The intensity of Fizzy at kinetochores in Mps1 
mutant TF4; B4-2 neuroblasts (in comparison to cytoplasmic levels) during 
metaphase, is comparable to that of wild-type TF4. Imaging was carried out 
using a Visitech spinning disk confocal microscope, with laser intensity and 
exposure settings standardised for the collection of comparable images. Twenty 
metaphase cells were quantified in each case. Kinetochore intensity was 
quantified using MetaMorph software. Error bars represent standard deviation. 
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Figure 5.7. Kinetochore recruitment of GFP-Mad2 is decreased by almost 80% 
in the B4-2 background. 
(A) Images of neuroblast cells in metaphase. GFP-Mad2 in the wild-type 
background (left panel) is strongly recruited to kinetochores with colchicine 
treatment, whereas in the B4-2 background (right panel) GFP-Mad2 kinetochore 
localisation is dramatically reduced. (B) An example of the regions used to 
quantify kinetochore localisation using MetaMorph software. (C) Graph to show 
quantification results for GFP-Mad2 fluorescence intensity at kinetochores in the 
wild-type and mutant B4-2 backgrounds, in colchicine-treated neuroblast cells. 
In the B4-2 background, only 20.5% of wild-type levels of GFP-Mad2 is 
recruited to kinetochores.  Error bars represent standard deviation. 
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Figure 5.8. With depletion of Mps1, neuroblasts treated with colchicine fail to 
arrest at metaphase, indicating that the SAC is ablated. 
 
Almost immediately after colchicine treatment, TF4 and TM2-413 neuroblasts 
display cells arresting at metaphase, with visible kinetochore localisation of 
Cdc20 (Fizzy) and Mad2, respectively (see red arrows, rows 1 and 3). In the 
B4-2 background, cells fail to arrest with 10µM colchicine after 175 min. 
Kinetochore recruitment of Cdc20 can be observed in the TF-4;B4-2 line (red 
arrows), but cells progress through metaphase to anaphase, indicative of a 
defective SAC (second row, white arrows). Weak Mad2 kinetochore recruitment 
can be observed in the TM2-413; B4-2 line (forth row, red arrows), but again, 
even after 175 min, cells are not arrested by colchicine, and are able to bypass 
the SAC (forth row, white arrows). This indicates that in the presence of only 
~16% Mps1, and even with normal levels of Cdc20 kinetochore recruitment, 
and weak levels of Mad2 recruitment, the SAC is not capable of a normal 
response, and cells bypass the SAC under the treatment of colchicine. Cells 
were prepared for imaging as described in 2.7.10, with time-lapse movies 
captured using confocal microscopy incorporating Visitech spinning disk 
technology. A minimum of five neuroblasts per line were colchicine treated and 
observed for checkpoint response. Scale bar represents 2µ. 
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5.3.Discussion 
These data suggest that with a significant reduction in Mps1 expression, the 
Drosophila spindle assembly checkpoint is unable to function. Although 
approximately 16% endogenous Mps1 is expressed in the B4-2 fly lines used in 
this study, it is unable to support the SAC response, even if it is able to sustain 
normal kinetochore localisation of Fizzy, and a proportion of Mad2 kinetochore 
localisation. Until now no other reports as to the effect of Mps1 depletion on 
Cdc20 localisation have been made.  
Although the original B4-2 fly line was originally generated by Page et al, (2005) 
the line itself was never characterised fully. The 4% viability of B4-2 lines was 
reported (consistent with the findings of this study), but the actual Mps1 status 
was never confirmed using biochemical analysis. These data illustrate that the 
B4-2 lines, as well as those derived from it for use in this chapter, have 
approximately 16% endogenous Mps1 expression, a reduction of 84% in 
comparison to wild-type.  
The inability of B4-2 cells to retain a functional checkpoint with an 84% 
reduction of Mps1 is consistent with observations in other systems, as well as 
the observed reduction in Mad2 kinetochore recruitment. Previous reports 
indicated that without Mps1, Mad2 kinetochore localisation is abolished. This 
complete loss of Mad2 recruitment to kinetochores at metaphase was observed 
in the apparent absence of Mps1, not one simply subject to a vast reduction in 
its expression. The fact that the B4-2 lines still express approximately 16% 
endogenous Mps1 may provide an explanation for the weak Mad2 kinetochore 
signals observed in this study. Because a reduction in Mps1 expression 
appears to result in a reduction of Mad2 kinetochore recruitment, it cannot be 
ruled out that the relationship between Mps1 and Mad2 localisation is dose-
dependent, rather than Drosophila proteins behaving slightly different to human 
and Xenopus Mps1 and Mad2. In order to determine whether the weak Mad2 
kinetochore signals were a result of the small amount of Mps1 remaining in B4-
2 cells, fly lines completely null for Mps1 would have to be generated or Mps1 
knockdown could be attempted in Drosophila S2 cells by dsRNAi. Either 
approach was too time consuming to be carried out as part of this thesis, as no 
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null fly lines are available at present, and as the Mad2 antibody available is 
unsuitable for immunostaining, S2 cells would need to be generated which 
express GFP-Mad2 before dsRNAi could be performed. Even then, a total 
knockdown of Mps1 would not be guaranteed.  
It should be noted that previous reports into the loss of SAC function in the 
absence of Mps1 in Xenopus suggested that this could be attributed to loss of 
proper localisation of checkpoint proteins including Mad2 and Bub1.  It could be 
speculated that without Mps1, if Mad2 and BubR1 are not recruited to 
kinetochores, formation of the MCC would not occur. This hypothesis was 
tested with the use of co-immunoprecipitation experiments, which implied that 
MCC formation was disturbed in the absence of Mps1. With regard to the role of 
failure of Mad2 to localise to kinetochores, as a potential cause of loss of 
checkpoint arrest, colchicine treatment of the TM2-413;B4-2 line display that, in 
Drosophila, the defective checkpoint is not coupled with a total loss of Mad2 
kinetochore localisation. The exact level of Mad2 required to be recruited to 
unattached kinetochores in Drosophila cells in order to allow SAC arrest in the 
presence of colchicine is not known. It can therefore not be ruled out that the 
decreased Mad2 kinetochore localisation observed in B4-2 lines is not enough 
to allow sufficient MCC formation. It also, however, cannot be ruled out that the 
decreased kinetochore localisation of Mad2 with the depletion of Mps1 is not 
the cause of the loss of checkpoint function. 
Another possible explanation for the ability of Mad2 association with 
kinetochores to a lesser extent in the relative absence of Mps1, relates to a 
recent publication using chemical inhibition of Mps1, in which it was speculated 
that only the recruitment of O-Mad2 to kinetochores was affected (Hewitt et al, 
2010). Without further investigation it cannot be ruled out that this is also the 
case in Drosophila, and that the Mad2 observed at kinetochores in the B4-2 
background relates to C-Mad2.   
A previous publication from our lab has provided evidence that, in Drosophila, it 
is BubR1 and not Mad2 that is required for kinetochore localisation of Fizzy. 
This paper proposes that Mad2 may act to retain Fizzy localisation on 
kinetochores rather than be required for its localisation there (Li et al 2010). The 
mechanism by which Mad2 may act to sustain Fizzy localisation at kinetochores 
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is yet to be investigated, but it could be presumed that a physical presence of 
Mad2 at kinetochores is likely. If this were to be the case, could the small 
amount of Mad2 which localises to kinetochores be capable of retaining Fizzy 
localisation? It would be interesting to see whether in an instance whereby 
Mad2 kinetochore localisation is abolished, rather than reduced, Fizzy 
kinetochore levels would still be comparable to wild-type. Again, it is possible 
that a fly line completely null for Mps1 could provide this scenario, allowing us to 
determine whether, if Mps1 expression was completely abolished, Mad2 
kinetochore localisation would also be abolished in a dose-dependent type 
fashion, and the result this may have on the ability of Fizzy to remain at the 
kinetochore. Studies in humans and Xenopus which claim to have knocked out 
Mps1 and observed abolished Mad2 kinetochore localisation and Mad2-Cdc20 
and BubR1-Cdc20 interaction (Xu et al, 2009) failed to investigate any effects 
this may have on Cdc20 localisation to, or sustenance on, kinetochores.   
The generated B4-2 lines did not allow for analysis of BubR1 kinetochore 
localisation. Unfortunately, the BubR1 antibody generated for use in this thesis, 
is not pure enough to be used in the immunostaining of neuroblast cells, and so 
this technique could not be used to determine whether BubR1 localises to 
kinetochores in the absence of 84% endogenous Mps1. Genetic techniques 
were used to attempt to cross RFP-BubR1 into the B4-2 background, but 
unfortunately the generation of this line was unsuccessful. It would be 
interesting to see whether BubR1 recruitment to kinetochores in the B4-2 
background is disturbed. If BubR1 and the majority of Mad2 is not recruited to 
kinetochores, but Fizzy kinetochore recruitment is not perturbed, co-
immunoprecipitation experiments to detect the binding of checkpoint proteins to 
Fizzy could be carried out to determine if protein-protein interactions have been 
abolished. This may also provide data into the ongoing debate as to whether 
Mad2 is actually part of the MCC complex (as proposed by Pines et al, 2008) 
and whether MCC can form in the absence of direct kinetochore interaction of 
all components.   
In conclusion, fly lines have been developed which allow for an initial 
investigation into the role of Mps1 in SAC signalling. Mps1 appears to be 
essential for a functional spindle checkpoint in Drosophila. With only 16% 
endogenous Mps1 present, Fizzy can effectively localise to kinetochores 
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whereas Mad2 kinetochore levels are decreased (although not abolished), yet 
cells do not display a checkpoint-induced metaphase arrest in response to 
colchicine treatment. It is unclear as to whether BubR1 kinetochore recruitment 
is affected by depletion of Mps1 in Drosophila, and whether the reduction of 
Mad2 at kinetochores is Mps1 dose-dependent. It cannot, therefore, be ruled 
out that the remaining 16% Mps1 in the B4-2 lines may be sufficient for enough 
Mad2 to be recruited to kinetochores to sustain the kinetochore recruitment of 
Fizzy. Further investigation must be carried out in the future to determine the 
effects of a null-Mps1 background on SAC protein kinetochore localisation, and 
how this can account for the observed checkpoint failure through biochemical 
analysis of disruption to protein-protein interactions within the MCC. As this 
aspect has been recently covered using other models, focussing on the 
potential dose-dependent effect of Mps1 on Mad2 localisation, or the previously 
proposed stabilisation role of Mad2 of Fizzy at kinetochores, may be of use in 
our current understanding of SAC signalling.    
 
 
 
 
 
 
 
 
 
 
 
 
159 
 
Chapter 6. Discussion 
The role of Cdc20 kinetochore localisation in formation of the MCC is a topic 
within the SAC response which remains poorly understood. Whether the 
complex is capable of forming in part or in full before localising to the 
kinetochore, or whether all components must localise to and directly interact 
with kinetochores for complex formation, is yet to be established. The 
interactions between Cdc20 and other MCC components has been linked to a 
number of conserved domains, such as the BubR1 KEN box, and 
phosphorylation sites within Cdc20 itself, as well as the localisation of the other 
MCC components and the requirement of other upstream factors in the 
signalling cascade. The importance of these conserved residues/domains within 
key SAC proteins is yet to be verified in Drosophila.  
Transgenic approaches in the investigation of specific residues, domains or 
upstream proteins which are implicated in the interaction between Cdc20 and 
other MCC components, could provide useful in establishing the link between 
their ability to interact with one another in relation to their ability to localise to 
kinetochores during mitosis. By potentially generating fly lines whereby the 
localisation of Cdc20 and other MCC proteins prevents their physical interaction 
at kinetochores, the kinetochore-dependent model of MCC formation (see 1.17) 
could be elegantly tested, with the localisation of proteins of interest available 
for imaging  within living cells. 
A recent publication from our lab (Li et al 2010) demonstrated that, in 
Drosophila, BubR1 appears to be more prominent than Mad2 in the localisation 
of Cdc20 to kinetochores, with depletion of BubR1 resulting in loss of Cdc20 
kinetochore association and ablation of the SAC response. Although these 
findings provided a system whereby Cdc20 kinetochore localisation was 
disrupted, potentially as a result of the loss of kinetochore-dependent MCC 
formation, the specific mechanisms and domains involved in the key 
interactions required for the incorporation of Cdc20 into this complex had not 
been investigated in this model organism.  
For the first time in Drosophila, this study builds upon current understanding of 
the key SAC proteins required in the checkpoint response, confirming a role for 
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specific residues within Cdc20 in its interaction with other MCC components, 
particularly BubR1, which could potentially be attributed, at least in part, to its 
phosphorylation by Cdk1. In addition to the role of Cdc20 phosphorylation in its 
incorporation into the MCC, we verify the requirement of the single conserved 
N-terminal BubR1 KEN-box motif in the Cdc20-BubR1 interaction. We also 
highlight the importance of Mps1 in the SAC response, and establish Drosophila 
lines capable of providing evidence of the requirement for Mps1 in checkpoint 
activation, as well as any role it may have in the localisation of Cdc20 and 
Mad2.  
It is widely accepted that in human cells, the phosphorylation of Cdc20 by 
protein kinases including MAPK, Cdc2 protein kinase Cdk1 and the SAC protein 
Bub1 (Tang et al., 2004a) are required for an active SAC. Studies in Xenopus 
confirmed that conserved sites within the N-terminal of Cdc20 are 
phosphorylated by Cdk1, mutation of which renders the checkpoint inactive. 
Ablation of these sites also decreased the interactions between Cdc20-BubR1 
and Cdc20-Mad2 (Chen et al 2003, Kramer et al 2000). Although these studies 
provide evidence of the role of Cdc20 phosphorylation in MCC formation, 
whether this is a result of failure of non-phosphorylatable Cdc20 to localise to 
unattached kinetochores was never explored. Three of the sites investigated in 
human and Xenopus studies are also conserved in Drosophila Cdc20, although 
whether they behave in a similar fashion to their human and Xenopus 
counterparts has until now, never been tested. The data presented in Chapter 3 
confirms that the three conserved residues (Thr63, Thr78, and Thr82) within 
Drosophila Cdc20 are phosphorylated by Cdk1. Mutation of these three 
residues reduced the overall phosphorylation of Cdc20 by approximately 69% 
(Fig. 3.3), implicating Cdk1 as a key kinase in the phosphorylation of Cdc20, 
specific to the three aforementioned conserved threonine residues.  
Immunoprecipitation experiments which probed for interaction of SAC proteins 
including Mad2 and BubR1 with the triple mutant Cdc20 (Figs. 3.4 & 3.5) are 
consistent with that observed in other systems, in that with ablation of Cdk1 
phosphorylation, the interaction with other MCC components is reduced. This 
was particularly apparent in BubR1, in keeping with previous implications into its 
prominent role in Cdc20 function (particularly localisation) as opposed to Mad2 
in Drosophila (Li et al 2010). The fact that the effect on the Cdc20-Mad2 
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interaction is less significant in embryos synchronised in mitosis (Fig. 3.5) is 
potentially interesting, in that it could correlate to the hypothesis that Mad2 may 
not be required for Cdc20 localisation to kinetochores in response to SAC 
activation, or potentially be required as part of the initial MCC. Instead, it may 
assume a role in maintaining Cdc20 at kinetochores (Li et al 2010, Pines et al, 
2009). In order to form a more specific hypothesis as to the incorporation of 
Mad2 into the MCC in Drosophila mitosis, further investigation would be 
required. With regard to the interaction of Cdc20 with the APC/C, these data 
suggest that the phosphorylation of Cdc20 is not required for the APC/C to 
interact with its activator, and that phosphorylation of Cdc20 at Thr63, 78, and 
82 are not required for normal mitotic progression.  
We were unable to verify whether the 69% reduction in Cdc20 phosphorylation 
caused by ablation of Thr63, 78 and 82 will disrupt the kinetochore localisation 
of Cdc20. Consequently, we were unable to verify whether any of the interaction 
results observed are due to the physical location of Cdc20 protein. However, 
this chapter still provides strong evidence for a role in Cdk1 phosphorylation in 
the formation of the MCC within the Drosophila SAC response.  
Although these data strongly suggest that Cdc20 phosphorylation by Cdk1 is 
required SAC for signalling, many other conserved regions exist within SAC 
proteins which are equally as likely to have a key role in protein function, and 
subsequently, the SAC response. Other key residues implicated in the 
incorporation of Cdc20 into the MCC, with regard to the Cdc20-BubR1 
interaction, reside within the single N-terminal Drosophila BubR1 KEN-box 
conserved from humans to yeast. Our lab has already determined that BubR1 is 
required for the localisation of Cdc20 to the kinetochore, however, the essential 
region of BubR1 required for this was undetermined.  To be able to generate 
transgenic fly lines in which BubR1 lacks an intact N-terminal KEN-box would 
provide an opportunity to determine the effect of the loss of this domain in the 
localisation and behaviour of Cdc20 in the future. Before embarking on a 
transgenic approach, we developed bacterial and yeast three hybrid systems 
whereby the importance of the BubR1 KEN-box can first be verified. During the 
course of these studies, the requirement of an intact N-terminal KEN box in the 
Cdc20-BubR1 interaction was proven in yeast (Hardwick et al 2010), but until 
now the role of the BubR1 KEN-box in Drosophila had never been tested.  
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In support of recently published findings in yeast, the data presented within 
Chapter 4 demonstrates a role for the N-terminal BubR1 KEN-box in the 
interaction between Cdc20 and BubR1, implicating it as a potentially essential 
motif in MCC formation in Drosophila. The requirement of Mad2 in this 
interaction is not apparent (Fig. 4.11), but without further investigation could not 
be ruled out as previous reports in other systems into the Cdc20-BubR1 
interaction have implicated Mad2 as essential  (Davenport et al, 2006). Based 
upon these findings, the generation of BubR1 KEN-box mutant fly lines, carrying 
GFP-Cdc20 for localisation analysis, are in progress by other lab members.  
A transgenic approach to the role of Mps1 in the SAC response with regard to 
localisation of Cdc20 and Mad2 was employed in the data presented throughout 
Chapter 5. With the incorporation of GFP-Fizzy and GFP-Mad2 fusion proteins 
into the Mps1 B4-2 weak allele line, a system was established, characterised 
and employed to verify the essential nature of Mps1. Previously, the effect of 
Mps1 depletion on SAC signalling had not been explored in Drosophila, but 
these data show that with depletion to approximately 16% wild-type levels of 
endogenous Mps1, the SAC is ablated. This was not unexpected, due to the 
lethal nature of the generated lines. It is clearly observed that when neuroblast 
cells which exist in the B4-2 background are treated with colchicine, the cell 
cycle fails to arrest at metaphase. Colchicine-induced metaphase arrest is 
clearly observed in control cells, consequently it can be assumed that Mps1 is 
essential in the Drosophila SAC, in accordance with research in Xenopus. 
Cdc20 localisation is unaffected by reduction in Mps1. It is likely that this would 
also be the case if Mps1 levels were completely abolished, but it cannot be 
ruled out that 16% endogenous Mps1 is sufficient to support Cdc20 localisation. 
No data as to the requirement of Mps1 in Cdc20 localisation in Drosophila or 
other models has been published. In order to verify this, dsRNAi experiments in 
S2 cells, staining for Cdc20 protein could be carried out, although this is not 
something currently available in our lab. Other approaches, including chemical 
inhibition of Mps1, could be used, but the specificity of such inhibitors has never 
been tested in Drosophila. 
 Mad2 kinetochore localisation is greatly decreased with reduced levels of Mps1 
(Fig. 5.7), although, not completely abolished. Approximately 20.5% Mad2 is 
capable of localising to kinetochores in the presence of 16% endogenous Mps1. 
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Whether this is indicative of a dose-dependant relationship between Mps1 and 
Mad2, or whether Mps1 is only required for the localisation of one of the two 
forms of Mad2 (Hewitt et al, 2010) would require further investigation. It would 
also be interesting to establish the behaviour of BubR1 in this B4-2 weak allele 
background. Unfortunately, attempts to generate this line (J. Huang) were 
unsuccessful.  
Overall, the data presented in this thesis present some novel results with regard 
to essential domains potentially required for MCC formation in Drosophila, 
having established systems which can be used for further investigation into 
whether Drosophila MCC forms in a kinetochore-dependent manner. Future 
direction includes the confirmation of the effect of mutation to the three 
conserved potential Cdk1 phosphorylation sites (Thr63, 78 and 82) on the 
localisation of Cdc20, as well as the role of the BubR1 KEN-box motif in 
localisation of both BubR1 itself and Cdc20. Once determined, current data into 
the interaction between SAC components under these conditions will become 
more meaningful with regard to the requirement of direct kinetochore 
localisation.  The role of Mps1 in the Drosophila SAC is apparent, and it would 
be interesting to include BubR1 analysis in this system. As verification of the 
Mad2 template model is key in the understanding of MCC formation, and the 
potential exists in the Mps1-null background to investigate differences in the 
localisation or maintenance of kinetochore signal between the different forms of 
Mad2, there appears to be a place for further research into verification of this 
hypothesis within investigation of the SAC response in Drosophila. 
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